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ABSTRACT 
Microglia perform a variety of functions both during development and throughout life, 
including regulating neuronal survival and death, synaptogenesis, angiogenesis and 
responding to brain injury. They are also involved in the acute and long-term responses to 
satiety signalling that become disrupted in overweight and obesity. Obesity is becoming a 
worldwide epidemic in today’s society. The prevalence of overweight and obese children is 
particularly concerning as the rate of childhood obesity is increasing. Obesity leads to a 
higher risk of developing short and long-term obesity-associated disorders, such as type 2 
diabetes, cardiovascular diseases, cognitive dysfunction, as well as increased susceptibility to 
infections. Obesity, in both children and adults, is associated with chronic low-grade central 
inflammation with an increase in microglial number and activity. However, it is not 
completely known how this activated microglial profile impacts childhood obesity and the 
effects on learning and memory.  
 
Here we used an established animal model of childhood obesity in rats to investigate 
microglia’s function in establishing and maintaining obesity-associated comorbidities. This 
model induces litter manipulations so that pups are suckled in small litters (of four rats) to 
allow neonatal overfeeding or control litters (of 12 pups). This neonatal overfeeding model 
allows a reduced competition for consumption of milk therefore inducing an accelerated 
growth and weight gain that persists at least into young adulthood. We have previously 
identified that rats suckled in small litters during development have a pro-inflammatory 
profile with an increase in microglial number and density in the hypothalamus. Using this 
model, we examined whether this pro-inflammatory profile seen in the neonatally overfed 
adult rats would extend into extra-hypothalamic regions, such as the hippocampus, and 
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impair learning and memory. We found that neonatal overfeeding induces microgliosis in the 
hippocampus during development and this persists into adulthood. To assess cognitive 
function in the neonatally overfed rats, we examined working memory in the novel object 
recognition task (NOR) and spatial memory in the delayed win-shift radial arm maze (RAM). 
Hippocampal microgliosis in our neonatally overfed rats was associated with poor 
performance in both the NOR and RAM tasks relative to controls. Interestingly, in control-
fed rats, the RAM learning task reduced cell proliferation in the dentate gyrus and neuronal 
numbers in the Cornu Ammonis (CA)3 as well as suppressed the microglial profile in the 
hippocampus and retrosplenial cortex. The neonatally overfed rats showed an impaired 
sensitivity to learning with a less effective microglial suppression and no neuronal or cell 
proliferation effects. Thus, neonatal over nutrition impairs learning and memory with a role 
for microglia.   
 
Subsequently, we investigated whether this hippocampal microglial profile induced by early 
life over nutrition would cause a hyper-activated response to a lipopolysaccharide (LPS) 
stimulus and whether this inflammation could be prevented by early life minocycline, a 
tetracycline antibiotic known to inhibit microglial activity. We found that neonatally overfed 
adult rats were hyper-responsive to an immune challenge, LPS, inducing a dramatic increase 
in the number of hippocampal microglial cells compared to control-fed rats. We also 
demonstrated that repeated neonatal injections, regardless whether with minocycline or with 
saline, markedly suppressed microglial number and density throughout the hippocampus, 
completely abolishing differences between the neonatally overfed and control-fed groups in 
responses to LPS. Collectively, this suggests that the neonatal nutritional environment can 
have long-term effects, including effects on the hippocampal immune responses in adulthood, 
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but also that exposure to a repeated injection protocol during development, irrespective of 
treatment, has prominent long-term impact on the microglial profile.  
 
The initial studies performed in this project outlined that microglia play an important role in 
cognition, showing that a reduction in microglial number and density in the hippocampus and 
retrosplenial cortex is necessary to learn a spatial task. Therefore, we generated a conditional 
microglial ablation model in rats (Cx3cr1- Dtr (diphtheria toxin receptor) model) to 
investigate whether specific depletion of microglia would alter learning and memory. Under 
basal conditions, insertion of Dtr on the promoter for the Cx3cr1 gene did not affect the 
microglial or monocyte profile. We also established that exposure to diphtheria toxin (DT) 
induced microglial depletion within 48 hrs of DT administration and microglial repopulation 
after 7 days. We identified that depletion of microglia did not alter cognitive function in a Y 
maze or NOR task. However, microglial repopulation transiently enhanced working memory 
in the NOR and novel place recognition tasks and this was associated with alterations in both 
immature and mature neuronal numbers in the hippocampus.  
 
Using this microglial ablation model, we have also revealed a novel role for microglia in 
acutely regulating feeding and metabolism. We demonstrated that microglial depletion 
induced acute weight loss and reductions in food intake. Further investigations into how 
depletion of microglia induced anorexia revealed that these Cx3cr1-Dtr rats did not display a 
sickness response and that despite the acute and reversible anorexia and weight loss, these 
rats had enhanced orexigenic signalling after elimination of microglia.  
 
Findings from this thesis indicate that microglia have additional roles outside of the 
historically-described functions. This includes acute and long-term responses to overfeeding, 
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as well as acute regulation of cognition and satiety signalling. The findings provide further 
insight into how microglia can affect cognition and responses to an immune challenge during 
childhood obesity and into how they can acutely influence satiety signalling.  
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CHAPTER 1 
Introduction and Background 
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Microglia are resident innate immune cells of the central nervous system (CNS). A physical 
barrier, known as the blood-brain barrier (BBB), is created during development which 
restricts these cells to the brain. Microglia are known to be a long-lived cell population that is 
capable of division and self-renewal during life without contribution from circulating blood 
cells under physiological conditions (1). These cells are in direct contact with and interact 
with neurons and synapses, as well as other glial cells in the CNS parenchyma (2-4). 
Microglia perform a variety of functions both during development and throughout life such as 
regulating neuronal survival and death, synaptogenesis, angiogenesis and responding to brain 
injury.  
 
1.1. The origin of microglia  
Microglia were first identified in 1899 by Franz Nissl and W. Ford Robertson and were 
described as “reactive glial elements” and “mesoglia” respectively (5). Although Robertson’s 
microglial origin hypothesis was later supported, it was proven that the “mesoglia” cells he 
described were in fact oligodendrocytes (6). The term microglia was invented by Pio del Rio-
Hortega in the 20th century, who described their activation in response to brain injury, their 
non-neuronal elements that were distinct from the neuroectodermal macroglia; 
oligodendroglia and astroglia, and their origin from the mesoderm (5, 7, 8). Throughout 
microglia’s history, there have been two main hypotheses of the origin of microglia. The first 
being that microglia originated from the mesenchyme, i.e. from subependyma adjacent to the 
lateral ventricles (9), from blood vessel-associated pericytes (10, 11). The second hypothesis 
was that microglia originate from yolk-sac macrophages (12).   
 
Although, at the time, neither of these hypotheses were experimentally verified, the first 
hypothesis was supported by a large number of scientists. It was proposed by del Rio-Hortega 
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that microglia were derived from the mesenchyme as microglia show similar features to 
blood leucocytes (8). Despite demonstrating that myeloid cells and microglia share particular 
enzyme expression such as acid phosphatase, non-specific esterase and nucleoside 
diphosphatase as well as the ability to bind the same lectins, this hypothesis was 
experimentally verified to be incorrect. Ashwell et al. discovered that microglia appear in the 
CNS prior to the development of cerebral blood vessels and before the production of 
monocytes in hematopoietic tissue, therefore they postulated that microglia may originate 
from undifferentiated hematopoietic precursors that enter the developing CNS (13). Alliot et 
al. detected developing mouse neuroepithelium at embryonic day (E) 8.5/9, which has the 
ability to differentiate into microglial-like cells (Mac-1+, Mac-3+, F4/F80+ and Fc-R+) (12).  
 
It was now becoming increasingly evident that the yolk-sac origin theory may correctly 
describe the site of origin for microglia and microglial progenitor cells. Alliot and colleagues 
demonstrated that in mice at E8.5/9, microglial progenitors were the only hematopoietic site 
in the embryo therefore leading to the conclusion that microglial precursor cells move from 
the yolk sac into the mesenchyme of the developing brain and become established in the 
neuroepithelium (12). It was found that these cells move into the mesenchyme initially via 
interstitial migration and later through the blood circulation (12). The presence of microglia 
in the brain at E8.5/9 in mice precedes haematopoiesis in other regions of the embryo such as 
the aorta-gonad-mesonephros region at E10.5 (14). This yolk-sac origin hypothesis has been 
illustrated in humans and some other species, including rodents. In humans, amoeboid 
microglial cells, starting at 4.5 weeks of gestation, express microglial markers such as ionized 
calcium-binding adapter molecular (Iba-1), Cluster of differentiation (CD)68, CD45 and 
Major Histocompatibility-II in the cerebral wall from the ventricular lumen and the 
leptomeninges (15).  
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1.2. Microglia morphology throughout the brain 
Microglia make up approximately 5-15% of cells within the human and rodent brain (16). 
The cell morphology differs throughout the brain depending upon the tissue type, region, age, 
sex and presence or absence of an immune challenge or injury (5). In the adult CNS, more 
microglia are found within the grey matter than the white matter (17). Grey matter microglia 
typically have a round soma and radial branching “ramified” processes whereas microglia in 
white matter have an elongated soma and processes orientate along fibre tracts (17). For 
example, in circumventricular and periventricular regions, where the BBB is devoid or leaky, 
microglia have a more compact morphology with fewer, shorter processes (17).  
 
 It was previously thought that, under static conditions, there are only two morphological 
phenotypes, resting or activated. A ramified morphology was often referred to as resting or 
quiescent and these cells would have a small soma and long thin processes under 
physiological conditions. Under a pathological condition, e.g. an immune challenge, the 
microglia would transform into an active or amoeboid morphology without processes and 
with a large soma. However, it is becoming increasingly evident that under physiological 
conditions, microglia are not resting but in fact monitor their environment and regulate 
homeostasis through scavenging functions and are now considered to be in a surveillant state 
(18-21). Thus, in adulthood, microglia are highly motile, with continuous extension and 
retraction of their thin long processes at a rate of 1.47 µm/min, while the soma remains 
relatively stationery (18, 19). It is suggested that this patrolling activity may detect danger 
signals appearing in the parenchyma very rapidly, as shown by two different groups in 2005. 
Both articles illustrated that microglial cells rapidly extend their processes toward either a 
laser lesion (considered an alarm signal) or to a local application of ATP (acting as a 
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chemoattractant) (18, 19). Furthermore, purinergic P2Y12 receptors and adenosine A2A 
receptors and their corresponding signalling pathways may control the oriented motility of 
microglia processes (22-24).  
 
1.3. Microglial embryonic brain development  
During embryonic development, the brain is the first organ colonized (25-27). Thus, yolk-sac 
derived microglia precursors start to migrate and colonize the mouse embryo between E8 and 
E10 (14, 28) and at E4.5 to 5 weeks in humans (15). Microglia’s invasion pattern during early 
embryonic development in the CNS is thought to occur in two waves (29). The first wave 
involves an initial gradual infiltration of microglial progenitors to colonize the brain 
occurring around E8.5 and E14.5 in mice (12, 29) and around E4.5 to 6 weeks in humans 
(15). This initial increase in microglial cells, which have an amoeboid morphology, is caused 
by a quick proliferation of already entered microglia as well as the invasion of new microglia 
precursor cells (15, 29). During this first wave, there is initially no vascular network until 
around E9.5 in mice (30, 31), thus, suggesting that microglia invade the brain via 
extravascular routes (32, 33). Monier and colleagues have shown that in humans, blood 
vessels gradually appear in the cerebral wall at E6 weeks but there are very few microglial 
cells at this stage (15). Interestingly, there is evidence suggesting that invasion and 
distribution of microglia may follow cues from neurons undergoing apoptosis (13, 29). 
During both embryonic and postnatal development, microglial cells are attracted by 
programmed cell death (PCD) of proliferating and post-mitotic neurons due to the 
overproduction of neurons during development and from their competition for survival 
(reviewed by (34)). This hypothesis has been confirmed by Xu and colleagues who have 
shown that microglia colonization of the zebrafish optic tectum was promoted by apoptotic 
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neurons (35). It is likely that apoptotic signals play a similar role in mammals, as mice 
microglia have also been found in areas of cell death (13, 29).  
 
The second wave of microglial cell influx occurs between E14 and E16 in the mouse and 
between E9 and 13 weeks in humans (15). The numbers of microglia in the brain increase 
rapidly at this time, with these cells now deriving from local proliferation and from a second 
wave of progenitor cells entering from the periphery (29). From around E17.5 in rodents and 
through the remainder of embryonic development, microglia disperse from the 
neuroepithelium and are redistributed in a non-uniform manner in a rostral to caudal gradient 
(13, 29).  
 
The third and final stage of microglial development occurs during the postnatal development 
period at around 4 weeks of age in mice. During this period and throughout life, microglia 
proliferate and self-renew, maintaining the cell population with no assistance from bone-
marrow derived macrophages (1, 36). Later microglial migration and early brain distribution 
are also likely regulated by neuronal-microglial signalling through, for instance, 
Cx3cl1/Cx3cr1 interactions; the former, c-x3-c motif ligand 1 (fractalkine), expressed by 
neurons and the latter, its receptor, expressed by microglia (37, 38). During the final stage 
and throughout life, microglia appear adult-like in morphology and distribution (39). There is 
a 2.2-fold increase in microglial numbers during this postnatal period, peaking at postnatal 
day (P)14 (40). Refinement of microglial cell numbers to the density maintained throughout 
adulthood is achieved by P42 (40, 41). 
 
Alongside morphological changes as microglia mature, the development of these cells follow 
specific temporal and region-specific changes in gene expression (42). For instance, early 
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microglia have an amoeboid morphology and elevated expression of cell cycle and 
differentiation genes, while neuronal gene expression peaks during the pre-microglial stage a 
few days before birth and these cells have a more ramified morphology. This expression is 
relatively reduced by adulthood (42). Interestingly, microglia reach their adult transcriptional 
identity by the second postnatal week of life (43). Matcovitch-Natan and colleagues have 
hypothesised that genetic and environmental perturbation can cause disturbances in the 
microglial environment, in stage-related expression profiles, which can disrupt the timing of 
microglial developmental programs and alter proper brain development (42). This idea is 
supported by studies which show that perinatal infection particularly effects the outcomes of 
brain development and determines the specificity of brain pathology (44-47). 
 
Interestingly, invasion of microglia into the brain and spinal cord parenchyma occurs 
simultaneously, however, these two areas of the CNS have different developmental stages. 
Microglia begin to invade the parenchyma of the spinal cord at the end of the neuronal 
migration, when local neuronal networks become functional (48), whereas migration into the 
brain is only at the onset of neurogenesis (14, 29, 49). Therefore, it is plausible that 
embryonic microglia have different functions in the brain and spinal cord (29, 48). For 
example, microglia may influence neuro-, glio- and angiogenesis (14, 29, 49) in the brain but 
within the spinal cord could contribute to the first functional neuronal networks (48). 
 
1.4. Microglia’s role during neurodevelopment 
During embryonic and postnatal development, microglia regulate neuronal survival and 
programmed cell death, synaptogenesis, axonal tract development and angiogenesis (Figure 
1.1. (24)).  
 
	 	
12	
	 	
 
Figure 1.1. Microglia functions in the CNS. (A) Microglia are aligned along the axonal tracts, supporting 
their development. (B) Microglia refine neuronal networks by promoting programmed cell death and 
phagocytosis. (C) Microglia regulate synapse formation and pruning, through the removal of synaptic spines. 
(D) Microglia express pattern recognition receptors, such as toll-like receptor (TLR) 4, that recognize pathogen- 
and danger associated molecular patterns (PAMPS and DAMPS); evolutionarily conserved structures on 
pathogens. Activation of these receptors triggers intracellular signal transduction, including transcription of 
nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB), leading to release of pro-inflammatory 
cytokines (24). 
 
1.4.1. Synaptic refinement 
Microglial cells contribute to the refinement of synaptic networks and to the functional 
maturation of synapses during postnatal development (37, 38, 50, 51). During development, 
there is an overproduction of synaptic contacts, therefore, requiring the elimination of 
inappropriate supernumerary synapses resulting in functional maturation of the remaining 
appropriate synaptic networks (52).  
 
1.4.1.1. Synaptic pruning 
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Microglia’s role in eliminating supernumerary synapses during development has been 
extensively studied.  Tremblay and colleagues were the first to demonstrate that microglia 
play a role in the phagocytic engulfment of synapses in non-pathological conditions during 
the late stages of postnatal development via sensory deprivation (dark adaptation) during the 
critical period of the visual cortex development in juvenile mice (4). Phagocytosis of 
supernumerary synaptic elements has also been shown in the hippocampus during the first 
postnatal weeks of development in rodents via electron and stimulated emission depletion 
(STED) microscopy of excitatory post-synaptic density (PSD-95) and pre-synaptic terminals 
(SNAP25) in the cytoplasm of microglial cells, suggesting that microglial cells phagocytose 
the synaptic elements (37). Paolicelli et al. have also demonstrated that pruning of 
supernumerary dendritic spines was delayed in the hippocampus of Cx3cr1 knockout mice, in 
which there is a delay of microglial cell recruitment (37). These animals also displayed 
several immature functional properties of excitatory synapses (37, 51). Microglia have also 
been identified to play a role in synaptic pruning in the cerebral cortex in non-human 
primates (53, 54). For example, synaptic density in the cortex is highest at 2-3 months of age 
and then has a gradual suppression to approximately 70% at 6 months of life in the macaque 
and the marmoset (53, 55). Interestingly, the microglial activation profiles of marmoset 
match those from the mice studies in the hippocampus between P15-P30 (56).  
 
This pruning process and the contribution to the elimination of supernumerary synapses has 
also been reported in the retinogeniculate system. During development, the retinal ganglion 
cell inputs from both eyes overlap until the beginning of the second week of postnatal 
development in mice and are henceforth rearranged to eye-specific regions. This process 
involves selective pruning of projections and is known to be mediated by the activation of the 
complement pathway with microglial cells phagocytosing those synapses that localize the 
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complement cascade initializing protein q (C1q) and complement 3 (C3) (57, 58). This group 
has also shown that deficiencies in this pathway, either by eliminating the C3 receptor found 
on microglia or by a reduction of the neuronal ligands C1q or C3, can decrease synaptic 
pruning and reduce synaptic elimination inducing retinogeniculate projection segregation 
deficits which can be observed long term in the adult brain (50).  
  
1.4.1.2. Synaptic formation 
Alongside, microglia’s role in synapse elimination, it is now clear that these cells also 
influence synaptic formation and functional maturation of synapses. This microglial influence 
may occur through the release of growth factors and cytokines (59, 60). One specific 
mediator that has been shown to control the maturation of synaptic circuits is the growth 
factor brain-derived neurotrophic factor (BDNF). Parkhurst et al. were the first to show that 
microglial elimination in juvenile mice impairs the turnover of spines in the pyramidal 
neurons of the motor cortex (61). This reduction of dendritic spine formation was reproduced 
when they specifically knocked out BDNF in microglia, thus suggesting that production of 
this growth factor by microglia is essential for the formation of new spines in the neonatal 
cortex and this influences performance during motor learning and fear conditioning in 
adulthood (61). They also demonstrated that specifically knocking out microglial BDNF 
secretion reduces the expression of synaptic proteins including N-Methyl-D-aspartate 
(NMDA) receptor subunits (61). It can also be hypothesised that BDNF may be involved in 
the functional maturation of thalamocortical synapses in the barrel field of the primary 
somatosensory cortex (38). The development of the barrel field occurs during the first 
postnatal week in mice with microglial recruitment occurring at P6 (38). However, in Cx3cr1 
knockout mice, this invasion of the barrel cortex is delayed by two days and is associated 
with a delayed functional maturation of excitatory synapses of a-amino-3-hydroxy-5-methyl-
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4-isoxazolepropionic acid (AMPA) and NMDA receptors (38). It is therefore likely that 
microglial BDNF is responsible for the functional maturation of the thalamacortical synapses 
(62). 
 
Particular cytokines are known to impact synaptic functions and could therefore be 
considered as important microglia-dependent mediators during postnatal developmental 
synaptic maturation. Interleukin-1b (IL-1b) is a proinflammatory cytokine produced by 
microglial as well as other CNS cells.  Low levels of this cytokine under normal 
physiological conditions are required for normal learning and memory (63). Moreover, 
Cx3cr1 knockout mice, which show deficits in hippocampal synaptic plasticity and in 
cognitive functions, are rescued by antagonising IL-1b signalling (64).  
 
1.4.2. Microglia regulate neuronal cell survival and death 
There is evidence that microglial cells sustain the survival and proliferation of neurons during 
CNS development allowing integration into neuronal circuits. During embryonic 
development, an activated microglial morphology is generally linked with phagocytic 
functions (65). It has been demonstrated that during the late stages of cortical neurogenesis, 
phagocytosis of neural precursor cells (NPC) occurs (66). Moreover, there is a significant 
increase in the number of NPCs upon suppression of microglial activation or microglial 
depletion as a consequence of a reduction in phagocytosis (66). Interestingly, Uneo et al. 
reported that during early postnatal development microglia display a trophic action on 
developing neurons and promote the survival of cortical neurons in the subcortical white 
matter and this trophic action is due to the release of the insulin-like growth factor-1 (IGF-1) 
(67). 
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Additionally, during embryonic development, higher densities of microglial cells are 
observed alongside specific developing axonal tracts, particularly on dopaminergic axons 
(68). Dopaminergic pathways are involved in many functions, including executive function, 
learning, reward, motivation, and neuroendocrine control. Squarzoni et al. have shown that 
outgrowth of dopaminergic axons can be modified by changes to microglia. For example, 
elimination of microglia causes an increased dorsal outgrowth of these axons, whilst maternal 
immune activation restricts dorsal extension and is associated with a pronounced ventral 
increase of dopaminergic innervation (68). These observations suggest that microglial cells 
control tyrosine hydroxylase-positive dopaminergic axon extension through phagocytic 
activity at E14.5 as they enter the subpallium. Surprisingly, microglia do not contact adjacent 
serotoninergic axons on thalamocortical or corticothalamic neurons, indicating that the 
microglial control of axon outgrowth is specific to dopaminergic fibres (68). Altogether, 
these findings indicate that microglial cells have a regulatory role to control the number of 
neurons produced and maintained in the CNS during development. This regulation is 
achieved by microglia acting on the proliferation, the survival and the death of neural 
progenitors and maturing neurons.  
 
1.5. The role of microglia during adulthood 
1.5.1. Microglial function in response to injury in adulthood 
Microglia of the healthy CNS were originally observed under static conditions and were 
believed, based on morphology, to be “resting” or “quiescent”. Recent advances in imaging 
techniques have demonstrated that unstimulated microglia are under a surveillant state where 
the cells repeatedly examine and monitor the CNS milieu and that their processes and 
arborisation are highly mobile (18, 19). Thus, in adulthood, under normal physiological 
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conditions, the soma of microglial cells remains stationary whilst the processes undergo 
cycles of formation and withdrawal, coming into contact with other CNS cells such as 
astrocytes, neurons and blood vessels to monitor changes in the microenvironment (18, 19). It 
is therefore now well accepted that microglial cells are not resting but are continuously 
surveying the healthy CNS (69) where they remove metabolic products and deteriorated 
tissue components as well as preserving neural networks (19).    
 
Microglia’s role in CNS injury during development and adulthood is similar. Microglia 
typically extend their processes towards the site of injury in response to an immune 
challenge, pathogen or injury, whilst the soma remains stationary (18, 19). Some conditions, 
such as chronic stress, can lead to a hyper-ramified morphology (reviewed in (70)). 
Importantly, Karperien and colleagues have shown that it can be difficult to interpret static 
microglial morphology and there are no strictly defined categories to describe a microglial 
cell’s function based on its morphology (70). For example, a microglial cell with shorter, 
fewer processes may be retracting its processes and orientating to a stimulus or it may be re-
ramifying after recovery. Additionally, microglial cells may show functional changes in the 
absence of any detectable change in morphology (71).  
 
In response to acute injury, microglia phagocytose cellular debris, which can be seen in 
bulbous formations at their ends with in vivo two-photon live imaging (18, 19). This function 
is mediated typically by two types of receptors that respond to the “eat me” “don’t eat me” 
signals upon recognizing pathogen- and danger-associated molecular patterns on pathogens 
or from metabolic products or dying/dead cells (5, 72). The functional diversity of microglial 
cells is dependent on the specific stimulus. When stimulated by microbial components, such 
as lipopolysaccharide (LPS), a component of the cell wall of Gram-negative bacteria, 
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microglial cells react by activating a phagocytosis program including activation of toll-like 
receptors (TLRs) leading to transcription of pro-inflammatory mediators including cytokines 
(73). These cytokines have been found to be neurotoxic at high concentrations and also 
increase inflammation (e.g. tumour necrosis factor -a (TNF-a)) (74), induce fever and other 
aspects of sickness behaviour (e.g. IL-6). Cytokines also regulate presentation of cell surface 
molecules involved in microglial activation and microglial-neuronal interactions (e.g. 
interferon g (IFNg) (5)). Importantly, humans, unlike rodents, have relatively low microglial 
TLR4 expression and no detectable IFNg receptor expression. These differences need to be 
taken into consideration when translating rodent data to humans (75, 76). Alternative to this 
pro-inflammatory response, when microglial cells are challenged by apoptotic cells or myelin 
debris, they respond by releasing anti-inflammatory agents. This is achieved ultimately by 
secreting anti-inflammatory mediators to downregulate and reduce the effects of pro-
inflammatory cytokines and promote neuronal survival (77). Cytokines such as IL-10, IL-4 
and transforming growth factor (TGF)-b are anti-inflammatory and modify the cell surface 
receptor expression on microglia and also downregulate the expression or attenuate the 
effects of pro-inflammatory IL-1b and TNF-a (78). It has been speculated that this anti-
inflammatory response is achieved by phagocytosis of apoptotic debris by activation of the 
triggering receptor expressed on myeloid cells (TREM) receptors on microglia. The 
microglia are neuroprotective and phagocytose apoptotic debris thereby suppressing pro-
inflammatory mediator secretions and upregulate chemokine synthesis (79). Although the 
TREM2 signalling pathway is not completely known, it is thought that the clearance of 
apoptotic neurons is due to the interaction between TREM2 and microglia. This interaction 
and hence apoptosis of neurons occurs when DNAX activation protein 12 (DAP12) binds to 
F-actin and initiates phosphorylation of ERK1/2 (80). Thus, microglial responses to acute 
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injury are dependent on the specific stimulus such that TLRs respond to microbial stimuli 
whilst TREM2 receptors mediate protective phagocytosis of apoptotic debris.  
 
1.5.2. Microglial function in neuronal plasticity in adulthood 
Apart from a role for microglia in response to injury, they are also key modulators of 
synaptogenesis, synapse survival, neuronal maturation, and neuronal activity in adults (81). 
Under normal physiological conditions, neurogenesis has been found in the subgranular zone 
(SGZ) of the dentate gyrus (82, 83) and the subventricular zone of the lateral ventricles (84). 
Hippocampal neurogenesis is maintained by the proliferation of neural stem cells located in 
the SGZ (85, 86). Only a few newborn cells are incorporated into the circuitry, and majority 
of these newborn cells are presumed to die at the immature neuron stage (87). Sierra and 
colleagues have shown that unchallenged ramified microglia are an essential component of 
the neurogenic SGZ niche and that microglia physically intermingle with neuroprogenitors, 
neuroblasts and newborn neurons (88). Thus, newborn neurons undergo death by apoptosis in 
the first one to four days of their life and are rapidly cleared out through phagocytosis by 
ramified microglia (88).  
 
Hippocampal adult neurogenesis is modulated by activity-dependent plasticity and learning. 
These hippocampal learning behaviours have been found to regulate the survival of newborn 
neurons but this is dependent on the timing between the birth of these newborn cells and the 
phases of learning (89-91). During a water maze task, young newborn neurons were also 
shown to be preferentially activated during memory recall (92). Increased adult neurogenesis 
in the hippocampus has been associated with rewarding experiences such as environmental 
enrichment, mating or physical activity (93). Alternatively, aversive experiences commonly 
associated with microglial activation and inflammation such as stress, immune challenges, 
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aging or social defeat exposure tend to decrease the production of new neurons (94). For 
example, microglia can shape memory circuitry and excessive activation of complement 
genes can be altered by exposure to a virus leading to over-pruning and cognitive 
impairments (95).  
 
Recent advances in microglial transgenic models have enabled us to identify that microglia 
may not be essential for neurogenesis and synaptogenesis but rather may modulate and 
support these functions, however, there are conflicting results. Elmore and colleagues have 
shown that near complete microglial ablation in mice with a colony-stimulating factor-1 
receptor (CSF-1R) inhibitor did not negatively impact learning and memory (36), whereas, 
other work has shown detrimental effects on motor (61) and spatial memory (96). These 
differences could be accounted for by the timing of their repopulation into the brain as the 
Elmore study conducted behavioural tasks when microglia were still depleted (36), whereas, 
the other studies were performed two to four days after depletion, when microglia were 
already repopulating the brain (61). It has also been demonstrated that microglial ablation 
causes a reduction in dendritic spine formation and elimination, both in the neurons of the 
motor cortex (61) and olfactory bulb (97), whereas Rice and colleagues have demonstrated 
that ablation of microglia increases hippocampal dendritic spines (98). It should be noted that 
eliminations (reductions) in dendritic spines were found in 10-week old mice (97) whilst 
dendritic spine formations (increases) were during late adulthood (i.e., in 10-month old 
mice), suggesting that microglia may mediate age-associated spine pruning. However, this 
was not directly tested by this work.  
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1.5.3. Other microglial functions in adulthood  
There are additional roles of microglia during adulthood, however, these functions were not 
investigated in this thesis therefore will not thoroughly be addressed. As one example, 
microglia have been found to play a role in pain (reviewed in (99)). Briefly, microglia 
become activated in response to nerve injury via the production of mediators such as 
neuregulin-1, matrix metalloproteinase (MMP)-2, MMP-9 and chemokine ligand 2 (CCL2). 
Upon activation, microglia release pro-inflammatory cytokines such as IL-6, IL-1b and TNF-
a that further potentiate the painful symptoms (100-102). Microglia are also known to be 
involved in the development of depression affecting both mood and motivation (reviewed in 
(103)). Hippocampal degeneration and neuroinflammation, i.e. microglial activation and high 
concentrations of pro-inflammatory cytokines such as IL-6 and TNF-a, occur prior to the 
onset of depression (104, 105). Importantly, when this inflammatory response is blocked with 
anti-inflammatory factors such as indomethacin and minocycline, there is a reduction in 
depressive-like behaviours (106, 107). Ischemic stroke occurs when there is deprivation of 
oxygen and other nutrients to the brain. Microglia are known to play essential roles in the 
development and management in the pathological state (reviewed in (108)), with current 
literature suggesting that microglia have a biphasic role depending on the spatiotemporal 
evolution of the structural damage (109, 110). Initially, during the acute phase, microglia 
have a detrimental role, adopting an activated morphology and producing harmful pro-
inflammatory mediators which exacerbate ischemic injury (111). These cells then contribute 
to tissue regeneration during the post-acute phase, aiding in repair of the damaged region 
(109, 110).  
 
Microglia appear to be involved in feeding and satiety regulation, with a particular focus on 
obesity-induced neuroinflammation, which will be discussed below.  
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1.6. Obesity and neuroinflammation 
1.6.1. Incidence of adult-onset obesity and obesity-associated health risks 
Obesity is a metabolic disorder that is characterised by abnormal or excessive accumulation 
and storage of lipids in the body (112) and has become an epidemic worldwide (113). 
Records from the Australian Bureau of Statistics indicate that 69.9% of males and 55.2% of 
females were classified as overweight in 2014 and 26% of males and 24% of females were 
classified as obese (114). Worldwide, over 2.8 million people die per year as a result of the 
health complications of being either overweight or obese (115).  
 
The body mass index (BMI, body mass divided by the square of one’s height) has commonly 
been used as a parameter to determine obesity. For adult Caucasian populations, overweight 
is classified at a BMI between 25-30 kg/m2 and a BMI > 30 kg/m2 is classified as obese (112, 
116). However, it has been recently argued that BMI does not provide an accurate indication 
of obesity as it does not take into consideration fat distribution and also fails to account for 
differences in sex and age (117, 118). Abdominal obesity (waist-to-hip ratio (WHR)), 
assessed by waist circumference, has become an additional measure to BMI and also predicts 
obesity-related health risks (119-121).  
 
Adult obesity-associated health risks 
The high prevalence of obesity-associated mortality has been linked to a cluster of metabolic 
diseases, including type 2 diabetes, cardiovascular diseases (particularly heart disease and 
stroke), muscoskeletal disorders (mainly osteoarthritis), many types of cancers (endometrial, 
breast and colon), cognitive impairments,  as well as an increased susceptibility to infections 
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(122). Although, BMI should be accompanied by WHR measurements, it has been reported 
that a BMI > 27 kg/m2 predisposes the individual to a 70% greater risk of developing a 
number of obesity related complications (123) and even modest body weight loss can 
improve or even reverse these complications (124).  
 
Aetiology of adult induced obesity 
Obesity develops due to energy imbalance which refers to the imbalance between the energy 
source (food intake) and energy expenditure. However, the interaction between several 
factors including behavioural, environmental, physiological and genetics have also been 
attributed to increasing the prevalence of obesity (125). The rates of obesity are at least 
partially accounted for by the shift in diets in recent years, including the greater availability 
of highly palatable food, especially fat-rich and fructose-rich foods (126). Excess calories and 
decreased energy expenditure lead to an exaggerated body weight gain, which is 
characterised by an increased fat mass, resulting in obesity (127). The currently identified 
genetic contribution to obesity is small, suggesting that lifestyle, such as behavioural and 
environmental factors, plays a more crucial role in the development of obesity (128). 
However, there are approximately 36 obesity susceptibility loci on genes that have been 
detected in humans that are speculated to predispose individuals to obesity if they have 
previously experienced starvation (129). More than half of these obesity susceptibility loci 
are shared across European and East Asian populations (130). Of particular interest, 
mutations on the human leptin receptor and melanocortin 4 receptor result in a distinct 
obesity syndrome (131, 132). The interaction between these genetic contributions with 
environmental conditions, including availability of high palatable foods and decreased energy 
expenditure, can accelerate the obese phenotype and provide avenues for successful 
preventative and therapeutic interventions (129).  
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1.6.2. Childhood obesity 
The prevalence of overweight and obese children worldwide is particularly concerning. In 
2013, 42 million children under the age of 5 were found to be either overweight or obese 
worldwide (133). Overweight and obesity in children is classified through the use of BMI 
growth curves which take into account the age and sex of the child as well as the normal age-
dependent adiposity. According to the Centres for Disease Control and Prevention (CDC), a 
child is considered to be overweight between the 85-94th percentile and obese at or above the 
95th percentile, although this is dependent on the age and sex of the child. WHO estimated 
that the prevalence of children under the age of 5 years old with a 98th percentile BMI has 
increased from 4.2% in 1990 to 6.7% in 2010 and is predicted to increase to 9.1% by 2020 
(134).   
 
Childhood obesity-associated health risks 
Obesity in childhood is strongly associated with becoming an obese adult such that 60-80% 
of obese children become obese adults (135). Childhood obesity is linked to an increased 
likelihood of a variety of illnesses in childhood and also later in life (133, 134). Childhood 
obesity also leads to a variety of acute health problems such as a higher incidence of asthma, 
early puberty, cognitive impairments (see Section 1.6.7.), muscoskeletal disorders and myriad 
cardiovascular risk factors such as hypertension, type 2 diabetes mellitus, dyslipidaemia, 
abnormalities in left ventricular mass and/or function, and hyperinsulinemia and/or insulin 
resistance (136). The onset of type 2 diabetes during childhood is linked with an increased 
rate of beta cell failure (137). Type 2 diabetes in children has also been associated with 
presentation of adult life complications earlier. These complications include cardiovascular 
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disease, visual impairment and kidney failure (137). Childhood obesity can also cause 
psychological issues such as low self-esteem and behavioural problems (138, 139).  
 
Aetiology of childhood onset obesity 
Childhood obesity has similar factors to adulthood obesity that contribute to the likelihood of 
an individual developing obesity, including genetics, environment, metabolism, and 
behaviour. Environmental factors due to foetal programming can permanently shape an 
individual’s phenotype including their weight regulation (140). In utero periods of maternal 
deprivation result in lower birth weight compared to controls, which is then accompanied by 
an increased “catch up growth” that is a significant risk factor for development of childhood 
obesity (141). Therefore, the nutritional environment during development is crucial in 
determining whether an individual develops obesity (142).  
 
1.6.3. Early life overfeeding – an animal model of childhood obesity  
There are numerous clinical studies showing that mothers who are exposed to over- or under-
nutritional environments during the gestational period, leads to their children having 
increased risk of becoming overweight adults (143-148). Additionally, studies have also 
shown that postnatal over- or under-nutrition can increase the susceptibility of becoming 
overweight in adulthood (143, 149). This susceptibility of over- or under-nutrition in 
offspring has also been shown in rodent studies where the early postnatal period is 
representative, in terms of brain development, of the third trimester in humans (145, 150-
154). For instance, rodents suckled in small litters, where they have greater access to their 
mother’s milk compared with controls, have accelerated growth and weight gain early on, 
and this excess weight and body fat persists at least to young adulthood (Figure 1.2) (142, 
155-159). In addition to metabolic dysfunction (142, 155, 160, 161), hypothalamic-pituitary-
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adrenal (HPA) axis dysfunction (162-164), reproductive problems (165, 166), changes in 
hypothalamic connectivity (167-170) and other complications, early life overfeeding leads to 
a potentiated febrile response to an immune challenge with LPS (157).  
 
To induce neonatal overfeeding in a rodent model, rat or mouse litter sizes can be 
manipulated on the day of birth (P0) so that pups are suckled in a small litter (e.g. of four 
pups for rats) to allow neonatal overfeeding or control litters (e.g. of 12 pups for rats). By 
reducing the litter size during the suckling period, competition for consumption of milk is 
reduced; the pups also receive milk that is higher in fat and thus show an accelerated growth 
and weight gain that is continued into adulthood (157, 171). Our model of over-nutrition 
during lactation (in small litters of four pups) is used to derive the neonatal overfeeding 
animal model for this thesis.   
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Figure 1.2. Neonatal overfeeding by small litter rearing leads to increased body weight throughout life. 
A) Preweaning weights of control-fed litter (CL) and small litter (SL; neonatally overfed). B) Adult (postnatal 
day (P)63) weights. C) Adult (P77) by dual energy X-ray absorptiometry (DEXA) images. D) Adult (P77) 
percentage fat was determined by DEXA. n = 8 per group. * p < 0.05. Data are mean + SEM (157). 
 
1.6.4.  Obesity associated with chronic low grade peripheral inflammation 
Obesity, in both children and adults, is associated with a chronic low-grade inflammation 
within peripheral metabolic tissue, with many reports providing evidence of peripheral 
inflammation in obesity-associated pathologies (172). Adipose tissue is a regulator of 
systemic energy homeostasis (173) and promotes inflammation in obesity as evidenced by 
macrophage infiltration in fat tissue of obese mice and humans with insulin resistance (174, 
175). Hotamisligil and colleagues were the first group to link the inflammatory process to the 
overexpression of TNFa in adipose tissue, in obese mice and rats, as well as in adipose tissue 
and muscle in humans (176). Moreover, there is a positive correlation between obesity and 
hyperinsulinemia, TNFa levels and mRNA in adipose tissue (177). Additionally, molecular 
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markers of inflammation have been found in metabolically active organs such as adipose 
tissue and the liver, including IL-6, IL-1b, CCL2, CCL3, CCL5, c-reactive protein, serum 
amyloid A and fibrinogen (178, 179).   
 
Recent advances in hypothalamic inflammatory research (described below) suggests that 
peripheral inflammation may be a result of central inflammation during obesity. This is 
evidenced by a recent study showing that 3 days of a high-fat diet (HFD) is sufficient to 
promote inflammation and gliosis in the hypothalamus of rats without apparent changes in 
peripheral organs, which develops over weeks to months (174, 180, 181). Moreover, specific 
low-grade chronic inflammation in the hypothalamus, via TNFa administration, modulates 
body glucose homeostasis leading to hyperinsulinemia and insulin resistance in the liver and 
skeletal muscle (182, 183). This work suggests that the peripheral inflammation is regulated 
by the cross-talk between the CNS and metabolic organs. For example, the hypothalamus 
modulates plasma glucose via vagal innervation to the liver (184) indicating that damage to 
the vagal nerve, hence vagal innervation and stimulation, due to obesity might lead to organ 
dysfunction and inflammation. Specifically, HFD-induced hypothalamic inflammation 
activates stress signalling, such as c-Jun N-terminal kinase (JNK) and the IkB kinase (IKK) 
that inhibit downstream mediators of the insulin pathways (185). 
 
1.6.5. Obesity associated with chronic low grade central inflammation 
Adulthood Obesity 
As outlined above, obesity is associated with not only peripheral inflammation but central 
inflammation, initiated in the hypothalamus. The hypothalamus, particularly the arcuate 
nucleus (ARC), lacks an effective BBB thus is able to respond directly to circulating nutrients 
(186). D’Souza and colleagues were the first to identify hypothalamic inflammation in 
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rodents that consumed a hyperlipidimic diet for 16 weeks (187). They observed significant 
increases in gene expression of IL-6, TNFa, and IL-1b in the ARC and lateral hypothalamus 
(LH) in rodents fed a hyperlipidimic diet compared to controls  (187). Since this initial 
observation, evidence has accumulated illustrating a functional contribution of hypothalamic 
inflammation to diet-induced obesity (DIO) susceptibility. Elevated pro-inflammatory 
cytokines in the hypothalamus develop within the initial 3 days of HFD exposure in rats and 
mice, prior to significant weight gain and parallel with the onset of leptin resistance and 
upregulation of neuronal stress markers (180, 188, 189). There is also a reduction in 
hyperphagia and weight gain associated with a HFD in mice with genetically diminished 
inflammatory signalling in hypothalamic neurons (185, 188), which is due to the preservation 
of leptin and insulin sensitivity (185, 188). 
 
Alongside HFD- and DIO- induced elevation of hypothalamic pro-inflammatory cytokines, 
an increase of both activated astrocytes and microglial cells has been found. For the purpose 
of this thesis, I will restrict the discussion to the accumulation of activated microglial cells 
after high fat feeding. During the initial exposure to HFD, within the first 3 days, activated 
microglia accumulate, via proliferation, in the mediobasal hypothalamus which has been 
suggested to mediate the inflammatory cytokine response (180, 187). Furthermore, exposure 
to a HFD for a period of up to 1 month also results in an increased expression of pro-
inflammatory genes in microglia isolated from the hypothalamus of these mice and ablation 
of microglia eliminates this inflammation (190). However, recent studies have reported that 
this hypothalamic pro-inflammatory cytokine gene expression in HFD-fed mice may either 
be 1) an acute reaction to the diet or 2) not a microglial-specific pro-inflammatory reaction to 
the diet, as an elevation in pro-inflammatory cytokines is apparent after short-term HFD but 
not after 4 or 8 weeks in microglia extracted from the hypothalamus (191). This finding is 
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consistent with another study that also did not observe a pro-inflammatory response after 8 
weeks of a HFD (192). Interestingly, however, Baufled and colleagues detected an increase 
in anti-inflammatory molecules in hypothalamic microglia after 8 weeks of a HFD, 
suggesting that microglia’s initial pro-inflammatory profile shifts into an anti-inflammatory 
one after long-term HFD (191). This temporal shift in the microglial profile after chronic 
HFD is similar to previously reported reactions to other stimuli. For example, an acute 
stimulation with LPS induces a pro-inflammatory profile but chronic LPS stimulation leads 
to an increase in anti-inflammatory markers (193, 194), suggesting that microglia actively 
regulate their response to prolonged HFD by downregulating genes involved in sensing 
microenvironmental alterations (191). This active regulation may be a protective mechanism 
aimed at preserving neuronal homeostasis (191).  
 
It has been speculated that hypothalamic inflammation may precede inflammation in other 
regions of the brain due to the lack of an effective BBB. There is evidence to suggest that 
inflammation and microglial accumulation in memory-dependent regions of the brain in 
obese humans and animals requires a longer high fat feeding regime. Indeed, in the 
hippocampus, short-term HFD does not induce the production of a pro-inflammatory profile, 
with a lack of elevation of pro-inflammatory cytokines and no differences in microglial 
accumulation or activation (180, 195) unless the diet includes high sugar (196). Furthermore, 
it seems the duration of a HFD must exceed 12 weeks for elevations in pro-inflammatory 
cytokines and microgliosis to occur (195, 197, 198). Other brain regions involved in 
cognition are also influenced by a diet high in fat. Cortical tissue have elevations in 
microglial activation after a HFD for 14 weeks (199) and increases in cyclooxygenase 2, 
prostaglandin E2 levels as well as nuclear factor-kappa B (NFkB) after a HFD for 5 months 
(200). 
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Childhood obesity 
Due to the overwhelming increase in childhood obesity and the increased susceptibility to 
becoming an obese adult given childhood obesity, there has been a great interest in 
determining whether exposure to highly palatable/ caloric diets during early life can have 
similar effects to adult diet-induced obesity with respect to the inflammation that ensues. It 
has been well documented that a HFD in utero, via maternal HFD intake, and during lactation 
is capable of programming inflammation within the hippocampus and amygdala of offspring 
long-term (201-203). This pro-inflammatory profile includes elevations in NFkB and IL-6 
expression and higher populations of microglial activation (201-203). Recent studies have 
shown a primed hippocampal microglial profile in adult offspring specifically from high-
saturated-fat diet-fed dams (202, 204).  
 
We have also demonstrated that neonatal overfeeding contributes to a primed basal pro-
inflammatory profile with increases in the number and density of Iba-1-positive microglia in 
the paraventricular nucleus of the hypothalamus (PVN) during early life. These effects persist 
into adulthood despite the rats being placed on a normal chow diet after weaning (159), and 
this co-occurs with accelerated weight gain compared to control-fed rats. Although we know 
that early life overfeeding increases pro-inflammatory cytokines and microglial activation in 
the hypothalamus, it is still unknown whether this inflammation extends beyond the 
hypothalamus into extra-hypothalamic regions such as the hippocampus and whether it can 
be detrimental to learning and memory long-term.  
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1.6.6. Microglial function in response to neuroimmune challenges in obesity  
Obesity is linked with an increased susceptibility to infection and abnormal neuroimmune 
responses in adult rats that were over-nourished during development (159). As previously 
described, microglia are capable of mounting an immune response against microbial 
components such as LPS. Upon systemic LPS administration, TLR receptors (mainly TLR4 
but also TLR2) are activated both in the periphery and in the CNS and induce a robust 
microglial activation and neuroinflammation (205). Two hours post-LPS injection results in 
extremely low brain concentrations of LPS (206), suggesting that immune mediators are 
primarily synthesised in the periphery and the circulating cytokines and prostaglandins 
transiently cross the BBB or enter the brain at circumventricular organs, indirectly inducing 
resident microglia to produce an inflammatory response (207, 208). This activation in 
response to LPS consists of an initial secretion of pro-inflammatory cytokines, with a 
particular emphasis on IL-1b as it is present under basal conditions and rapidly induces a 
response to the LPS stimulus (209).  
 
The response to an LPS stimulus is characterized by reduced motivation for food and fluids, 
alterations in core body temperature, hyperalgesia, as well as social withdrawal (210). In 
humans, the inflammatory response to LPS is transient and normally resolves within 24 hours 
since LPS is non-replicating. This inflammatory response is considered to be biphasic with an 
early pro-inflammatory cytokine phase which initiates within 1.5-3.5 hours and resolves after 
6-12 hours. This is then followed by an anti-inflammatory phase in which cytokines peak 
after 2 hours and remain slightly elevated for at least 8 hours (211, 212). There are differing 
reports on the time course of an LPS response in rodents. However, locomotor suppression 
during the active (dark) phase of the circadian cycle and hyperthermia during the inactive 
(light) phase persists for over 24 hours. Additionally, microglial activation and secretion of 
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pro-inflammatory cytokines have been found to be elevated from as early as two hours 
(average four to six hours) post-injection, remaining elevated for 24 hours (213-215).  
 
The microglial response to a single LPS dose under normal conditions is well documented, 
however, our understanding of the central responses to LPS during obesity is lacking. 
Valdearcos and colleagues have found that a diet high in saturated fatty acids stimulate the 
pro-inflammatory activation of primary hypothalamic microglia within 24 hours post-LPS 
(190). Reports have examined the effects of over-nutrition on the response to LPS during 
development. The first study was performed by Bilbo and Tsang, who illustrated that 
maternal HFD increased protein levels of IL-1b and microglial activation in the hippocampus 
of adult mice (202). Secondly, our group has reported that despite being weaned onto a 
normal chow diet at three weeks of age, adult rats that were overfed during development have 
an increased basal and LPS-induced pro-inflammatory profile in the hypothalamus, 
particularly in the PVN, with an increase in cytokines and microglial activation in this region 
(159). However, we do not know whether this inflammatory response to an LPS stimulus 
extend into extra-hypothalamic areas, such as the hippocampus, that might be important in 
learning and memory.  
 
1.6.7. Obesity-induced cognitive impairments  
The association between obesity and cognitive function is well documented in humans and 
rodents. A higher BMI in non-demented middle-aged adults is associated with deficits in 
learning, memory and executive functioning in some studies (216-220). In rodents, HFD-
induced alterations in memory are dependent on the duration of diet exposure. Thus, mice or 
rats that are fed a HFD for 5 to 8 weeks performed similarly to control mice in a recognition 
task (novel object recognition) (221, 222). However, given a sufficient exposure time to a 
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HFD, i.e. between 12 to 21 weeks, obese mice and rats display impaired recognition memory 
(222-224). This HFD-induced recognition memory impairment has been shown to be 
significantly improved with anti-inflammatory and anti-oxidant agents, either bardoxolone 
methyl (an oleanolic acid synthetic derivative) or rhein (main ingredient of rhubarb) (223, 
224). Furthermore, hippocampal inflammation associated with long-term HFD (20 to 22 
weeks) significantly impairs spatial memory performance in the Morris Water Maze (MWM) 
in mice. These mice display a deterioration in spatial learning and memory, taking longer to 
learn the location of the escape platform and being less able to recall their training when the 
platform is removed than control mice (197, 198). Deterioration of spatial learning and 
memory was also found in (16 to 20 week HFD-fed) mice that undertook a Stone T-Maze 
task (225) and a Y-Maze task (195). Partial reversal of spatial learning and memory 
impairments in the MWM was achieved by treatment with anti-inflammatory and anti-
oxidant agents, ursolic acid (197) or resveratrol (198), which were also able to suppress 
activation of microglial cells and pro-inflammatory cytokines in the hippocampus.  
 
Crucially, there is also evidence that disruptions to early life nutrition that produce a pro-
inflammatory profile can also induce long-lasting effects on learning and memory. Reported 
human epidemiological studies have shown a correlation between maternal obesity and poor 
cognitive performance of children (226, 227). Studies indicate that executive functioning and 
memory and learning is poorer in children or adolescents with obesity compared to healthy 
weight equivalents (228-230). In rodents, maternal HFD during gestation and lactation in 
mice impairs the performance in the MWM, as well as anxiety-related behaviours and 
working memory (201, 204, 231, 232). Spatial memory performance is also disrupted in the 
Barnes maze in maternal HFD fed adult offspring (233) and exposure to a Western “cafeteria 
diet”, during the lactation period, impairs anxiety-related behaviours, exploration, and 
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working memory in the adult offspring (234, 235). Juvenile HFD-induced obesity also leads 
to poorer performance in the Radial arm maze (RAM) (236) as well as impaired long-term 
spatial reference memory in the MWM (237). These animals also had poorer short-term 
memory, therefore had difficulty consolidating the previously learnt task. Contrary to these 
findings, Bilbo and colleagues have shown adult rats fed a saturated-high fat diet in utero, 
and throughout lactation have an improved, not disturbed, performance in the MWM (202). 
Moreover, better spatial memory performance was also observed in three-month old 
offspring of maternal HFD Peromyscus mouse dams (238), as well as in 3-4-month-old 
piglets (239, 240). Although previous rodent literature has shown that maternal HFD effects 
spatial memory in offspring, it is still unknown whether over-nutrition during development 
via our neonatal overfeeding model will impair cognition.   
 
1.7. Microglial ablation under normal physiological conditions 
Throughout this introduction, we have shown a substantial amount of evidence suggesting 
that microglia are able to not only influence responses to brain injury but also are involved in 
synaptic development and connectivity, and refinement of neural circuits which impact 
cognitive learning and memory. Throughout this thesis, the role of microglia in injury that 
include long-term responses to over-nutrition during development via our neonatal 
overfeeding model will be investigated. We will examine whether neonatal overfeeding alters 
the hippocampal microglial profile and thus impairs spatial memory and responses to an 
immune challenge such as LPS. If the hippocampal, alongside the hypothalamic, microglial 
profile is altered during developmental over-nutrition, we may be able to specifically target 
microglia to reverse these deficits. Thus, it is important to specifically understand the role of 
microglia both under normal physiological and pathological states. This can be achieved by 
strategically depleting microglia from the CNS. In order to specifically ablate microglia, 
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there have been a range of depletion approaches employed by either pharmacological or 
genetic methods (Table 1.1. and Table 1.2.).  
 
Table 1.1. Overview of pharmacological microglia depletion studies 
Condition Method Efficiency 
(%), Species 
Physiological effect Reference 
Health Liposomal 
clodronate 
90 
Macaque, rats 
In utero depletion in the cerebral cortex 
significantly increases the number of NPCs. 
(66) 
 Liposomal 
clodronate 
> 70 
Rat 
Neonatal depletion lasted approx. two weeks. 
Increased locomotion and decreased anxiety and 
despair behaviours in juveniles and throughout 
life. 
Females had a blunted corticosterone response to 
acute stress in adulthood. 
(241) 
 Liposomal 
clodronate 
~60 
Rat 
Does not alter neuronal death in prolonged 
hypothermic cardiac arrest 
(242) 
 PLX3397 > 99 
Mice 
No negative outcome. (36, 243) 
 PLX3397, 
liposomal 
clodronate  
80 
Mice 
Transient and reversible changes in spatial 
memory and social behaviour. 
(96) 
 PLX5562 80 
Mice 
Reduces spine density formation and elimination 
in young (developing) but not mature adult-born 
granule cells (abGCs) in the olfactory bulb. 
Increased odor-evoked responses. 
(97) 
 PLX5622 ~ 85 
Mice 
Reduces weight gain, food intake and total body 
fat in high fat diet mice but not chow diet mice. 
(244) 
 PLX5622 ~ 98 
Mice 
No negative cognitive outcomes alone.  
Surgical trauma reduced cognition and is more 
pronounced and persistent with diet-induced 
obesity.  
Perioperative depletion protected cognition. 
(245) 
Pathology Liposomal 
clodronate 
>40 No negative outcomes. (242) 
 PLX3397 70-80 
Mice 
Reversible changes in spatial memory induced by 
neural lesion, increased dendritic spines. 
(98) 
 PLX3397 70-90 
Mice 
Amelioration of tauopathy and neurotoxicity in 
Alzheimer’s Disease (AD) mouse models. 
(246) 
 PLX3397 93-97 
Mice 
Bigger infarct size and dysregulation of neuronal 
signaling leading to neuronal death in middle 
cerebral artery occlusion (MCAO). 
(247) 
 PLX3397 >80 
Mice 
Does not ameliorate amyloid-β levels in AD 
mouse models, rescues dendritic spine loss, 
improvements in contextual memory. 
(248) 
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 PLX5562 >90 
Mice 
Transient and reversible changes in spatial 
memory in cranial irradiation mice. 
(249) 
 PLX3397 ~90 
Mice 
Exacerbates neurological deficits and brain 
infarction via the production of inflammatory 
mediators, leukocyte infiltration and cell death by 
astrocytes. 
(250) 
 PLX5562 ~90 
Mice 
Fast repopulation (3 days following drug 
withdrawal). 
Neuronal loss and microglial depletion elicits a 
prolonged neuroinflammatory response (elevated 
levels of cytokines, chemokines signals) and are 
resolved by microglial repopulation. 
(251) 
 PLX3397 >90 
Mice 
Neuroprotective. Attenuation of neurological 
deficits and brain oedema in models of 
intracerebral hemorrhage and a reduction in 
leukocyte infiltration in the brain. 
(252) 
 GW2580 
 
>90 
Mice 
Improved performance in memory and 
behavioural tasks and prevented synaptic 
degeneration in AD mouse model. 
(253) 
 GW2580 
 
~30 in late stage 
ALS 
Mice 
Depleted peripheral macrophages as well as 
microglia.  
Slowed down Amyotrophic Lateral Sclerosis 
(ALS) disease progression, attenuated motor 
neuron cell death, protected skeletal muscle 
denervation.  
(254) 
 GW2580 >60 
Mice 
Reduced neurogenesis and resorted neuronal 
differentiation to normal levels in a mouse model 
of prion disease. 
(255) 
 GW2580 >60 
Mice 
Reduction in neuronal damage and progression of 
prion disease. 
(256) 
 
 
 
 
 
 
 
 
 
 
	 	
38	
	 	
Table 1.2. Overview of genetic microglia depletion studies 
All models listed in mice. 
Condition Method Efficiency (%) Physiological effect Reference 
Health CX3CR1CreER:iDTR  > 90 Loss of synapse formation, negative 
effect on learning tasks. 
(61) 
 CX3CR1CreER:iDTR  > 90 No negative outcome. (257) 
 CD11bhigh-
CX3CR1-GFPhigh 
~99 Increases dorsal extension of 
dopaminergic axons at embryonic day 
14.5  
(68) 
 CD11b-DTRRMT 60 Localized to the medial basal 
hypothalamus, increased number of 
microglia after recovery compared to 
controls. 
(190) 
 CX3CR1CreER/+: 
R26iDTR+ 
 
>90 Does not alter acute pain responses but 
abolishes chronic pain (mechanical and 
thermal hypersensitivity).  
Repopulated microglia can engage in the 
development of neuropathic pain after de 
novo but not pre-existent nerve injury 
(258) 
Pathology CD11b-HSVTK  >90 Reduction of inflammation in 
experimental autoimmune 
encephalomyelitis (EAE). 
(259) 
 CD11b-HSVTK  75 No effect on neuronal survival after 
mechanical injury. 
(260) 
 CD11b-HSVTK  75 Bigger infarct size and neuronal death in 
MCAO. 
(261) 
 CD11b-HSVTK  90 No effects on amyloid plaque formation 
or neuritic dystrophy in AD. 
(262) 
 CD11b-HSVTK  80-90 No effect on seizure sensitivity in 
temporal lobe epilepsy (TLE). 
(263) 
 CD11b-HSVTK ~60 Does not alter axonal injury in a mouse 
model of repetitive concussive traumatic 
brain injury (TBI). 
(264) 
 
1.7.1. Pharmacological Approaches 
Minocycline, is a microglial-inhibitory tetracycline-derived antibiotic. It is capable of 
crossing the BBB upon systemic administration. It is FDA approved and clinically used as a 
broad-spectrum antibiotic (265). Minocycline has a high bioavailability in humans (200 mg/ 
24 hrs) and it is efficiently absorbed by the gastrointestinal tract (266). Experimentally, 
minocycline is soluble and therefore can easily and efficiently be administered via i.p. 
injection (267, 268). Minocycline can also be delivered by oral administration from drinking 
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water (269, 270). However, delivery of drugs via voluntary consumption of water does not 
take into consideration the individual variability in the amount of water consumed by rodents, 
so this must be considered during experimental design. This antibiotic has been shown to be 
neuroprotective (271, 272) and to successfully ameliorate neuroinflammation in many models 
of brain injury and neurodegeneration (267, 272-276). Interestingly, O’Connor and 
colleagues demonstrated that pre-treatment with minocycline can attenuate LPS-induced 
central IL-1b without affecting plasma IL-1b, suggesting that minocycline’s anti-
inflammatory actions are restricted to the brain (277). The literature has largely focused on 
minocycline’s ability to ameliorate neuroinflammation, both microglial activation and 
elevations in pro-inflammatory cytokines, at the site of neonatal hypoxic-ischemic insult in 
rodents (267, 272, 273, 278, 279). The mechanisms involved in minocycline’s effects on 
neuroinflammation are currently unknown. However, it has been suggested that amelioration 
of microglial activation by minocycline is achieved via down-regulation of MHC-II 
expression through inhibition of IRF-1 and Protein Kinase Ca/bII (280). Minocycline has also 
been reported to have a non-specific action on neurons, potentially due to the Cx3cr1/ 
Cx3cl1interaction, therefore caution is required when drawing conclusions (281-283).  
 
There are currently two more specific pharmacological approaches which have been used to 
selectively ablate microglia experimentally, clodronate liposomes and CSF-1R. For 
clodronate liposomes, microglial cells engulf the liposomal particles and release the 
encapsulated, toxic clodronate which induces apoptosis (284). Prior to the development of 
other pharmacological approaches for in vivo studies, clodronate liposomes were typically 
used in organotypic hippocampal sections where they were administered onto the section in 
media (285-287). However, recently this approach has also been studied in vivo, via intra-
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hippocampal administration. Using this compound, mice devoid of microglia have transient 
and reversible changes in spatial memory and social behaviour (96). 
 
As previously described, CSF-1R is exclusively expressed on myeloid cells, including 
microglia in the CNS, under physiological conditions, therefore another pharmacological 
approach is to specifically target CSF-1R signalling with the use of the systemically 
administered CSF-1R-inhibiting drugs (PLX3397 and PLX5562) (36, 96, 243, 288). These 
small molecule CSF-1R inhibitor drugs are known to cross the BBB and thus rapidly deplete 
microglia. Recent literature has suggested that PLX5562 may be the better of the two 
inhibitors (289). PLX3397 inhibits both CSF-1R and c-Kit, whilst PLX5562 specifically 
inhibits only CSF-1R. Dagher et al. have illustrated that c-Kit is not essential to robustly 
deplete microglia or aid in the regeneration of the microglial population (289). Reports of 
CSF-1R inhibitors have found contradictory findings about the effects of microglial 
depletion. Li and colleagues have found that elimination of microglia by PLX3397 can be 
neuroprotective in the context of intracerebral hemorrhage (252). However, this inhibitor also 
can exacerbate neuroinflammation and brain injury with an increase in astrogliosis and a 
cytokine storm, with an increase in pro-inflammatory cytokines, under normal physiological 
conditions (36) and in the context of brain ischemia (247, 250). In addition to these two CSF-
1R inhibitors, GW2580 has also been found to inhibit microglia and macrophage 
proliferation in mice models of neurodegeneration and protect against neuronal damage (253-
255). However, these CSF-1R inhibitors are not strictly specific for CSF-1R and also inhibit 
FLT3, PDGFR and KIT kinases (290, 291). Furthermore, systemic treatment via chow 
ingestion, leads to broad myelosuppression, affecting macrophages, osteoclasts and mast cells 
(292). According to the material safety documents, CSF-1R agents are only soluble in DMSO 
and not water, therefore administration by injection either systemically (i.p./ s.c.) or centrally 
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(intra-regional) is not possible as DMSO is toxic to rodents (293). Importantly, to our 
knowledge there have been no reports of ablating microglia in rats using CSF-1R agents. 
Unpublished data from our collaborators at MD Anderson Cancer Centre have suggested that 
these CSF-1R agents are unable to eliminate microglia in rats (personal communication, 
Grace, 2017), therefore other methods of microglial ablation are required in rats.  
 
1.7.2. Genetic Approaches 
Depletion of microglia can also be achieved via genetic manipulation using cell type 
promoters that are coupled with suicide genes. These suicide genes generally encode either a 
toxin, an enzyme that converts a pro-drug into a toxic agent, or a protein for the specific cell 
type leading to apoptotic cell death specifically in the cells of interest (294). Diphtheria toxin 
(DT), which is originally derived from the Corynebacterium diphtheriae, is a widely-used 
immunotoxin/ suicide gene activator to deplete cells of interest, including microglia. Honjo 
and colleagues found that DT’s mode of action is via cytosolic inhibition of cellular protein 
synthesis, ultimately leading to cell death (295). The main advantage of these suicide genes is 
that there are few side-effects on other peripheral tissue. These models also have a higher 
efficiency than pharmacological approaches (294).  
 
To achieve microglial ablation, transgenic mice models of microglial ablation express a 
suicide gene on either the chemokine receptor, Cx3cr1, or under the specific CD11b 
promoter. There are two independent laboratories that have generated Cx3cr1 mice models 
(61, 296). Yona and colleagues introduced a CreER cassette into the Cx3cr1 locus, whereas 
the Parkhurst study inserted a CreER–IRES-eYFP cassette into the locus (61, 296). Both of 
these Cre lines were crossed to iDTR (diphtheria toxin receptor) animals producing 
Cx3cr1CreER:iDTR mice. Therefore, upon systemic administration of DT in these mice, 
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microglia can robustly be eliminated with an efficiency of greater than 90% (61, 257). 
Although Cx3cr1 is not exclusively expressed in microglia and is also found in other myeloid 
cells, these studies were able to specifically deplete microglia and not peripheral monocytes/ 
macrophages. This is achieved by the lost expression of Cre in other myeloid cells due to the 
rapid turnover (approximately 40 days) (297, 298) compared to the low turnover of microglia 
(approximately 96 days) (1, 17, 41). However, the necessity to administer tamoxifen 30 days 
prior to microglial ablation, reduces the diversity of these models. Another genetic approach 
to studying microglial depletion is via transgenic mice that express herpes simplex virus 
thymidine kinase (HSVTK) under the specific CD11b promoter. Microglial ablation is 
achieved upon administration of the pro-drug ganciclovir. Microglial depletion in these 
transgenic mice can reduce neuroinflammation in experimental autoimmune 
encephalomyelitis (EAE) (259). 
 
1.7.3. Comparison of pharmacological and genetic approaches to depleting microglia 
Despite the differences in the methodology used to deplete microglia, there have been some 
overall similarities between models. All of these approaches, have found that depletion of 
microglia within the CNS is fast and robust, ranging from 80 to > 99% depending on the 
treatment and the region of interest (36, 61, 96, 243, 257, 289). Independent of methodology, 
microglial repopulation capacity is similar, with repopulation at around one week after 
depletion without obvious deficits in microglia (36, 61, 96, 243, 257, 289). Elmore and 
colleagues have suggested that the rapid repopulation of microglia is due to a novel local 
progenitor cell population in the brain expressing the neuronal stem cell marker nestin (36, 
243). Although Bruttger et al. demonstrated a similar microglia repopulation capacity, they 
could not find a novel progenitor pool that repopulate the microglial population but rather 
identified local proliferating microglia that were able to escape the ablation treatment (~5-
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10% of the original population) that co-expressed nestin together with the microglial marker 
Iba-1 (257). Importantly, it was recently identified that nestin-positive microglial precursors 
do not maintain proliferation of microglia in the steady state (41).  
 
Despite these similarities, reported functional differences between treatments have been 
reported. While one study did not report disturbances in homeostasis (61), others have shown 
mild astrogliosis and short-term pro-inflammatory cytokine storms (36, 243, 257). There 
have also been reported differences in performance in learning and memory tasks after 
microglial ablation. For example, loss of motor dependent synapse formation and decreased 
performance in motor learning tasks (61) as well as alterations in social behaviours have been 
reported (96) compared with improvements in spatial memory in the Barnes Maze (36). 
These differences could be due to the different ablation models or may be related to the 
timing of the performed tests. For instance, in the Elmore study, behavioural tests were 
conducted when the microglia were still depleted (36), whereas in the Parkhurst study, the 
testing protocols were performed two to four days after depletion, when microglia were 
already repopulating the brain (61). 
 
It is noteworthy that currently all approaches for microglial depletion have been performed 
on mice rather than rats. This preference is likely to be related to the availability of genetic 
manipulation techniques in mice compared to rats. This lack of rat models is particularly 
concerning given the vast differences found between these species in relation to 
neuroscience-related research. Crucially, there are important and fundamental differences 
between mice and rats in their learning and memory abilities in various tasks (299-301). 
Additionally, rats are more similar to humans in a variety of neurological and psychiatric 
disorders compared to mice, including in addictive and impulsive behaviours and in models 
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of neurodegenerative diseases (reviewed in (302)). For example, both rats and mice have 
been extensively used as models for AD and an essential pathological hallmark is the 
formation of tangles via hyper-phosphorylation of the tau protein. Rats and humans, unlike 
mice, have six isoforms of the tau protein, therefore, rats may have a higher degree of 
similarity in tangle formation to humans than mice do (302). Additionally, adult-born 
hippocampal and neocortex rat neurons mature faster, similar to that of humans, are more 
likely to escape cell death and are more likely to be recruited into learning circuits than mice 
neurons after a spatial memory task (303). As a rodent model of human neurological 
diseases, the rat offers many advantages over the mouse. Therefore, it is important to 
understand how ablation of microglia affects various aetiologies of neurological conditions 
in different species in order to further understand human physiology and potential treatments 
of neurological diseases.  
 
1.8. Hypothesis and aims 
Human studies have suggested a link between childhood obesity and impairment of cognitive 
behaviour and neuroimmune dysfunction during adulthood. Researchers have investigated 
the association further through the use of rodent models and have discovered that microglia 
might influence this outcome. We have previously demonstrated that neonatal over-nutrition 
is associated with hypothalamic inflammation with an increase in activated microglia and 
elevated expression of pro-inflammatory cytokines. We therefore hypothesised that neonatal 
over-nutrition could influence cognitive behaviour and neuroimmune function and this would 
be associated with microglia. 
 
This hypothesis was assessed by the following aims: 
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Aim 1: To determine if the hypothalamic inflammation seen in neonatally overfed rats could 
extend into extra-hypothalamic regions such as the hippocampus and retrosplenial cortex and 
cause cognitive impairments.  
To test this aim we therefore examined neonatally overfed rats’ cognitive function in the 
novel object recognition and the delayed win-shift RAM. To assess how neonatal overfeeding 
impacts on the ability to modulate learning-associated brain regions to facilitate memory, we 
examined the effects of the RAM on neuronal proliferation and microglial profiles. This 
chapter has been published in the Journal of Neuroinflammation in 2016, entitled “Early life 
overfeeding impairs spatial memory performance by reducing microglial sensitivity to 
learning”.  
 
Aim 2: To determine if hippocampal microglia are hyper-activated in response to LPS by 
neonatal overfeeding both in vitro and in vivo and whether this inflammation could be 
ameliorated by minocycline.  
To test this aim we examined neonatally overfed and control-fed rats’ neuroinflammatory 
profiles in response to LPS. We then attempted to suppress hippocampal microglial activation 
during the neonatal period to the normal microglial profile of control-fed rats with 
minocycline, a known inhibitor of microglial activation. This chapter has been published in 
the Journal of Neuroendocrinology in 2017, entitled “Neonatal overfeeding by small-litter 
rearing sensitizes hippocampal microglia responses to immune challenge: Reversal with 
neonatal repeated injections of saline or minocycline”.  
 
Aim 3: To validate the effectiveness of a transgenic rat model (Cx3cr1-Dtr rat) for ablation 
of microglia.  
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As our initial studies showed that neonatally overfed rats have an increased 
neuroinflammatory profile in the hypothalamus and hippocampus resulting in cognitive 
impairments, we generated a model of microglial ablation in rats (Cx3cr1-Dtr model) to 
examine whether this inflammation could be altered by depletion of microglia. Prior to 
assessment, we needed to validate the transgenic model. We therefore investigated whether 
the insertion of the Dtr into the promoter for the Cx3cr1 would alter the phenotype under 
basal conditions by assessing differences in flow cytometry and microglial profiles. We then 
determined the time course of microglial depletion and repopulation after exposure to DT.  
 
Aim 4: To assess the role of microglia in adult cognition after microglial depletion and 
microglial repopulation.   
As we and others have previously seen cognitive impairments associated with an increased 
neuroinflammatory profile, we hypothesised that depletion of microglia would positively 
alter cognitive outcomes. Therefore, we examined cognitive function in Y maze, NOR and 
novel place recognition after microglial depletion and microglial repopulation. We have then 
assessed the effects of microglial elimination and repopulation on neuronal numbers and 
synapse density.  
 
Aim 5: To determine how microglial depletion induces anorexia and weight loss.  
Whilst validating our transgenic rat model, we revealed that elimination of microglia and 
monocytes induces acute anorexia and short-term weight loss. We hypothesised that this 
microglial depletion-induced weight loss and reduction in food intake was due to 
impairments in satiety signalling and not a sickness response. We have therefore examined 
the rats’ performance in activity and anxiety behavioural tasks (open field, elevated plus 
maze and light/dark test). We also assessed basal circulating feeding signals (ghrelin and 
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leptin signalling) after depletion of microglia and the weight and feeding responses to 
exogenous ghrelin. 
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2.1. Introduction 
Obesity is now an epidemic in our population and is associated with deficits in cognitive 
processing, such as learning, memory and executive function (216, 217). However, not all 
obese subjects develop cognitive deficits (304, 305), and the factors that influence individual 
vulnerability to this complication are largely unknown. We propose that early life 
overfeeding may program cognitive dysfunction in obese individuals. 
 
It has been speculated that inflammation may contribute to cognitive dysfunction in some 
obese subjects (306). Poor cognitive ability in obese humans has been correlated with 
systemic markers of chronic low-grade inflammation (307, 308). A long-term diet consisting 
of high fat has shown hippocampal microgliosis (microglial proliferation, accumulation and 
activation (309)) alongside astrogliosis, and elevated tumour necrosis factor (TNF)α (197, 
198). Several studies have demonstrated that high-fat diet (HFD)-fed mice have impaired 
spatial memory function in behavioural tests, taking longer to learn the escape platform 
location in the Morris water maze (MWM) compared to controls (197, 198). Furthermore, 
treatment with anti-oxidant anti-inflammatory agents such as Resveratrol or ursolic acid 
significantly improves the cognitive impairments, as well as the microgliosis and elevated 
cytokines, that are associated with a diet high in fat (197, 198).  
 
Despite studies suggesting a link between obesity/ HFD, central inflammation and cognition, 
there is evidence of cognitive resilience under these conditions in both human (304, 305) and 
rodent studies (180). Schwartz and colleagues have demonstrated that a short-term HFD (2 or 
3 weeks) elevates microglial, astrocyte, and cytokine markers in the hypothalamus but has 
little to no effect on extra-hypothalamic inflammation, including the cortex and hippocampus 
(180). In the previously mentioned studies where diet was associated with hippocampal 
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inflammation and cognitive impairment that is partially reversible with anti-inflammatories, 
the rats underwent a diet high in fat for 20 to 22 weeks prior to behavioural testing (197, 
198), therefore, suggesting that hippocampal inflammation and the associated memory 
deficits take much longer to develop than hypothalamic dysfunction.  
 
We have a model which reflects overfeeding during pregnancy and post-partum in humans 
resulting in childhood obesity as well as an increased susceptibility to obesity in adulthood 
(147). We have previously shown that early life diet can strongly influence body weight long-
term (147). Rodents suckled in small litters, where they have greater access to their mother’s 
milk compared with control-fed rats, have accelerated growth and weight gain early on and 
this excess weight and body fat persists at least to young adulthood (155, 156, 158, 159). We 
have demonstrated that early life overfeeding and the obesity that ensues results in 
pronounced hypothalamic inflammation. Particularly, the paraventricular nucleus of the 
hypothalamus (PVN) shows microgliosis and an increase in the expression of 
proinflammatory genes (159, 310). Despite evidence suggesting that the effect of an adult 
HFD is reversible, at least in the hippocampus (195, 311), we have demonstrated that rats that 
are overfed during early life retain hypothalamic microglial priming into adulthood despite 
the commencement of a normal diet at weaning. These animals also have a significantly more 
reactive central and peripheral immune response to inflammatory challenges throughout life 
(157, 159, 310). 
 
As we have seen such pronounced and lasting hypothalamic inflammation after early life 
overfeeding, we hypothesised here that this inflammation in the neonatally overfed rats 
would extend into extra-hypothalamic regions such as the hippocampus and the retrosplenial 
cortex and that this might lead to cognitive deficits. We therefore examined basal 
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microgliosis in our neonatally overfed rats compared to control-fed rats, as well as 
investigated cognitive function in the novel object recognition task (NOR) and delayed win-
shift radial arm maze (RAM) in adult neonatally overfed and control-fed rats. We also 
examined the effects of the RAM on neuronal proliferation and microglial profiles to assess 
how neonatal overfeeding impacts on the ability of the hippocampus and retrosplenial cortex 
to facilitate memory (312, 313).  
 
2.2. Materials and Methods 
2.2.1. Animals  
We obtained timed pregnant Wistar rats from the Animal Resources Centre, WA, Australia. 
On arrival at the RMIT University Animal Facility, the dams were housed at 22°C on a 12 hr 
light/dark cycle (0700 – 1900 hr) and provided with ad libitum pelleted rat chow and water. 
All procedures were conducted in accordance with the National Health and Medical Research 
Council Australia Code of Practice for the Care of Experimental Animals and the RMIT 
University Animal Ethics Committee approved these. 
 
2.2.2. Litter Manipulation 
Pregnant Wistar rats generally give birth to litter sizes of 12-16 pups. Therefore, to create an 
overfed environment we performed a litter size manipulation. On the day of birth (postnatal 
day 0; P0) all pups were removed from their dams and randomly reallocated to new dams in 
litters of 12 (control litter; control-fed) or 4 (small litter; neonatal overfeeding) as we have 
previously described (142, 147, 157, 198). Dams did not receive any of their own pups and 
each new litter was made up of 50% males and 50% females. Excess pups were culled. We 
have previously shown that this manipulation results in SL pups being significantly heavier 
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by P7 and heavier throughout life (142, 147, 157, 198). Following pup reallocation, the litters 
were weighed as whole litters on P0, P7 and P14 unless otherwise stated. At weaning (P21), 
the pups were separated into same-sex littermate pairs and left undisturbed until 
experimentation, except for the usual animal husbandry.  
 
2.2.3. Brain Collection 
On P7, P14 or approximately P70 we deeply anesthetized a cohort of rats with Lethabarb 
(approximately 150 mg / kg pentobartbitone sodium i.p.). These rats were transcardially 
perfused with phosphate buffered saline (PBS: 4°C, pH 7.4), followed by 4% 
paraformaldehyde in PBS (PBS: 4°C, pH 7.4). All experiments took place between 0900 and 
1300 hr to limit potential effect of circadian rhythms on any parameters measured. After 24 
hrs of post-fixation in the same fixative, the brains were removed and placed in 20% sucrose 
in PBS (4°C). We proceeded to cut the forebrains into 30 µm (40 µm for neonatal sections) 
coronal sections using a cryostat. Sections were cut in a one in five series and were stored at 
4°C until use.  
 
2.2.4. Immunohistochemistry 
Sections through the hippocampus and retrosplenial cortex were immunolabelled for a variety 
of different markers as summarised in Table 2.1. One 1 in 5 series of sections from each 
animal was used for each marker. Randomly selected sections from each treatment group 
were processed at the same time in batches. To remove endogenous peroxidase activity, brain 
sections were immersed in 0.3% hydrogen peroxidase (H2O2) in PBS and incubated for 15 
min. Afterwards, sections were washed 5 x 5 min in 0.01M PBS. Sections were blocked for 
30 min with either 3% normal horse serum (NHS) or bovine serum albumin (BSA), 0.3% 
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Triton X-100 in 0.01M PBS to reduce non-specific protein binding. The sections were 
incubated in the primary antibody overnight at 4°C as described in Table 2.1. The primary 
antibody was diluted in the blocking buffer solution. Following the incubation period, 
sections were washed 5 x 5 min in 0.01M PBS to remove excess primary antibody solution 
and then incubated with the secondary antibody for 90 mins. Afterwards sections were 
washed 5 x 5 min, then incubated in Avidin-Biotin Horseradish Peroxidase (HRP) Complex 
(ABC; 1:200 of A, 1:200 of B in 0.01M PBS) for 45 min. Again, sections were washed and 
then incubated in 12 mg diaminobenzidine (DAB) (with or without 1% cobalt chloride and 
1% nickel sulphate) for 10 min then 0.05% H2O2 was added to the DAB solution to visualise 
the HRP activity. The reaction was stopped when the contrast between specific cellular and 
non-specific background labelling was optimal. Sections were mounted onto slides, air-dried, 
dehydrated in a series of alcohols, cleared in histolene and coverslipped.  
 
Table 2.1. Primary and secondary antibodies used in immunohistochemistry 
Antigen Primary Antibody Secondary Antibody 
Ionized calcium-binding 
adapter molecule-1 (Iba-1) 
Rabbit-anti Iba-1 (Wako 
Chemicals, Osaka, Japan) 
 
(1:1000) 
Biotinylated anti-goat (Vector 
Laboratories, Burlingame, CA, 
USA) 
(1:200) 
Neuronal nuclei (NeuN) Rabbit-anti NeuN (Abcam, 
Cambridge, England, UK) 
(1:5000) 
Biotinylated anti-rabbit 
(Vector Laboratories) 
(1:200) 
Doublecortin (DCX) Goat-anti DCX (Santa Cruz 
Biotechnology Inc., Dallas, 
TA, USA) 
(1:500) 
Biotinylated anti-goat (Vector 
Laboratories) 
 
(1:500) 
 
Hippocampal and retrosplenial sections were assessed by an experimenter blinded to 
treatment groups for numbers and density of cells positive for Iba-1 and for numbers of cells 
positive for NeuN and DCX. An experimenter blinded to treatment condition assessed the 
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sections for differences in numbers of cells with Iba-1 labelling and in density and area per 
cell of Iba-1 labelling, as described (314, 315), using photomicrograph images imported into 
image analysis software Image J (National Institutes of Health, Bethesda, MD, USA). 
Briefly, all photomicrograph images were taken using an Olympus upright microscope 
(Olympus BX41; Olympus, Melbourne, Vic, Au) with a 20 times objective lens using an 
Olympus DP72 digital camera (Olympus) and LabSens image capture software v1.6 
(Olympus) software. Images were taken at 4140 x 3096-pixel density. Brain regions were 
identified according to the Paxinos and Watson Rat Brain Atlas (316), in the hippocampus 
four sections between 2.76 and 3.48 mm caudal to bregma; retrosplenial cortex: four sections 
between 2.76 and 3.48 mm caudal to bregma. 
 
Using Image J, we auto-subtracted background and converted each image to 16-bit for 
analysis, then cropped each image to take a representative sample from each region of 
interest within each section. We then assessed numbers of Iba-1-positive cells and density of 
staining using the thresholding method, as described (314, 315). A schematic representation 
of each sampled region of interest assessed is shown in Figure 2.2.1. A. For each region, we 
sampled the three to four sections, 120 µm apart. We saw no differences between the 
rostrocaudal levels for any of the regions, so we took the sum counts and mean density of the 
images as our sampled result. We present analysis from several subfields of the hippocampus 
since there are regional differences in microglial distribution between these regions, with 
microglial density in the CA3 region being lower than in the CA1 region and the dentate 
gyrus (DG), and this heterogeneous distribution may participate in the modulation of 
hippocampal activity (317).  
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The thresholding procedure involves adjusting the pixels of the image to be included in the 
quantification to those that encompass the staining of interest and not the background staining 
(Figure 2.2.1 B-D). We determined the threshold intensity for each brain region by 
calculating the average optimal (manual) threshold for each animal in the control-fed group 
(CL). This was then applied to all the groups assessed for that region. We did this separately 
for cell count, total density and area per cell; the latter is presented as an area fraction, i.e. the 
percentage of thresholded material within the region of interest (314, 315). For NeuN, we 
manually counted NeuN-positive cells in the CA1 and CA3 sub-regions of interest and 
conducted thresholding with the Image J software for the DG. For DCX, we manually 
counted DCX-positive cells in the SG/Granular region of the DG. No DCX-immunoreactive 
cells were visible elsewhere.  
 
 
Figure 2.2.1.: A) Schematic image (adapted from Paxinos and Watson, 2009) illustrating the brain regions from 
which we quantified Iba-1-stained microglia. Regions of interest (red squares) was quantified unilaterally. (B–
D) Images depicting the thresholding method used to quantify Iba-1-stained cells. B) An unprocessed image of 
Iba-1-positive cells. C) The same image when thresholded to calculate the number of Iba-1-positive cells. D) 
The same image when thresholded to quantify overall density of Iba-1-positive staining. Note both the cell body 
and the processes are included in the quantification. DG, Dentate gyrus. 
 
CA1
CA3
DG
A'(3.80 B
C D
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2.2.5. Immunofluorescence   
Hippocampal sections were immunolabelled with fluorescent markers as summarised in 
Table 2.2. One 1 in 5 series of sections from each animal was used for each marker. Sections 
from each treatment group were randomly selected and processed at the same time in batches. 
Sections were washed with 0.01M PBS and blocked for 30 min with 3% BSA, 0.3% Triton 
X-100 in 0.01M PBS. The sections were incubated in the primary antibody overnight at room 
temperature (RT) as described in Table 2. Following the incubation period, sections were 
washed 5 x 5 min in 0.01M PBS to remove excess primary antibody solution and then 
incubated with the fluorescent secondary antibody for 90 minutes (kept in the dark from this 
point). Afterwards sections were washed, then incubated in DAPI as a nuclear counterstain 
(10 min; 1:2000 from 5 mg/ml stock), followed by immediate coverslipping with Dako 
(Dako, Glostrup, Denmark).  
 
Table 2.2. Antibodies and concentrations used in immunofluorescence  
Antigen Primary Antibody Secondary Antibody 
Ki67 Rabbit-anti Ki67 (Abcam, 
Cambridge, England, UK) 
(1:500) 
Alexa Fluoro 594 anti-rabbit 
(Life Technologies Carlsbad, 
CA, USA) 
(1:500) 
Synaptophysin (SYN) Mouse-anti SYN (Sigma-
Aldrich, St Louise, MO, 
USA) 
(1:1000) 
Alexa Fluoro 488 anti-mouse 
(Life Technologies) 
 
(1:500) 
Activated Caspase-3 Rabbit-anti Caspase-3 
(Abcam) 
(1:250) 
Alexa Fluoro 594 anti-rabbit 
(Life Technologies) 
(1:500) 
 
2.2.6. Behaviour 
2.2.6.1. Y-Maze 
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The Y-maze is used to assess spatial recognition memory in animals and is dependent on the 
rodent’s ability to store information about its surrounding environment using spatial cues 
(318, 319). Dr. Jason C.D. Nguyen ran the Y-Maze and analysed the data. The Y-maze 
consisted of three arms with equal angles between all arms (50 cm long x 17 cm wide x 32 
cm high). Salient visual cues of different geometric shapes and contrasting colours were 
placed around the maze on the walls of the room to allow the rat to orientate itself to its 
environment as albino Wistar rats are able to discriminated colour of certain wavelengths 
(320). The test day consisted of two phases; trial and test, with an inter-trial-interval (ITI) 
period in between sessions. During the trial phase, rodents have access to two of the three 
arms (start arm, and familiar arm) and were allowed to freely explore the maze for 8 min. The 
rodents were placed back into their home cage for a 1 hr ITI period. The maze was cleaned 
with 70% ethanol to remove foreign odours. The rodent was then again placed back into the 
maze, facing the start arm, with access to all three arms for an additional 5 min. Both phases 
were filmed for subsequent behavioural analysis. The time the rodent spent in each arm was 
recorded manually by stopwatch and the number of entries into the novel arm during the test 
phase was also recorded. Videos were assessed by an experimenter blinded to treatment 
groups. 
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Figure 2.1. Y-maze. Rodents were allowed to explore the two unblocked arms for 8 mins. After 1 hr, access to 
the previously blocked arm was unblocked and the rodent was allowed to explore all three arms. Spatial cues 
were placed around the Y-maze as represented in the schematic.  
 
2.2.6.2. Novel Object Recognition Task (NOR) 
The NOR; first developed by Ennaceur and Delacour in 1988, is widely used to evaluate the 
rodents working memory ability via recognition of a novel object in the environment. This 
task is based on the differential exploration of familiar and novel objects with rodents 
exhibiting their natural tendency to explore the novel object when paired with a familiar 
object for a longer period of time (321). The objects were identical both in height and volume 
but differed in shape and appearance. The task consists of three phases: habituation, 
acquisition and a retention phase. All of which was completed in an empty open field arena (a 
black plywood box, 65cm x 65cm x 65cm). Salient visual cues of different geometric shapes 
and contrasting colours were placed around the maze on the walls of the room to allow the rat 
to orientate itself to its environment (320). 
 
1 hr
Trial Phase
5 min
Test Phase
5 min
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Figure 2.2. Novel object recognition task. Rodents were freely allowed to explore the arena as well both 
identical objects during the acquisition phase. After a 1 hr inter-trial interval, rodents were placed back into the 
arena with one familiar and one novel object and allowed to explore the arena once again.  
 
The habituation phase consists of the rodents undergoing two sessions of 3 min habituation to 
the empty open-field arena on the two consecutive days preceding the memory testing to 
allow the rats to become familiar with the new environment. The acquisition phase involves 
the rat being placed in the arena with two identical objects (A + A) for 3 min. During this 
time, the rat is allowed to freely explore both objects and the arena. To prevent coercion to 
explore the objects, rodents were placed into the arena facing the wall with its back to the 
objects. The rats returned to their home cage for a 1 hr ITI period. Following this ITI period, 
rodents were placed back into the arena with one of the familiar objects (A) and a novel 
object (B) for 3 min.  
 
The arena was cleaned with 70% ethanol after each animal and session to remove foreign 
odours that can affect explorative behaviours. All sessions were recorded on a Digital video 
camcorder (Canon) for later analysis. The time the rodent interacted with each object was 
determined by manual scoring of the videos. Interaction included body contact and sniffing 
A  A  B A  
1	hour 
Acquisition	Phase 
3	min 
Retention	Phase 
3	min 
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of the object but not by leaning against, standing on, turning around on or sitting on the 
objects. Videos were assessed by an experimenter blinded to treatment groups. 
 
2.2.6.3. Radial Arm Maze (RAM; Delayed spatial win-shift procedure) 
Assessment of spatial, reference and working memory was achieved via testing the rats in a 
delayed spatial win-shift procedure on the RAM, adapted from Packard et al. (Packard et al 
1990). Dr. Jason C.D. Nguyen assisted with the RAM experiments running half of the cohort 
so the trials could be completed in a timely fashion; I ran the other half. Each of us handled 
the same set of rats each day to avoid the stress of a novel experimenter. Testing was carried 
out in an eight-arm radial maze, consisting of an octagonal central platform (34 cm diameter) 
and eight equally spaced radial arms (87 cm long, 10 cm wide). At the end of each arm was a 
food well (2 cm in diameter and 0.5 cm deep). At the start of each arm was a clear Perspex 
door that controlled access in and out of the central area. Each door was controlled by a 
computerised control system enabling the experimenter to regulate access to the arms. Salient 
visual cues of different geometric shapes and contrasting colours were placed around the 
maze on the walls of the room to allow the rat to orientate itself to its environment. 
 
Rodents were habituated to the maze during the first two days of testing, in two 10 min 
sessions. After the final habituation session of the day, the rodents were returned to their 
home cages and given approximately 20 grain reward pellets (45 mg; Bio-Serv). Throughout 
the entirety of the test, access to food was restricted to 80% of the rats’ body weight per 
animal per day to encourage food-seeking behaviour in the maze. Following habituation, 
rodents underwent 24 bi-daily trials consisting of a 5 min training phase, a 5 min ITI where 
the rodent was returned to the home cage and finally a 5 min test phase. During the 5 min 
training phase, four of the eight arms are blocked. These are pseudo-randomly chosen with 
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no more than two adjacent arms being blocked at a time such that the combination of arms 1, 
3, 4, 5 is excluded because 3, 4 and 5 are adjacent arms but 1, 2, 5, 7 is a valid combination 
because only 1 and 2 are adjacent (322-324). The four unblocked arms were baited with three 
grain reward pellets. During this phase of the experiment the rodent is allowed to exploring 
the maze for 5 min or until it has explored all of the open baited arms and has retrieved the 
grain pellet reward from all of the baited arms. After a 5 min ITI in their home cage we 
reintroduced the rat to the maze with all eight arms opened and the previously blocked arms 
baited with grain reward pellets, with the previously open arms left empty.  
 
 
 
Figure 2.3. Delayed-win shift radial arm maze schematic representation with spatial cues placed around 
the maze. During the training phase, rodents are allowed to explore 4 pseudo- random selected arms baited with 
grain pellets whilst the other 4 arms are blocked. After a 5 min ITI, rodents are placed back into the maze. With 
all arms open. Previously blocked arms are then baited with grain pellets (325). 
 
An arm entry was recorded when the animal had moved all four paws off the central platform 
into the arm. All arm entries for each rat was recorded in real time. Two types of errors were 
recorded: working error (re-entry of an arm that had been baited and visited) and reference 
error (entry into an arm that was baited during the training phase). Testing continued until the 
Training phase Test phase
5	min	delay
Non-baited	arm
Baited	arm
Blocked	arm
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rodents made no more than one error in the test phase. To assess learning-induced changes in 
neuron and microglial numbers, we perfused the rats 24 hours after the last RAM trial.  
 
2.2.7. Data Analysis 
We analysed neonatal and adult changes separately. For neonates, we compared Iba-1 cell 
counts and density for each region using two-way analysis of variance (ANOVA)s with 
neonatal nutritional environment (control-fed/ neonatally overfed) and age (P7/14) as 
between factors. Where significant interactions were found, we then performed Tukey’s post-
hoc tests. For adults, we used Student’s unpaired t tests to assess cell counts and density for 
each region, Y Maze and novel object recognition, and two-way ANOVAs to assess post-
RAM changes with litter size and RAM as between factors and Tukey’s post-hoc tests. For 
the RAM, training and test phase, data were binned into blocks of four and data analysed 
using two-way ANOVAs with litter size and block as between factors, followed by Tukey’s 
post-hoc tests. We also performed Pearson’s correlational analyses for the RAM data to 
assess if there were any correlations between learning and weight, microglia counts or 
density in any region, Ki67, or DCX. Data are presented as the mean ± SEM. Statistical 
significance was assumed when p ≤  0.05. 
 
2.3. Results 
2.3.1. Neonatal overfeeding accelerates weight gain  
We have previously seen that Wistar rat pups suckled in small litters have accelerated weight 
gain compared to the control-fed equivalents during early life that persists into adulthood 
(142, 147, 157, 159, 310, 326, 327). In this cohort, the groups were significantly different at 
P14, but not at P7 (litter size by age interaction: F(3, 29) = 40.17, p < 0.001).  
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2.3.2. Neonatal overfeeding induces microgliosis in the CA1 region of the hippocampus at 
P14 
We have previously shown that neonatal overfeeding alters hypothalamic microgliosis from 
as early as P14 and this persists into adulthood (159). This lead us to investigate whether 
early life overfeeding alters extra-hypothalamic regions, in particular the hippocampus, 
which is involved in cognitive function. Jinno et al have suggested that microglial density 
might be involved in site-specific vulnerability of the hippocampus, and that the 
heterogeneous distribution of microglia would participate in the modulation of hippocampal 
activity (317). Therefore, we considered it was important to examine the different subfields. 
Neonatal overfeeding increased both microglial number and density in the Cornus Ammonis 
(CA)1 region of the hippocampus at P14 compared with control-fed rats and both were also 
increased in neonatally overfed rats at P14 compared to P7 (number: significant effect of 
litter size (F(3,29) = 21.73, p < 0.001) and age (F(3,29) = 8.311, p < 0.007), density: significant 
effect of litter size (F(3,29) = 8.006, p < 0.008) and age (F(3,29) = 7.673, p = 0.010); Figure 2.4. 
A, B). Main effects of age and litter size were seen in other hippocampal regions however 
there were no specific effects of neonatal overfeeding with post-hoc comparisons. In the 
CA3, neonatal overfeeding suppresses the overall number of microglia (F(3,24) = 4.76, p = 
0.039; Figure 2.4. E) and age led to an increase in overall density of microglia (F(3,24) = 4.790, 
p = 0.038); Figure 2.4. F). There was a main effect of age in the hilus of the dentate gyrus 
(DG) with an overall increase in density (F(3,24) = 13.072, p = 0.001); Figure 2.4. G, H). 
Density and microglial numbers were also increased overall with age in the sub-granular/ 
granular zone (number: (F(3,24) = 13.177, p = 0.001) and density (F(3,24) = 9.819, p = 0.005); 
Figure 2.4. K, L), specifically elevated microglia and more dense microglia in the P14 
neonatally overfed sub-granular/ granular zone region than in P7 neonatally overfed rats.  
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Figure 2.4. Numbers and density of ionized calcium-binding adapter molecule-1 (Iba-1)-stained cells at 
postnatal (P)7 and 14 in rats raised in control-fed (CL) and small (SL) litters. A-D) CA1. E, F) CA3. G, H) 
Dentate gyrus (DG) hilus. I, J) DG molecular. K, L) DG sub-granular (SG)/ granular region. Data are mean ± 
SEM. * p < 0.05. C, D) Representative photomicrographs of the CA1 region from P14 rats illustrating 
differences in numbers and density of Iba-1-stained cells. Scale bars = 50 µm.  
 
2.3.3. Neonatal overfeeding induces long-term changes in hippocampal microgliosis. 
An accelerated weight gain in rats suckled in small litters persisted into adulthood compared 
to control-fed rats as previously shown in Ziko et al. 2014 (data not shown). As we have 
previously seen microgliosis in the hypothalamus of neonatally overfeed rats persisted into 
adulthood (159), we therefore investigated if hippocampal microgliosis was also sustained 
long-term. Surprisingly, microgliosis and denser microglia did not persist into adulthood in 
the CA1 (Figure 2.5. A, B) and CA3 regions (Figure 2.5. C, D). However, we did see an 
effect of neonatal overfeeding in the DG, which is an important region for neurogenesis. 
Neonatal overfeeding led to elevated microglial density in the hilus (t(10) = 3.647, p = 0.005; 
Figure 2.5. E, F) and subgranular/granular (t(10) = 2.647, p = 0.024; Figure 3.5. I, J) regions of 
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the DG compared with control-fed rats. Microglial density in the molecular region of the DG 
reached near significance between the groups with a p value of 0.073 (Figure 2.5. G, H).   
 
 
Figure 2.5. Numbers and density of ionized calcium-binding adapter molecule-1 (Iba-1)-stained cells at 
postnatal 70 in rats raised in control-fed (CL) and small (SL) litters. A, B) CA1. C, D) CA3. E, F) Dentate 
gyrus (DG) Hilus. G, H) DG Molecular. I, J) DG sub-granular (SG)/ granular region. Data are mean ± SEM. * p 
< 0.05. K, L) Representative photomicrographs of the DG region from P70 rats illustrating differences in 
numbers and density of Iba-1-stained cells. Scale cars = 50 µm.  
 
2.3.4. Overfeeding during critical development stages affects cognitive function in tests of 
learning and memory 
Our findings to this point show that neonatal overfeeding conferred a mild but notable 
hippocampal microgliosis, we therefore tested if this was reflected in changes in cognitive 
function, specifically with respect to learning and memory. Neonatal overfeeding did not 
affect performance in the number of entries into the novel arm of the Y maze nor the duration 
of time spent in the novel arm (Figure 2.6. A, B). However, subtle differences in learning and 
memory were seen in the novel object and RAM. Control-fed rats spent a longer duration 
exploring the novel object (positive discrimination ratio) indicative of their natural 
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explorative tendency, which suggests that these rodents are able to recall the task, whereas 
neonatally overfed rats did not spend more time exploring the novel object (negative 
discrimination ratio) thus were unable to recall the task. This difference between the groups 
was significant (t(10) = 9.21, p < 0.001; Figure 2.6. C). 
 
 
Figure 2.6. Behavioural testing of learning and memory. (A, B) Y maze (A, B), (C) novel object recognition 
test, (D-F) radial arm maze and (G-I) contextual fear conditioning (G-I) in adult rats raised in control (CL) and 
small (SL) litters. A-C) Data are mean ± SEM. D-F) Data are mean + SEM. A-C. D: * P < 0.05 in CL compared 
with CL block 1. E, F: * p < 0.05 in CL compared with CL block 7; # p <0.05 in SL compared with SL block 7.  
 
In RAM, the control-fed group initially had significantly more working memory errors during 
the training phase compared to the neonatally overfed rats, however, improved by day 4 
(litter size by block interaction: F(13,120) = 2.31, p = 0.038; Figure 3.6. D), whereas neonatally 
overfed rats showed no differences. The control-fed group showed a significant improvement 
in working memory during the test phase (significant effect of block: F(13,120) = 3.57, p = 
0.003; Figure 2.6. E), however, this was not apparent until day 14. The control-fed rats also 
significantly improved more quickly in comparison to neonatally overfed in their reference 
memory in the test phase (significant effect of block: F(13,120) = 7.91, p < 0.001; Figure 2.6. 
F). Control-fed rat errors where statistically indistinguishable from criterion by day 6 whilst 
the neonatally overfed rat errors were still significantly different from criterion at day 12.  
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2.3.5 Effects of neonatal overfeeding on learning-induced changes in the hippocampus 
and retrosplenial cortex 
Our findings prompted us to investigate if neonatal overfeeding induces a change in 
neurogenesis or synaptogenesis in the hippocampus in response to a learning task, the RAM, 
in comparison to a second group of control rats that did not undergo RAM training. Despite 
expectations that a learning task would stimulate neurogenesis in our control-fed rats that 
experienced the RAM, we found that control-fed rats had suppressed numbers of proliferating 
cells so that following the RAM neonatally overfed animals had significantly more Ki67-
positive cells than control-fed rats (significant litter size by RAM interaction: F(3,18) = 4.32, p 
= 0.052; Figure 2.7. A). These proliferative differences are unlikely to be accounted for by 
differences in neurogenesis as RAM also suppressed the number of immature neurons (DCX) 
seen in the subgranular/ granular zone of the hippocampus for both groups (significant litter 
size x RAM interaction: F(3,26) = 5.316 p = 0.029; Figure 2.7. B, C). The total number of 
mature neurons in the CA3 was supressed in the control-fed rats that underwent the RAM 
task, so that there were significantly more NeuN-positive cells in the neonatally overfed than 
control-fed rats (significant effect of litter size: F(1,32) = 14.70,  p = 0.001; Figure 2.7. H). 
However, the total number of neurons were not affected by the learning task in the CA1 or 
dentate gyrus (Figure 3.7. D-G); in the subgranular/granular region there was a significant 
main effect of litter size with the neonatally overfed having more neurons overall, but no 
differences with post-hoc tests (F(3,32) = 7.32, p = 0.011; Figure 2.7. D). The RAM task did 
not affect apoptosis as detected by numbers of cells positive for activated caspase-3 (Figure 
2.7. I-K). Neonatal overfeeding lead to more synaptophysin overall. However, there was no 
effect of RAM and no post-hoc differences (significant effect of litter: F(3,187 = 4.85, p = 
0.042; Figure 2.7. L). 
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Figure 2.7. Effects of a learning task on neuroproliferation. Numbers of hippocampal proliferating cells (A; 
Ki67), immature neurons (B, C; doublecortin (DCX)), total neurons (D-H; neuronal nuclei (NeuN)), apoptotic 
cells (I-K; caspase-3), and synaptic density (L; synaptophysin) at postnatal day 70 in rats raised in control (CL) 
and small (SL) litters under basal conditions and 24 hr after the last radial arm maze (RAM) training session. 
Data are mean ± SEM. N = 6-12 per group. * p < 0.05. Representative photomicrographs of hippocampal B) 
DCX and G) NeuN. Scale bars = 50 µm. DG = dentate gyrus.  
 
Our findings that microglia can be programmed by neonatal overfeeding (159, 310) alongside 
previous work showing microglial involvement in learning and memory (198) led us to 
investigate whether neonatal overfeeding contributes to changes in the hippocampal 
microgliosis profile in response to a learning task; the RAM. Rodents that were subjected to 
the RAM showed altered microglial profiles compared to control-fed and neonatally overfed 
rats that did not undergo the learning task, markedly suppressing microglial density 
throughout the hippocampus (Figure 2.8. A-L). Microglial density was suppressed in control-
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fed rats after the RAM training in the CA1 region (density: significant effect of RAM: F(3,31) 
= 13.731, p < 0.001; Figure 2.8. B) as well as significantly fewer microglia and less Iba-1 
staining (density) in the CA3 region in control-fed rats (number: significant effect of RAM: 
F(3,28) = 9.518, p = 0.005; density: significant effect of RAM: F(3,27) = 10.979, p = 0.003; 
Figure 2.8. C, D). A reduction in density was found in the three regions of the DG in the 
animals subjected to the RAM in both groups and abolished basal control-fed and neonatally 
overfed differences (hilus: number: significant effect of RAM: F(3,29) = 13.008, p < 0.001; 
density: significant effect of RAM: F(3,27) = 58.429, p < 0.001; Figure 2.8. G, H. Molecular: 
number: significant effect of RAM: F(3,29) = 9.285, p = 0.005; density: significant RAM by 
litter size interaction: F(3,27) = 12.278, p = 0.002; Figure 2.8. I, J. Sub-granular/ granular: 
number: significant effect of RAM: F(3,29) = 8.280, p = 0.007; density: significant effect of 
RAM: F(3,27) = 22.65, p < 0.001; Figure 2.8. K, L). We also found that neonatally overfed rats 
(but not control-fed) microglial density, in the molecular region, was negatively correlated 
with learning (i.e. reduced microglial density was correlated with more bin 5 reference 
memory errors; R2 = 0.607; p = 0.014; Figure 2.8. M). There was also no within-group or 
overall correlation with learning and weight markers and no correlation with learning and 
weight (Figure 2.8. N), despite that the neonatally overfed group weighed significantly more 
than the control-fed as previously described (RAM controls = 350.1 ± 6.3 at P57 vs 
neonatally overfed = 376.1 ± 8.9 g; t(18) = 2.70, p = 0.028).  
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Figure 2.8. Numbers and density of ionized calcium-binding adapter molecule-1 (Iba-1)-stained cells at 
postnatal 70 in rats raised in control (CL) and small (SL) litters under basal conditions and 24 hr after the 
last radial arm maze (RAM) training session. CA1 (A, B, E). CA3 (C, D, F). Dentate gyrus hilus (G, H). 
Molecular region (I, J). Sub-granular (SG)/ granular region (K, L). Scatterplots between SL, but not CL, Iba-1 
density and RAM reference errors bin 5 in the molecular region of the DG (M). Scatterplots showing lack of 
correlation between CL and SL body weight and RAM reference error bin 5 (N). Data are mean ± SEM. N = 6-
12 per group. * p < 0.05. Representative photomicrographs of the CA1 and CA3 regions from rats illustrating 
differences in microglial density after a learning task (E, F). Scale bars = 50 µm. DG = dentate gyrus.  
 
Differences in the hippocampal microglial profile in the control-fed rats subjected to the 
RAM led us to investigate the retrosplenial cortex as previous studies indicate that this region 
is reciprocally connected with the hippocampus and is essential for developing and retaining 
spatial memories in tests such as the RAM (328-330). Microglial numbers were reduced in 
the dysgranular region of the retrosplenial cortex in both RAM groups (significant effect of 
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RAM: F(1,32) = 19.59, p < 0.001; Figure 2.9. A), with a significant main effect of RAM but no 
group differences in density (F(1,32) = 6.75, p = 0.014; Figure 2.9. B). Additionally, numbers 
and density were only affected in control-fed rats but not neonatally overfed in the granular 
region (number: significant effect of RAM: F(1,31) = 12.14, p =  0.001; density: significant 
effect of RAM: F(1,30) = 12.91, p = 0.001; Figure 2.9. C, D). The learning task thus had clear 
effects on microglial profiles in both the hippocampus and retrosplenial cortex, 
predominantly in control-fed rats. 
 
 
Figure 2.9. Numbers and density of Iba-1-positive cells in the retrosplenial cortex. (A, B) retrosplenial 
dysgranular cortex (RSD) and (C-E) retrosplenial granular cortex (RSGc). Data are mean ± SEM. N = 6-12. * p 
< 0.05. Representative photomicrographs of Iba-1. 
 
 2.4. Discussion 
This study is the first to (A) show the effects of neonatal overfeeding on hippocampal 
inflammation in association with cognition; (B) examine whether the effects of diet on 
cognition can persist long-term if the overfeeding is during the neonatal period (during the 
first 3 weeks of life), compared to dietary effects in adults which are partially reversible; and 
(C) determine the changes in microglia that occur in cognitive-processing regions in response 
to a learning task in both the control-fed and neonatally overfed state. 
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Neonatally overfed rats performed less successfully in tests of hippocampal-dependent 
working and spatial memory. They were unable to recognise a previously encountered object 
in the NOR test and were less efficient in their memory acquisition in the RAM, taking 
longer to approach criterion for both reference and working memory. Cognitive deficits have 
also been seen in other studies of early life diet. Juvenile HFD-induced obesity led to poorer 
performance in the RAM (236) as well as impaired long-term spatial reference memory in the 
MWM (237). These animals also had poorer short-term memory, therefore had difficulty 
consolidating the previously learnt task. Contrary to our findings, there is literature to suggest 
that maternal HFD during pregnancy and lactation results in improved memory compared to 
control-fed counterparts (201, 202). This difference in cognitive function could potentially be 
due to the model of early life diet. These studies induce obesity in pups via maternal diet 
during pregnancy and lactation. Fatty acids are crucial for both brain development and 
myelination. Therefore, a change in composition of fatty acids present during development 
may have significant consequences. In these studies, rats from a HFD dam do not exhibit 
cognitive impairment, suggesting that elevated levels of fatty acid during development may 
be beneficial (201, 202). Our model of neonatal overfeeding does not change the composition 
of fatty acids rather just the amount of dam’s milk available therefore impairments in 
memory still occur.  
 
Spatial learning is known to have two distinct phases: an acquisition (early) phase in which 
improvements in performance occur rapidly, and an asymptotic (late) phase during which 
asymptotic levels of performance are reached (89). Acquisition of the learning task during the 
WMW promotes an elevation in the survival of newborn neurons generated a week before the 
commencement of the task. Maturation of adult neurons exhibit similarities to hippocampal 
neuronal development and is known to be a four-week process therefore these week-old 
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neurons are at an intermediate level of maturity (89). At the start of the asymptotic phase in 
which the task has been mastered, apoptosis of newborn neurons that are 7 to 9 days old is 
induced (89). These intermediate level neurons have begun to receive depolarizing 
GABAergic inputs and extend their projections into the CA3 region of the hippocampus 
beginning to integrate into functional circuits (90). These neurons have also begun 
communicating glutamatergic outputs at the expense of new, immature neurons that lack 
afferent inputs, to reduce noise in the network (90). This learning-induced apoptosis is 
followed by an increase in cell proliferation providing the hippocampus with new young 
neurons (89, 90). This process is critical to learning the spatial task and rats with the highest 
level of learning-induced decrease of immature cells perform the best in the MWM (89). 
Prevention of apoptosis in the asymptotic but not in the acquisition phase, with caspase-3 
inhibition, delays acquisition of spatial memory in the task, reflecting impaired learning (90). 
Both of our groups of rats showed similar levels of newborn neurons, as detected by DCX. 
However, only the control-fed rats had reduced levels of cell proliferation and reduced total 
neuronal numbers in the CA3, potentially indicating only the control-fed rats were capable of 
stimulating learning-induced apoptosis of immature neurons and suppressing cell 
proliferation until the task had been mastered. It is noteworthy that during our RAM task we 
did not explore the same parameters as previous published studies. Our RAM task was 
terminated immediately upon our rats reaching criterion, after 14 days (25 sessions) of 
training and does not correspond to that of studies conducted with the MWM where learning 
acquisition had stabilised (89, 90), therefore this may explain why we do not see increases in 
apoptosis in either group. 
 
In addition to an inability to suppress cell proliferation and CA3 neuron numbers, we found 
differences in microglia after the RAM task between our neonatally overfed and control-fed 
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rats. We had previously hypothesised that overfeeding during development would result in 
primed hippocampal microglia that were able to hyper-respond to a spatial learning task, 
resulting in a pro-inflammatory profile (306). Contrary to our initial hypothesis, we found 
that hippocampal microglia were not affected by the RAM to the same degree in the 
neonatally overfed compared to control-fed rats. Microglia are known to play a key role in 
learning and memory, regulating apoptosis and synaptic plasticity (331). A ramified state of 
microglia is necessary for the elimination of synapses and structural plasticity, which is 
crucial for normal cognition. An altered microglial profile results in synaptic dysfunction and 
in turn could alter cognition (331). This phenomenon is apparent in studies of HFD in 
adulthood whereby HFD can reversibly increase microglia’s internalization of synaptic 
contacts, leading to memory deficits (195). Furthermore, Parkhurst et al have shown that 
short-term microglial depletion in CX3CR1CreER mice affects synaptic remodelling as well as 
reduces spontaneous glutamate release therefore impairing learning and memory in various 
regions of the brain (61, 96).  Alternatively, longer-term microglial depletion using a 
different model can significantly improve memory performance (36). It has been 
demonstrated that microglia are the only cell type in the brain that express colony-stimulating 
factor 1 receptor (CSF1R) under normal conditions (332, 333). Elmore and colleagues have 
demonstrated that mice given PXL3397, an inhibitor of CSF1R, for 2 months had a 99% 
depletion of microglia across the brain. These mice performed significantly better compared 
to control mice in the Barnes maze, a spatial learning task. Long-term microglial depletion 
resulted in these mice remembering the location of the escape route faster in the Barnes maze 
with no difference in locomotion or other behaviours as well as no differences in contextual 
fear conditioning (36). This study supports our own findings that the physiological response 
of the normal (control-fed) rat to a spatial learning task (RAM) is to reduce numbers of 
microglia in the hippocampus and retrosplenial cortex may be crucial to successful learning. 
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It appears from our data that rats overfed during early life are less efficient at doing this. 
Moreover, our data also suggest that a certain threshold of microglial activation is necessary 
for appropriate learning. Microglial density was negatively correlated with learning 
performance in the molecular region of the dentate gyrus in the neonatally overfed rats.  
 
We found no within-group or overall correlations between learning and weight, which 
suggests that the long-term effects of early life diet on the brain are more important than 
weight per se for cognitive function. It remains to be determined if early life overfeeding 
leads to long-term changes in microglial responsiveness. Previous literature has illustrated an 
association between a diet high in saturated fat when introduced during adulthood and a 
systemic pro-inflammatory profile (334). This profile results in an increase in circulating pro-
inflammatory cytokines that contribute to systemic insulin resistance as well as stimulating a 
central pro-inflammatory response at the level of the hypothalamus (172, 306, 335). In rodent 
models, microgliosis within the hypothalamus occurs as early as 24 hr after the HFD 
commencement and is also linked with the death of pro-opiomelanocortin cells after 2 weeks 
(180). It has become increasingly apparent that a HFD can cause hypothalamic inflammation, 
which can disrupt normal feeding- and metabolism-related signalling. However, it is still 
unknown how central inflammation might influence cognition. Microgliosis induced by HFD 
results in a reduction of hypothalamic neurogenesis (336) and impaired plasticity (337) and 
this could potentially disrupt hypothalamic connectivity within brain regions important in 
cognitive function, such as the hippocampus and retrosplenial cortex. There is evidence to 
indicate that prolonged exposure to a HFD may contribute to inflammation that extends 
beyond the hypothalamus into extra-hypothalamic regions. Microgliosis is apparent in the 
hippocampus after 20 weeks of a HFD and the associated cognitive dysfunction improved 
with resveratrol (198). Maier and colleagues have also shown an elevation in hippocampal 
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interleukin (IL)-1β after 12 and 20 weeks HFD, and central IL-1RA improved the cognitive 
function of these rodents (311). It is postulated that a similar process is occurring in neonates, 
however, as the microglia are maturing at this time the changes may be more permanent. 
Leptin plays a role in hippocampal development therefore increases in leptin, occurring with 
neonatal overfeeding, could alter neurogenesis and synaptogenesis during development and 
permanently change the response to a memory task (338, 339). Recent studies have shown 
that early life perturbations can lead to hippocampal microglial priming such that they retain 
a more activated phenotype throughout life and are more sensitive to stimuli (47, 204, 340). 
For instance, microglia are primed to be more reactive to an LPS challenge throughout life 
after neonatal infection with Escherichia coli at P4 (47). These rats that were neonatally 
challenged also have impaired contextual memory in the presence of a novel neuroimmune 
challenge, however, the microglial response was not assessed in this study. We therefore 
speculate that neonatal overfeeding is priming the hippocampal microglia to be more 
sensitive to neuro-inflammatory stimuli and are less able to down-regulate or reduce their 
input when needed for a learning task, and thus, these neonatally overfed rats’ role in 
regulating neurogenesis and synaptic plasticity is impaired. 
 
In summary, we have shown that these neonatally overfed rats have long-term learning and 
memory deficits, which are associated with reduced ability to regulate neurons and microglia 
in the context of a learning task. The early life environment may play a vital long-term 
contribution to cognitive processes and therefore may partially explain why some individuals 
with obesity display cognitive dysfunction whilst others do not.  
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CHAPTER 3 
Neonatal overfeeding sensitises hippocampal 
microglial responses to immune challenge: 
reversal with neonatal repeated injections of 
saline as well as minocycline 
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3.1. Introduction  
As discussed in the previous chapter, early life diet in children and animals can strongly 
influence body weight long-term (147, 148, 159, 171, 202). As such, children and rodents 
that overeat or have poor diet during vulnerable windows of development are at significant 
risk of long-term obesity and the myriad associated comorbidities that ensue (341). For 
instance, rodents suckled in small litters, where they have greater access to their mother’s 
milk compared with controls, have accelerated growth and weight gain early on; this excess 
weight and body fat persists at least to young adulthood (155, 156, 158, 159). Neonatal 
overfeeding leads to metabolic dysfunction (142, 155, 160), hypothalamic-pituitary-adrenal 
(HPA) axis dysfunction (162, 163), reproductive problems (165), and other complications. In 
addition to these complications, neonatal overfeeding leads to a potentiated febrile response 
(157) as well as hypersensitivity or “priming” of hypothalamic microglia, one of the major 
immune cell populations in the brain (159). Hypothalamic microglia in the neonatally overfed 
are increased in number and density under basal conditions, reflective of a pro-inflammatory, 
hyper-activated profile. They also hyper-respond to stimulation with lipopolysaccharide 
(LPS) and this is associated with elevated circulating cytokines (159), suggesting neonatal 
overfeeding leads to an increased response to immune challenge. 
 
This programming effect of early life diet on microglia extends beyond the hypothalamus; 
microglia are also increased in density in the hippocampus in adults that have been overfed as 
neonates as we showed in Chapter 2 and (342). Similarly, recent studies have shown a primed 
hippocampal microglial profile in adult offspring from high-saturated-fat diet-fed dams (202, 
204). Performance in hippocampally-mediated learning tasks is less efficient in these rats 
(202, 204) and it appears from Chapter 2 of this thesis that microglia are less responsive to a 
learning task in neonatally overfed rats than in control-fed (342). Microglia have region-
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specific heterogeneity with different responses to stimuli in different brain regions (343-346). 
The HPA axis is activated during an immune challenge. The hippocampus is an important 
region for glucocorticoid feedback inhibition of the HPA axis alongside the paraventricular 
nucleus of the hypothalamus (PVN) (347). High concentrations of both glucocorticoid and 
mineralocorticoid receptors are found in the hippocampus which aids in the reduction of 
basal and stress induced glucocorticoid release (347, 348). Neonatally overfed rats have a 
primed microglial profile under basal conditions in both the hypothalamus and hippocampus, 
and noting the integral role of the hippocampus in responding to immune challenge (349, 
350), we hypothesised that hippocampal microglia from neonatally overfed rats would be 
hyper-activated in response to LPS, leading to an altered ability to respond to the immune 
challenge.   
 
We therefore tested hippocampal microglial responses to LPS in vitro and in vivo in rats that 
had been suckled in small litters (neonatally overfed; SL) compared to those that had been 
suckled in normal-sized litters (control-fed; CL). To restore normal hippocampal microglial 
responses, we then attempted to suppress microglial activation during the neonatal period 
with the second generation antibiotic, minocycline (268). Minocycline effectively crosses the 
blood-brain barrier after systemic administration (351, 352), and is a known inhibitor of 
microglial activation (271, 272). Minocycline has been shown to ameliorate 
neuroinflammation at the site of hypoxic-ischemic insult in neonatal rodent studies (267, 272-
274, 353). Unexpectedly, we found that the injection protocol, even in the saline-treated rats, 
markedly suppressed microglial number and density throughout the hippocampus. It also 
reversed the effects of neonatal overfeeding on microglia. There was no additional effects of 
minocycline. Our outcomes have significant implications for future study design and also 
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suggest that the negative effects of neonatal overfeeding, on at least microglial 
responsiveness, may be mitigated by neonatal experience.   
 
3.2. Materials and Methods 
3.2.1. Animals  
As described in Chapter 2, we obtained timed pregnant Wistar rats from the Animal 
Resources Centre, Murdoch, WA Australia. On arrival at the RMIT University Animal 
Facility at gestational day 16, we singly-housed the dams at 22 °C on a 12 hr light/dark cycle 
(light: 0700 – 1900 hr) and provided them with ad libitum pelleted rat chow and water. All 
procedures were conducted in accordance with the National Health and Medical Research 
Council Australia Code of Practice for the Care of Experimental Animals, and experiments 
were approved by the RMIT University Animal Ethics Committee. 
 
3.2.2. Litter manipulation and minocycline treatment 
To create our early life overfeeding model, we performed litter manipulation as described 
previously in Chapter 2 (section 2.2.: Litter Manipulation). We have previously reported 
weight data from this cohort of rats (those shown here in Figure 3.2. and Figure 3.3.) and 
have previously analysed their HPA axis responses to an immune challenge and have found 
that the neonatally overfed rats have a dampened efficiency of the adrenally-mediated 
response to LPS (164). 
 
For the neonatal treatment, we administered either minocycline (22.5 mg / kg i.p. in saline, 
100 µL) or vehicle (saline, 100 µL) once every second day during the three-week suckling 
period starting on postnatal day (P)1 to control-fed and neonatally overfed pups (268) (Figure 
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3.1. B). Each litter had equal numbers of minocycline and saline-treated pups. To administer 
the minocycline (or vehicle), we removed the entire litter of pups from the dam, completed 
the injections, then returned the whole litter unit to the dam. Each pup was handled for 
approximately 10 s on each injection day and was separated from the dam for a maximum of 
10 min. We refer to this treatment throughout the manuscript as the injection protocol.  
 
Figure 3.1. Timeline of the experimental design. Litter size manipulation is performed on the day of birth 
(postnatal (P)0) into litters of 12 (control-fed; CL) or 4 (neonatally overfed; SL). Litters are randomly? 
assigned to either A) non-injected or B) the neonatal injection protocol during the suckling period until 
weaning (P21). Pups are weaned into pairs and left undisturbed until experiment during adulthood (P70). 
C) To further examine the impact of the injection protocol on microglia, we performed another experiment 
on a different cohort of non-injected pups.  
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3.2.3. Hippocampal microglial responses to immune challenge 
To determine if hippocampal microglia were hyper-responsive to an immune challenge in 
neonatally overfed animals, we gave adult (P70) control-fed and neonatally overfed rats an 
i.p. injection of LPS (100 µg / kg / mL; E. coli, serotype 0.127:B8; L-3129; Sigma-Aldrich, 
St Louis, MO, USA) or pyrogen-free saline, 24 hr prior to cull (Figure 3.1. A). 
 
At 24 hr after LPS injection, we deeply anaesthetized the rats and processed the tissue for 
immunohistochemistry as described in Chapter 2 under the section 2.2.3. Brain Collection. 
Immunohistochemistry was performed to assess microgliosis for ionized calcium-binding 
adapter molecule-1 (Iba-1) as previously described in Chapter 2 under the section 2.4. 
Immunohistochemistry.  
 
3.2.4. Microglial cell isolation and in vitro immune stimulation  
To assess microglial responsiveness in vitro, we euthanized a cohort of otherwise untreated 
control-fed and neonatally overfed rats in early adulthood (P70) with a lethal dose of sodium 
pentobarbital (Figure 3.1. A). We rapidly extracted the brains, and dissected the two 
hippocampi on ice. Whole hippocampi were placed in ice cold Dulbecco’s PBS 
supplemented with 0.2% glucose (sDPBS). These experiments were conducted in accordance 
with previous literature that states isolated microglial cultures do not change their phenotype 
after 4 hrs post-isolation (354-356). Moreover, we directly analysed freshly isolated 
microglia, which have been shown to be more representative for the in vivo status of 
microglial cells at the time of isolation (356, 357).  
 
Tissue was homogenized according to the methods previously described by Frank et al (356, 
358, 359). Briefly, we finely minced the whole hippocampi with a razor blade in DPBS and 
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transferred the minced tissue to an iced tissue homogenizer. The homogenate was filtered 
through a 40 µM cell strainer (BD Biosciences Discovery Labware, Australia) and was 
pelleted at 1500 rpm for 10 min.  A Percollâ density gradient was created by resuspending 
the pellet in 70% isotonic Percollâ (Sigma-Aldrich), followed by 37% and 30% Percollâ 
layers and topped with DPBS. The gradient was spun for 45 min at 3400 x rpm at 20 °C with 
minimum acceleration and brake. Microglia were extracted from the 37 / 70% interface. 
Following isolation, hippocampal microglia from cage-mate pairs were combined and stained 
with Trypan blue and the numbers of viable cells were counted under the microscope based 
on dye exclusion. We obtained a density of > 5 x 105 cells. Cells were pelleted at 1500 x rpm 
for 5 min at room temperature (RT) and then separated for either flow cytometric assessment 
or in vitro immune stimulation.   
 
For flow cytometric assessment of microglial purity and immunophenotype, microglia were 
stained with both CD11b-FITC (a microglial marker to assess microglial purity) and CD45-
PE (a non-microglial macrophage marker to assess contamination with other brain 
macrophages) (356). Briefly, microglia (> 3 x 104 cells) were suspended in incubation buffer 
(sDPBS) and kept on ice for 30 min prior to staining. Antibodies and the isotype controls 
(1:100; Anti-Rat CD45-PE, Anti-Rat CD11b-FITC, Mouse IgG2a K Isotype Control FTC, 
Mouse IgG2a K Isotype Control PE; EBiosciences, Waltham, MA, USA) were diluted in the 
incubation buffer and incubated on ice for 1 hr. Cells were washed and resuspended in DPBS 
and immediately analysed by flow cytometry.  
 
Isolated microglia were analysed on a FACSCanto II cytometer (BDBiosciences, North 
Ryde, NSW, AUS). For each staining condition (isotype control and antibody of interest), 1 x 
104 events were collected. Quantitation of positively labelled cells was determined by setting 
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the threshold on background staining of isotype control. The mean fluorescence intensity of 
each sample was measure and expressed as a fold increase. To ensure that the population of 
cells analysed were a pure population of microglia (CD11bhigh/ CD45low), we performed 
gating on size and granularity to exclude the debris.  
 
For in vitro immune stimulation, microglia (3 x 104 cells per well) were resuspended in 100 
µL / well of media (RPMI + 10% Fetal Bovine Serum (FBS)). To assess microglial cytokine 
responsiveness, cells were challenged with LPS (E. coli, serotype 0.127:B8; L-3129; Sigma) 
at a concentration of either 10 or 100 ng / mL, or media alone (356) for 4 hr at 37°C, 5% 
CO2. At the end of incubation, 100 µL of media was collected, centrifuged at 1500 x rpm for 
1 min at RT, and kept frozen for cytokine analysis.  
 
To assess changes in LPS-stimulated hippocampal microglia, cultured supernatant fluids 
were analysed for two pro-inflammatory cytokines, interleukin-6 (IL-6) and tumour necrosis 
factor-α (TNF-α) in a simultaneous, multiplexed format using a Bio-Plex Pro rat cytokine 
assay. All procedures were carried out according to the recommended procedure (Bio-Plex 
Pro Array System, Bio-Rad Laboratories Inc., Hercules, CA, USA). The data were analysed 
using Bio-Plex Manager Software 6.1 (Bio-Rad).  
 
3.2.5. Assessment of body fat composition via EchoMRI in adult neonatally injected rats 
One week prior to cull, a cohort of adult (P63) control-fed and neonatally overfed rats that 
had been treated as neonates with minocycline or saline underwent a magnetic resonance 
imaging (MRI) scan to assess fat and lean mass (Figure 3.1. B). Rats were briefly restrained 
for the duration of the 90 s scan. 
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3.2.6. Effects of minocycline on adult microglia and central susceptibility to LPS 
To determine if the increased microglial activation after LPS in adult rats that had been 
overfed as neonates could be reversed by neonatal microglial inactivation with minocycline, 
we also examined immunohistochemical responses to LPS (as described above; Figure 3.1. 
B). We assessed this in a cohort of adult control-fed and neonatally overfed rats that had been 
treated as neonates with minocycline or saline (as described above).  
 
3.2.7. Assessment of plasma corticosterone 
To assess basal HPA axis function in adults that had been overfed as neonates, versus 
control-fed, and either not injected (Figure 3.1. A) or given the injection protocol (saline; 
Figure 5.2.1 B), we measured plasma corticosterone concentrations. We used a standard rat 
corticosterone ELISA (Abnova Corp., Taipei, Taiwan). The inter-assay variability for this 
assay was 7.2% coefficient of variation (CV), intra-assay variability 4.8% CV, and lower 
limit of detection 40 pg/ mL. We assayed samples from all treatment groups together in 
duplicate.  
 
3.2.8. Data Analysis 
As described for the experiments in Chapter 2 section 2.7. data were analysed by SPSS using 
multi-factorial analyses of variance (ANOVAs) with Tukey’s post-hoc tests where significant 
interactions were found. We analysed weight data using mixed-design ANOVA. Data are 
mean ± SEM and statistical significance was assumed when p < 0.05.  
 
3.3. Results 
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3.3.1. Neonatal overfeeding increases the microglial response to LPS in adults 
Neonatal overfeeding increased susceptibility to the central effects of an immune challenge in 
the Cornus Ammoni (CA)3 and CA1 regions of the hippocampus at 24 hr after i.p. LPS 
(Figure 3.2. A-E), however, there were no differences in density. Thus, after LPS injection, 
the numbers of microglia were significantly higher in the CA3 region in neonatally overfed 
than control-fed rats, and were also significantly elevated after LPS compared with saline-
treated animals (significant effect of litter size: F(1,36) = 12.28, p = 0.001 and LPS: F(1,36) = 
8.61, p = 0.006; n = 6-16). The neonatally overfed rats also showed increased numbers of 
microglia in the CA1 region compared to control-fed rats (significant effect of litter size: 
F(1,39) = 13.61, p = 0.001 and LPS: F(1,39) = 5.88, p = 0.02). Numbers of microglial cells were 
also increased in the hilus with neonatal overfeeding (significant effect of litter size: F(1,35) = 
14.68, p = 0.001; Figure 3.2. G) and subgranular/granular (significant effect of litter size: 
(F(1,35) = 13.17, p = 0.001; Figure 3.2. I) regions of the dentate gyrus (DG) but not in the 
molecular region of the DG (Figure 3.2. K). 
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Figure 3.2. Numbers and density of ionized calcium-binding adapter molecule-1 (Iba-1)-immunolabelled 
cells 24 hours after an i.p. saline or lipopolysaccharide (LPS) injection at postnatal day (P)70 in rats 
raised in control-fed litters (CL) and small litters (neonatally overfed; SL). A, B) CA3 region. C, D) CA1 
region. G, H) Dentate gyrus (DG) hilus. I, J) DG subgranular/granular region. K, L) DG molecular region. 
Data are mean ± SEM. N = 6-16 per group. Stripes represent animals that are injected with LPS. E, F) 
Representative photomicrographs of the CA3 (E) or the dentate gyrus (F) region from control-fed and 
neonatally overfed rats at P70 injected with saline or LPS i.p. illustrating differences in numbers of Iba-1-
positive microglia. Scale bar = 50 µm. * main effect of litter size. # main effect of LPS. p < 0.05.  
 
Additionally, in the DG, the previously reported finding (Chapter 2; Figure 3.4.) that density 
was increased in neonatally overfed rats with respect to control-fed rats under basal and LPS-
stimulated conditions (342) was replicated here (Figure 3.2. H, J, L). Thus, there was a 
significant effect of litter size on density in the hilus, subgranular/granular, and molecular 
regions, with neonatally overfed rats having higher density than control-fed (hilus: F(1,36) = 
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30.44, p < 0.001; Figure 2H, subgranular/ granular: F(1,36) = 27.87, p < 0.001; Figure 3.3.1.J 
and molecular: F(1,35) = 39.40, p < 0.001; Figure 3.2. L). 
 
3.3.2. Neonatal overfeeding does not affect microglial sensitivity to an LPS challenge in 
vitro 
Since our in vivo studies had revealed that the hippocampus, at least the CA3 and CA1 
regions, was more sensitive to the effects of LPS on microglia in neonatally overfed than 
control-fed rats, we next aimed to determine if this was an effect specific to microglia. We 
thus examined specific microglial responses to LPS by stimulating them in isolation.  
 
Quantitation of cells positively labelled for CD11b and CD45 verified there were no 
differences in the expression of either marker between the groups, indicating our isolation 
protocol was equally effective in both the neonatally overfed and control-fed rats (Figure 3.3. 
A). For both TNFα and IL-6 there was a significant effect of treatment with LPS. 100 ng / 
mL LPS significantly increased TNFα (F(2,39) = 13.32, p < 0.001; n = 8; Figure 3.3. B) in 
neonatally overfed rats only compared with no LPS and significantly increased IL-6 (F(2,39) = 
44.78, p < 0.001; Figure 3.3. C) in control-fed and neonatally overfed rats compared with no 
LPS. There were no significant differences between the control-fed and neonatally overfed 
groups, indicating microglial sensitivity to LPS in vitro was not affected by neonatal 
overfeeding.  
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Figure 3.3.  A) Characterisation of hippocampal microglial culture from rats raised in control-fed (CL) 
and small (neonatally overfed; SL) litters. Hippocampal cell expression of B) tumour necrosis factor α 
(TNFα) and C) interkeukin-6 (IL-6) in response to either 10 ng/mL or 100 ng/mL lipopolysaccharide 
(LPS) stimulation in vitro from control-fed and neonatally overfed rats. Data are mean ± SEM. N = 9 per 
group. ^ p < 0.05 Tukey post-hoc after main effect of dose.  
 
3.3.3. Neonatal overfeeding and effects of minocycline 
Although we did not see in vitro differences between the microglial responses of the 
neonatally overfed control-fed rats in adulthood, our in vivo results showed microglial 
responses to an immune challenge in adults are increased in these animals relative to control-
fed responses. We thus aimed to reverse or mitigate the long-term effects of neonatal 
overfeeding on microglial responses by inhibiting microglial activation concomitant with 
overfeeding.  
 
The course of minocycline injections had no immediate effect on neonatal weight (significant 
time by litter size effect: F(3, 108) = 107.54, p < 0.001; Figure 3.4. A; n = 16-18) with both 
groups of neonatally overfed rats weighing more than control-fed rats at P14 and P21. The 
weight difference in adulthood between control-fed and neonatally overfed rats was also 
maintained, even slightly increased, after minocycline injections (significant effect of litter 
size: F(1, 60) = 25.41, p < 0.001 and treatment: F(1, 60) = 9.33, p = 0.003; Figure 3.4. B).  
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Figure 3.4. Effects of neonatal repeated injections on metabolic measures. Effects of injections on A) pre-
weaning weight (P7-P21). B) adult weight in rats raised in control-fed (CL) and small (neonatally overfed; SL) 
litters. C) lean mass, D) fat mass and E) percentage of fat mass at P70 in rats raised in control-fed and small 
(neonatally overfed) litters. Data are mean ± SEM. N = 14-16 per group. * main effect of litter size. $ main 
effect of minocycline treatment. p < 0.05. 
 
The differences in body mass in control-fed and neonatally overfed rats were also maintained 
despite neonatal minocycline. Lean mass, total fat mass and percentage fat mass were 
significantly increased in the neonatally overfed compared with the control-fed rats (lean 
mass: significant effect of litter size: F(1, 60) = 17.44, p < 0.001 and treatment: F(1, 60) = 5.41, p 
= 0.023; Figure 3.4. C, total fat mass: significant effect of litter size: F(1, 60) = 45.18, p < 0.001 
and treatment: F(1, 60) = 5.08, p = 0.028; Figure 3.4. D and percentage fat mass: significant 
effect of litter size: F(1, 60) = 29.28, p < 0.001; Figure 3.4. E). 
 
3.3.4. Neonatal injection protocol markedly reduces microglial numbers and density; no 
additional effect of minocycline.  
We hypothesised that the altered microglial profile that we have previously seen in the 
neonatally overfed rats (Chapter 2 and (342)) would be suppressed to that of control-fed 
levels with minocycline administered during the suckling period. We thus analysed 
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hippocampal microglia from these rats that had been injected as neonates with either saline or 
minocycline. We unexpectedly found not only no beneficial effect of minocycline, but that 
our finding (previously observed in two separate experiments – Chapter 2 / (342) and here) of 
neonatal overfeeding-induced increases in hippocampal microglia number and density was no 
longer evident in this cohort (Figure 3.5.; n = 7-9). In the CA3 region, there was a main effect 
of immune challenge on the number of microglia (significant effect of immune challenge: 
F(1,54) = 12.312, p = 0.01; Figure 3.5. A) but no effect on density (Figure 3.5. B). In the CA1 
region, there was a significant interaction between litter size and immune challenge on 
density of microglia: F(1,54) = 4.576, p = 0.037; Figure 3.5. F), but no specific effects of 
neonatal overfeeding with post-hoc comparisons. Neonatal overfeeding did not affect the 
number of microglia in the hilus region of the DG (Figure 3.5. G), however, it suppressed the 
density of microglia overall (significant interaction between litter size and minocycline 
injection: F(1,55) = 4.518, p = 0.038 and an interaction between litter size and immune 
challenge: F(1,55) = 4.042, p = 0.005; Figure 3.5. H). Specifically, there was reduced 
microglial density in the neonatally overfed vehicle-treated rats that were given LPS as adults 
(SL nSal/ aLPS) compared to control-fed (CL nSal/ aLPS), and reduced microglial density in 
the control-fed minocycline-treated rats that were given LPS as adults (CL nMino/ aLPS) 
compared to control-fed vehicle-treated that were given adult LPS rats (CL nSal/ aLPS). In 
the sub-granular/granular zone, there was an interaction between litter size, minocycline-
injection and immune challenge (F(1,57) = 4.049, p = 0.049; Figure 3.5. J) on microglia 
density, however, there were no effects with post-hoc analysis. We also found no effect of 
any of the treatments in the number of microglia between the control-fed and neonatally 
overfed animals regardless of injection in the sub-granular/ granular region (Figure 3.5. I). 
Neonatal overfeeding suppressed the number and density of microglia in the molecular 
region of the DG (number: significant interaction between litter size and immune challenge: 
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F(1,55) = 4.869, p = 0.032; Figure 3.5. K, and, density: significant interaction between litter 
size and immune challenge: F(1,54) = 4.244, p = 0.044; Figure 3.5. L) with specifically fewer 
microglia in the neonatally overfed vehicle-treated rats that were given LPS (SL nSal/ aLPS) 
compared to control-fed vehicle-treated (CL nSal/ aLPS).  
 
 
Figure 3.5. Numbers and density of ionized calcium-binding adapter molecule-1 (Iba-1)-labelled cells at 
postnatal day (P)70 in rats raised in control-fed (CL) and small (neonatally overfed; SL) litters that were 
saline or minocycline injected during the suckling period (P1-21) as well as given an adult immune 
challenge with lipopolysaccharide (LPS) (or saline). A, B) CA3 region. E, F) CA1 region. G, H) Dentate 
gyrus (DG) hilus. I, J) DG subgranular/ granular region. K, L) DG molecular region. Data are mean ± 
SEM. N = 7-9 per group. C, D) Representative photomicrographs of the CA3 region from P70 injected 
neonatally overfed rats (SL) that were injected with saline (C) or LPS (D) during adulthood illustrating no 
differences in numbers and density of Iba-1-labelled cells. Scale bar = 50 µm. # main effect of LPS. * x # 
litter size by minocycline treatment interaction. ^ Tukey post-hoc after litter size by minocycline treatment 
interaction. p < 0.05. 
 
Interestingly, the neonatal injection protocol, whether with minocycline or with saline, 
appeared to significantly suppress microglial numbers and density in all groups. Figure 3.6. 
illustrates the data shown in Figure 3.2. superimposed on those from the experiment in Figure 
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3.5. Data from Figure 3.6. show high numerical similarity with data we have previously 
reported (Chapter 2 and  (342)). Given the apparent effect of the neonatal treatment regimen, 
we re-processed the hippocampal tissue from our previously published animals (310) to 
verify this result was not due to tissue processing or age of the tissue/duration of storage. 
Microglial numbers and density were not different from the published data and Figure 3.6. 
(data not shown).  
 
 
Figure 3.6.  Comparison between Figure 3.2. and Figure 3.5. of numbers and density of ionized calcium-
binding adapter molecule-1 (Iba-1)-labelled cells at postnatal day (P)70 in rats raised in control-fed (CL) 
and small (neonatally overfed; SL) litters. These animals were injected with saline or minocycline during 
the suckling period (P1-21) as well as given an adult immune challenge with lipopolysaccharide (LPS). 
Blue shaded bars on the graphs represent previously seen non-injected microglial profile from Figure 3.2. 
A, B) CA3 region. C, D) CA1 region. E, F) Dentate gyrus (DG) Hilus. G, H) DG subgranular/ granular 
region. I, J) DG molecular region. Data are mean ± SEM. N = 7-9 per group.  
 
To statistically compare the effects of the neonatal injection protocol and neonatal 
overfeeding alone, we examined an additional cohort of control-fed and neonatally injected 
rats that had been processed at the same time as our minocycline cohort, but for a different 
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study (Figure 3.1.C). These were not otherwise handled except for the usual husbandry and 
weekly weighing during the neonatal period. The non-injected animals (CL and SL non-
injected) showed the same microglial profiles as previously reported. The neonatally overfed 
animals that were not injected (SL non-injected) during the suckling period showed an 
increased microglial density in the hilus region of the DG, compared to the control-fed (CL 
non-injected) and neonatally overfed saline-injected animals (SL nSal/ aSal) (number: 
significant effect of litter: F(1,21) = 5.326,  p = 0.031; Figure 3.7. A and injection F(1,25) = 
23.793, p < 0.001; Figure 3.7. B and density: significant interaction between litter and 
injection: F(1,23) = 32.797, p < 0.001; Figure 3.7. B). In the sub-granular/granular zone, the 
neonatally injected rats (both CL nSal/ aSal and SL nSal/ aSal) had significantly fewer 
microglia and reduced microglial density compared to non-injected rats (CL and SL non-
injected; number: significant effect of injection: F(1,23) = 15.747, p = 0.01; Figure 3.7. C and 
density: significant interaction between litter and injection: F(1,23) = 125.472, p < 0.01; Figure 
3.7. D). Neonatal injections (both CL nSal/ aSal and SL nSal/ aSal) also suppressed the 
number and density of microglia in the molecular region compared to non-injected animals 
(CL and SL non-injected; number: significant effect of injection: F(1,22) = 28.466, p < 0.01; 
Figure 3.7. E and density: significant interaction between litter and injection: F(1,23) = 55.876, 
p < 0.01; Figure 3.7. F). 
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Figure 3.7.   Comparison of numbers and density of ionized calcium-binding adapter molecule-1 (Iba-1)-
stained cells at postnatal day (P)70 in injected (saline) rats and a separate cohort of non-injected rats 
raised in control-fed (CL) and small (neonatally overfed; SL) litters. A, B) Dentate gyrus (DG) hilus. C, 
D) DG subgranular/ granular region. E, F) DG molecular region. Data are mean ± SEM. N = 7-9 per group. 
* main effect of litter size. & main effect of injection. ^ Tukey post-hoc after litter size by injection 
interaction. p < 0.05. 
 
To assess if the neonatal injection protocol caused a generalized suppression of microglia 
throughout the brain, we also assessed two regions we had investigated in previous studies, 
the arcuate nucleus of the hypothalamus (ARC) and PVN. Similar to previously published 
data (159), there was no change in either the microglial number or density in the ARC under 
basal conditions (Figure 3.8. A, B), but neonatal overfeeding (SL non-injected) led to a 
significant increase in microglial numbers in the PVN (Figure 3.8. C), with no change in 
density (Figure 3.8. D), compared with CL non-injected. Neonatally overfed animals that 
were saline-injected (SL nSal/ aSal) had a reduced number and density of microglia in the 
ARC compared to the non-injected animals (CL and SL non-injected; number: significant 
effect of treatment: F(1,20) = 54.312, p < 0.001; Figure 3.8. A and density: significant effect of 
treatment: F(1,20) = 38.591, p < 0.001; Figure 3.8. B). The previously reported effect of 
neonatal overfeeding to increase PVN microglial number and density was also abolished in 
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the neonatally injected group (both CL nSal/ aSal and SL nSal/ aSal; number: significant 
litter size by treatment interaction: F(1,19) = 7.668, p = 0.012; Figure 3.8. C and density: 
significant effect of treatment: F(1,19) = 63.696, p < 0.001; Figure 3.8. D). Together these data 
suggest that our neonatal injection protocol caused a generalized suppression of microglial 
activity that was able to over-ride any effects of neonatal overfeeding to increase numbers of 
these cells, with no additional effect of minocycline.  
 
 
Figure 3.8. Numbers and density of ionized calcium-binding adapter molecule-1 (Iba-1)-stained cells at 
postnatal day (P)70 in rats raised in control-fed (CL) and small (neonatally overfed; SL) litters that were 
non-injected or injected with saline. A, B) Arcuate nucleus of the hypothalamus (ARC). C, D) 
Paraventricular nucleus of the hypothalamus (PVN).  Data are mean ± SEM. N = 5-8. * main effect of litter 
size. & main effect of injection. ^ Tukey post-hoc after litter size by injection interaction. p < 0.05. 
 
3.3.5. Neonatal injection protocol increases basal corticosterone concentrations in 
neonatally overfed offspring 
To determine if the generalized suppression of microglial activity is due to the neonatal 
injection protocol causing a long-term upregulation in HPA axis activity or basal 
glucocorticoid secretion, we assessed basal corticosterone concentrations. We saw no basal 
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corticosterone differences between the non-injected neonatally overfed and control-fed adult 
rats 24 hr after saline injection (Figure 3.9.) and saline-injected control-fed (CL nSal/ aSal) 
corticosterone concentrations were not significantly different from those of non-injected 
animals. Basal corticosterone levels were elevated in neonatally overfed rats that were saline 
injected (SL nSal/ aSal) during the suckling period compared with both the neonatally 
overfed non-injected (SL non-injected) and the control-fed injected rats (CL nSal/ aSal; 
significant litter size by treatment interaction: F(1,16) =4.769, p = 0.044; n=5; Figure 3.9.). 
However, this is unlikely to account for our microglial findings since the control-fed rats 
were not similarly affected.  
 
Figure 3.9. Basal plasma corticosterone concentrations of non-injected and injected rats raised in control-
fed (CL) and small (neonatally overfed; SL) litters. Data are mean ± SEM. N = 5. ^ Tukey post-hoc after 
litter size by injection interaction. p < 0.05. 
 
3.4. Discussion 
This study is the first to show that neonatal overfeeding increases hippocampal microglial 
responses to an immune challenge with LPS and that neonatal injections (in this case with 
either saline or minocycline) can have pronounced long-term effects on microglia which is 
sufficient to over-ride the impact of the neonatal overfeeding. Notably, saline injections were 
just as effective as minocycline at suppressing microglial activity long-term.  
 
The neonatal nutritional environment, as induced by altering the litter size in which the 
animals were raised, can have significant long-term programming effects. Our group has 
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previously demonstrated that changes to the neonatal nutritional environment can alter body 
weight into adulthood as well as altering microglial profiles within developing brains and it 
predisposes the animal to a sensitized basal microglial profile in the hypothalamus during 
adulthood (159, 310). We have also previously shown that adult neonatally overfed animals 
have dramatically increased microglial numbers in the PVN 24 hrs after an LPS challenge 
(159). This microglial programming in adults that have been overfed as neonates extends 
beyond the hypothalamus into the hippocampus as shown in Chapter 2 (and (342)). Here we 
demonstrate that adult neonatally overfed rats have increased microglial numbers in the CA3 
in response to an LPS challenge compared with control-fed rats. Other early life 
manipulations can lead to similar hyper-responsive microglia. A peripheral immune 
challenge with E.coli or LPS in early life results in increased microglial numbers and an 
activated phenotype in the adult brain (202, 340). Similarly, maternal high-fat diet (HFD) 
predisposes the offspring to an increase in hippocampal expression of microglial activation 
markers at birth, as well as increased microglial activation both basally and in response to an 
LPS challenge in adulthood (202). Nonetheless, our findings that neonatally overfed 
microglial cell numbers, particularly in the CA3, are increased after an LPS challenge support 
our findings that neonatally overfed rats have hyper-responsive microglia. 
 
This increase in microglial numbers in the CA3 region in our neonatally overfed animals led 
us to investigate whether these findings are likely to be due to an exclusive effect on 
microglia. It is noteworthy that culturing isolated microglia for an extended period can result 
in loss of the microglial phenotype (354-356). However, we only stimulated the microglia 
culture for 4 hours, therefore, the microglial phenotype should be similar to in vivo microglial 
cells. We found that microglial sensitivity to LPS in vitro was not affected by neonatal 
overfeeding suggesting that other cell types may be interacting with microglia to produce the 
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response. Astrocytes are known to form an interaction with microglia and this is an important 
mechanism allowing the inhibition of excessive microglial activation (360). Therefore, it is 
possible that our neonatally overfed animals have reduced astrocyte numbers or complexity 
enabling them to hyper-respond to an immune challenge in vivo compared to control-fed rats. 
The absence of this and other cell types in our in vitro isolated microglia experiments could 
explain why the differences induced by neonatal overfeeding are not seen in this preparation. 
Furthermore, the neonatal injection protocol caused generalized microglial suppression in 
both adult neonatally overfed and control-fed rats, however, it failed to alter the neonatal 
overfeeding-induced weight gain, further suggesting that other cells types are involved 
alongside microglia to maintain long-term changes in response to early life diet.  
 
To our knowledge, this is the first study to demonstrate that repeated injections during the 
suckling period suppress the number and density of microglia in the hippocampus in 
adulthood. However, other early life treatments can have similar effects on microglia (361, 
362). Handling refers to neonatal rats being exposed to short periods of maternal absence in a 
novel environment (approximately 15 mins) daily for the first 2-3 weeks of life. Adult rats 
that are infected with E. coli at P4 coupled with neonatal handling (P1-10, 15 mins daily) 
exhibit decreased gene expression of CD11b, glial fibrillary acidic protein (GFAP), and IL-
1β in the hippocampus under basal conditions compared with non-handled control-fed rats 
(361). These adult rats also display a suppression of CD11b gene expression 2 hrs after an 
immune challenge with LPS and have dramatically improved spatial learning and memory in 
the Morris water maze compared with those that are not handled as neonates (361). It has 
been speculated that microglia of neonatally handled rats shift to take on an anti-
inflammatory profile via epigenetic modification of the Interleukin-10 (IL-10) gene 
specifically within the microglia (362), but this remains to be tested with either neonatal 
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handling or multiple injections. We have demonstrated here that non-injected neonatally 
overfed animals have an increased microglial response to LPS in the hippocampus relative to 
control-fed rats, particularly in the CA3 region, and that this response is suppressed in adult 
neonatally injected rats. Thus, our data support the hypothesis that neonatal handling coupled 
with an injection can produce an anti-inflammatory microglial profile.  
 
Obesity and diets high in fat have been associated with systemic inflammation and more 
recently central inflammation (187). It has become increasingly apparent that a HFD can 
cause hypothalamic inflammation, which can disrupt normal feeding- and metabolism-related 
signalling via the activation of microglia (180, 187, 189). This central inflammation can 
contribute to leptin and insulin resistance, therefore, causing weight gain and maintaining an 
elevated body weight (187, 189). Our group has demonstrated that neonatal overfeeding 
contributes to a primed basal pro-inflammatory profile with increases in number and density 
of Iba-1 positive microglia in the PVN during early life, which persists into adulthood (159) 
and this co-occurs with the maintenance of accelerated weight gain compared to control-fed 
rats. Interestingly, in the present study we found the drastic suppression of microglial number 
and density in adult rats that underwent repeated injections was not localized to the 
hippocampus but this trend was also seen in the hypothalamus. Furthermore, this microglial 
suppression did not affect weight gain during the suckling period or in adulthood. Maternal 
separation does not affect body weight or ingestion of standard lab chow (363), therefore, it is 
possible that an additional increase in microglia is occurring in these neonatally overfed pups 
during the suckling period, that dissipates after weaning, which is affecting normal feeding- 
and metabolism- related signalling compared to control-fed rats.  
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Under normal physiological conditions, corticosterone is considered to be anti-inflammatory. 
However, stressful stimuli can sensitize central pro-inflammatory responses and activation of 
microglia. To investigate if the repeated neonatal injections effects on microglia were 
associated with long-term changes to the HPA axis, we measured basal circulating 
corticosterone in neonatally non-injected and injected (saline) adult rats. Our current findings 
are consistent with previous studies from our group, showing that corticosterone levels in 
non-injected neonatally overfed rats are not significantly different from non-injected control-
fed rats (147, 157, 164). Surprisingly, we found that the neonatally overfed animals that 
underwent repeated neonatal injections had significantly increased basal corticosterone levels 
compared to the non-injected equivalent and this difference was not seen in the neonatally 
injected control-fed animals. Repeated neonatal injections induced a potentiated 
corticosterone response in animals that were overfed during development which could 
suggest that the HPA axis in these animals is sensitized.  
 
Previous literature shows confounding evidence on the effects of maternal separation of pups 
during development on basal corticosterone; however, this is likely due to the different 
separation protocols. In adulthood, animals that were handled during the suckling period 
display a reduction in plasma corticosterone concentrations (361, 364, 365). However, a 
longer period of maternal separation during this developmental period (180 min/day) 
increases basal corticosterone concentrations (366-372). Interestingly, Llorente and 
colleagues have also shown similar findings to our study, whereby a neonatal injection period 
between P7-P12 increases basal corticosterone compared to the non-injected rats (373).  
 
The neonatal litter size manipulation model undoubtedly has elements incidental to feeding 
that may influence physiology long-term (150, 159). However, these do not provide a simple 
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explanation for our findings. For example, Meaney and colleagues have shown maternal 
attention suppresses HPA axis responses to stress throughout life via maternal contact-
mediated changes in histone acetylation and NGF1-A binding to the glucocorticoid receptor 
promoter to increase expression of this receptor and enhance the efficiency of glucocorticoid 
negative feedback (374). Dams will spend approximately the same time in high intensity 
nursing and grooming behaviours irrespective of the size of the litter, therefore more 
attention would be imparted to each of the neonatally overfed pups than to the control-fed 
pups (375-377). Thus, one would anticipate those from the neonatally overfed group to have 
suppressed HPA axis responses to stress and perhaps reduced basal circulating 
corticosterone; the opposite profile to the one we see here. Likewise, neonatal overfeeding 
can induce changes in circulating satiety hormones such as ghrelin that have a role in stress 
regulation (168, 378). However, this effect on ghrelin’s role in stress regulation appears to be 
exclusive to females despite persistent changes in other functions of this hormone in males 
(167, 168). We thus currently do not have an explanation for why basal corticosterone is 
elevated in the neonatally overfed that have had the neonatal injection protocol and not in the 
other groups. 
 
In the current study, we aimed to test the effects of neonatal minocycline; a known microglial 
inhibitor (272), on the hippocampal microglial profile both under basal conditions and after 
an LPS challenge. We hypothesised that a minocycline regimen during the suckling period 
would attenuate the increased microglial response to an LPS challenge in our adult neonatally 
overfed rats. Neonatal minocycline had no effect on the number or density of microglia in 
adulthood regardless of whether the rats were exposed to LPS or not. The results from the 
minocycline aspect of this experiment were inconclusive due to the over-riding effect of the 
repeated injection regimen itself. Ideally, an alternative form of drug administration would 
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need to be adopted to gain a conclusive result as to whether minocycline administration could 
reduce microglial activation after neonatal overfeeding. Our treatment regimen was based on 
studies of hypoxia-ischemia showing this dose, administered via i.p. injection, could 
successfully ameliorate neuroinflammation at the site of hypoxic-ischemic insult (268). A 
common alternative form of minocycline administration is via oral administration from 
drinking water (269, 270). However, delivery of drugs via voluntary consumption of water 
does not take into consideration the individual variability in the amount of water consumed. 
Additionally, the drug must be able to accumulate in the dam’s milk to enable delivery to the 
suckling pups and may therefore not be reliably delivered to each pup at the same dose (379). 
Importantly, the nature of our model where the neonatally overfed pups consume more milk 
from the dams means the neonatally overfed pups would unavoidably receive more 
minocycline. Alternatively, drug delivery could be achieved via oral gavage of the drug into 
either the pharynx or the esophagus, which would give exact concentrations of minocycline 
(379, 380). Previous literature recommends oral gavage to commence after P4 to reduce 
damage to the tissue (380). We needed to begin our regimen following litter manipulation to 
try and prevent the early effects on microglia, therefore, this technique would not be suitable. 
This process is also stressful to the pups and involves removing the litter and handling them, 
therefore, likely, providing the same result as we have shown here with a reduction in 
microglia despite early life overfeeding. Thus, the effect of reversing microglial priming 
during neonatal overfeeding remains untested but our experiments reveal important effects of 
repeated injections in the neonatal period.  
 
In summary, we have shown that neonatal overfeeding leads to a hyper-responsive basal 
microglial profile in the hippocampus and this is associated with an increased response to 
LPS in this region relative to control-fed responses, and that cellular populations additional to 
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microglia may be important for these responses. In our attempts to reverse the neonatal 
overfeeding-induced microglial effects, we also revealed that our neonatal injection protocol, 
whether with minocycline or with saline, strongly suppressed microglial numbers and density 
without reversing any of the metabolic effects of neonatal overfeeding. Although the 
mechanism behind the impact of neonatal injection on microglia remains to be determined, it 
does not appear to be explained by an effect on HPA axis function. These findings have 
significant implications for all studies employing injection protocols in neonatal experimental 
animals and raise interesting questions about the impact of various stimuli on neonates in 
general.  
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4.1. Introduction 
Microglia are known as central nervous system (CNS)’s resident immune cells. Microglia 
perform a variety of functions, particularly contributing to homeostasis both during 
development and throughout life (62, 381) as well as regulating synaptogenesis, neuronal 
maturation and activity. Previous work, including our own, has shown microglia are highly 
sensitive to dietary influence, becoming activated acutely and long-term in the presence of a 
high-fat diet (HFD) (180, 187, 189, 310) or early life overfeeding (159, 310). This microglial 
activation, is evident in the hypothalamus within 3 days of a HFD (180). We have also 
demonstrated that early life overfeeding and the obesity that ensues results in pronounced 
hypothalamic inflammation (159, 310). The paraventricular nucleus of the hypothalamus 
(PVN) is particularly sensitive to the effects of early life overfeeding showing an increase in 
microgliosis and an exacerbated expression of proinflammatory genes compared to control-
fed rats (159, 310). Previous literature on adult HFD suggests that microgliosis is reversible 
(195, 311). However, we have shown that the hypothalamic microgliosis in our rats that are 
overfed during development is retained into adulthood despite the commencement of a 
normal diet at weaning. We have also demonstrated that these adult neonatally overfed rats 
have a significantly more reactive central and peripheral immune response to inflammatory 
challenges throughout life suggesting that microglia are particularly sensitive to adverse early 
life events (157, 159, 310).  
 
This inflammation can extend beyond the hypothalamus into extra-hypothalamic areas such 
as the hippocampus, which is involved in learning and memory (180). Approximately 8 
weeks of a HFD is required for extra-hypothalamic inflammation to develop (180). This 
hippocampal inflammation results in mice having impaired spatial memory function in 
behavioural tests, with mice consuming a high-fat diet for 20 and 22 weeks taking longer to 
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learn the location of an escape platform in the Morris Water Maze and recalling their training 
poorly in the probe trial (197, 198). Additionally, we have also shown that adult rats that 
were overfed during development and fed a chow diet thereafter also have impairments in 
spatial memory function (Chapter 2) / (342)).  
 
To better understand the role of microglia in both physiological and pathological states, a 
range of depletion approaches, both pharmacological and genetic, have been developed in 
which microglia are specifically ablated from the brain. A commonly used pharmacological 
approach to study the role of microglia is the tetracycline antibiotic, minocycline. This 
approach has been shown to be neuroprotective (271, 272) and successfully ameliorate 
neuroinflammation in many models of brain injury and neurodegeneration (267, 272-276). 
However, minocycline has a non-specific action on neurons making it difficult to draw 
conclusions using this drug (281-283). Additionally, we have shown that the use of 
minocycline to mitigate the effects of over nutrition during development is unsuitable. It was 
necessary to administer minocycline to the pups via intraperitoneal (i.p.) injections to ensure 
the same amount of minocycline was given to both the neonatally overfed and control-fed 
litters, however, we found that the neonatal injection period, regardless of saline or 
minocycline injection, reduced the number and density of microglia (Chapter 3 / (382)). 
Other pharmacological approaches to deplete microglial include specifically targeting 
colony-stimulating factor 1 receptor (CSF-1R) signalling via the use of the systemically 
administered drugs (PLX3397 and PLX5562) (36, 96, 243, 288). Microglial ablation has also 
successfully been achieved through genetic manipulation. This is accomplished either by 
directly inducing tamoxifen expression of the diphtheria toxin (DT) in the target cells 
(Cx3cr1 or CD11b expressing cells) or cell type-specific expression of the diphtheria toxin 
receptor (Dtr) in combination with the systemic application of DT so that only cells carrying 
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the receptor are susceptible to death (61, 190, 257). Previous literature has shown that 
microglia ablation can have effects on memory and are appropriate for testing the role of 
microglia in memory function (36, 61).  
 
It is noteworthy that currently all approaches for genetic microglial depletion have been 
performed on mice rather than rats. This preference is likely to be related to the availability of 
genetic manipulation techniques in mice that are only recently becoming available for rats. 
This lack of rat models is particularly concerning given the vast differences found between 
these species in relation to neuroscience-related research. Recently, Francis and colleagues 
have demonstrated that there is differential expression of genes between C75BL/6 mice and 
Sprague Dawley rat in hippocampal neurons (4713 out of a total of 10,833 genes) compared 
to 54 differentially expressed genes between two different mouse strains (C75BL/6 and 
Balb/c) (383). Additionally, there are important and fundamental differences between rats 
and mice with respect to learning and memory in various tasks (299-301). Mice often need 
longer habituations and training sessions and experience more stress and anxiety (302). 
Additionally, rats are more similar to humans in a variety of neurological and psychiatric 
disorders compared to mice such as addictive and impulsive behaviours and in models of 
neurodegenerative diseases (reviewed in (302)). Therefore, it is important for our 
understanding of microglial function to be able to investigate microglial ablation in rats as 
well as mice.  
 
As such, we have created a Cx3cr1-Dtr transgenic rat that provides a new experimental 
model for specifically examining microglial function in the rat. It will allow us to specifically 
investigate the role of microglia in early life overfeeding and the obesity that ensues. Cx3cr1, 
the fractalkine receptor, is highly expressed on microglial cells and monocytes (43). This 
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Cx3cr1-Dtr rat model was generated for us by SAGELabs (now Horizon Discovery, Saint 
Louis, MO, USA) using CRISPR/Cas 9 technology. Briefly, the rats have a Dtr gene 
sequence inserted into the promoter region of the gene coding for Cx3cr1 allowing specific 
ablation of microglia and monocytes with a subcutaneous (s.c.) injection of DT. To validate 
the model, here we first investigated whether this insertion would alter the animal’s 
phenotype under basal conditions. We also determined the time course of DT-induced 
microglial depletion and the recovery period of these microglial cells after depletion.  
 
4.2. Materials and Methods 
4.2.1. Animals 
All experiments were conducted in accordance with the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes, with approval from the RMIT University 
Animal Ethics Committee.  
 
To specifically ablate Cx3cr1-containing cells, we generated a knock-in rat model on a 
Wistar Han background using CRISPR/Cas9 technology, in which the Dtr is expressed under 
the control of the endogenous Cx3cr1 promoter sequence. For this, a targeting vector 
containing a 2A peptide-Dtr gene was inserted via homologous recombination into the 3’ 
untranslated region of the Cx3cr1 genomic locus (Location: 8q32; Gene ID: 171056; 
Ensembl ID: ENSRNOG00000018509). The Cx3cr1-Dtr rats were produced by SAGELabs 
(now Horizon Discovery) using pronuclear microinjection of an sgRNA/Cas9 complex and 
Dtr donor (forward primer 5’: cctcaacccctttatctacgc; reverse primer 3’: ccaacatttgcacgagagac) 
followed by embryo transfer to pseudopregnant females. Resulting live births were screened 
for mutations by PCR and sequencing of the region flanking the Cas9 targeting site. The 
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selected founders were backcrossed to wildtype (Wt) Wistar Hans to generate a heterozygous 
(HET) F1 generation, which were shipped to Australia where they were housed at Monash 
Animal Services (MAS) and then used to breed Cx3cr1-Dtr (HOM) and Wt offspring for 
testing. 
 
In these experiments, we used 72 male rats aged between 9 and 11 weeks. Specific n are 
indicated in the results. They were transported from MAS to RMIT when of age for 
experimentation and kept under standard laboratory housing conditions, with a 12 hr light 
cycle (0700 – 1900 hr), an ambient temperature of 22 °C and free access to water and 
standard rat chow. DT, originally derived from Corynebacterium diphtheria (Sigma-Aldrich), 
was administered as two separate injections, 8 hr apart, of 25 ng/g DT in sterile saline, s.c., 
according to the protocol of Uneo and colleagues (67). Application of DT result in cytosolic 
inhibition of cellular protein synthesis, leading to cell death (295). Basal and post-DT tissue 
collection were performed after the rats were deeply anaesthetized with 150 mg/kg sodium 
pentobarbital i.p. Additional specific experiments are described below.  
 
4.2.2. Genotype characterization 
To determine the rats’ genotypes, tail samples were collected by the staff at MAS at 
approximately postnatal day (P) 7 and immediately frozen. Briefly, we incubated the samples 
for 24 hrs in an extraction buffer with proteinase K to digest RNA. This was followed by 
conventional qPCR to generate gDNA. For this purpose, 1 µg of total DNA was reverse 
transcribed, using JumpStart Taq ReadyMix (Sigma-Aldrich). The PCR mix contained 1x 
JumpStart Taq ReadyMix, 1 µL cDNA and 10 µM primer (Forward: 
agccacaagcactggccacacca and Reverse: tccactgggaggctcagcccatgac). Thermocycling 
conditions were: 1 cycle of 95 °C for 5 min; 35 cycles of denaturation 95 °C for 30 sec, 35 
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cycles of 60 °C for 30 sec, 35 cycles of 68 °C for 2.5 min and a final extension of 68 °C for 5 
min then held at 4 °C. Wt were identified by not having the 3’ region Dtr insert, and Cx3cr1-
Dtr +/+ (HOMs) have 2 additional Dtr inserts in both the 3’ and 5’ region. 
 
4.2.3. Microglia characterization 
To determine microglial numbers and morphology, we deeply anaesthetized the rats and 
processed the tissue for immunohistochemistry as described in Chapter 2 under the section 
2.3. Brain Collection. Immunohistochemistry was performed to assess microglia for ionized 
calcium-binding adapter molecule-1 (Iba-1) as previously described in Chapter 2.4. 
Immunohistochemistry. For each region we selected a sub-region of interest, identified 
according to the Paxinos and Watson Rat Brain Atlas (316), and analysed four sections 120 
µm apart for each region per animal,  in the PVN images were taken between 1.80 and 1.92 
mm caudal to bregma; in the arcuate nucleus (ARC) and lateral hypothalamus (LH) images 
were between 2.04 and 2.16 mm caudal to bregma; and in the hippocampus (HC) between 
2.52 and 4.56 mm caudal to bregma.  
 
4.2.4. Monocyte characterization 
To determine numbers of circulating and spleen monocytes, we collected the blood samples 
on EDTA over ice and separated the blood using Ficoll-Paque PLUS (GE Healthcare 
Australia Pty. Ltd, Parramatta, NSW, Aus). Spleen was collected in cold phosphate buffer 
saline (PBS) and minced into a single cell suspension. For flow cytometric assessment of 
monocyte immunophenotype, monocytes were stained with cluster of differentiation 
(CD11b-FITC, CD4-PE (monocyte markers to assess monocyte purity) and CD3-PerCP (a 
non-monocyte marker to assess contamination with other immune cells). Therefore, 
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monocytes are CD11b+, CD4+ and CD3-. Briefly, monocytes (3 x 104 cells) were suspended 
in incubation buffer (1 x Dulbecco’s PBS (DPBS)) and kept on ice for 30 min prior to 
staining. Antibodies and the isotype controls (CD11b/c FITC, CD4 PE, CD3 PerCP: 1:100, 
mouse, Jomar Life Research, Scoresby, VIC, AUS) were diluted in the incubation buffer and 
incubated on ice for 1 hr. Cells were washed and resuspended in 1 x DPBS and immediately 
analysed by flow cytometry.  
 
Monocytes were analyzed on a FACSCanto II cytometer (BDBiosciences, North Ryde, 
NSW, AUS). For each staining condition (isotype control and antibody of interest), 1 x 104 
events were collected. Quantitation of positively labeled cells was determined by setting a 
threshold on the background staining of the isotype controls.  
 
4.2.5. Gene expression 
 To assess changes in gene expression, we dissected hypothalami and hippocampi over ice 
from Wt and Cx3cr1-Dtr rats and conducted quantitative real-time PCR (qRT-PCR). The 
samples were immediately snap-frozen on liquid nitrogen and stored at -80 °C until use. We 
isolated total RNA using QIAzol reagents and RNeasy Mini Kits (QIAGEN, Valencia, CA, 
USA). We determined RNA concentrations using a spectrophotometer, NanoDrop 
2000/2000c (Thermo Fisher Scientific, Wilmington, DE, USA) and 1 µg RNA was 
transcribed to cDNA using iScript cDNA synthesis kits (QIAGEN, Valencia, CA, USA), 
according to the manufacturer’s instructions.  
 
We performed qRT-PCR using TaqMan Gene Expression Assays (Applied Biosystems, 
Mulgrave, VIC, Australia) on a QuantStudio 7 Flex (QIAGEN). We compared a relative 
quantitative measure of the target gene expression with an endogenous control, B2M. See 
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Table 4.1 for primer details. We analysed mRNA expression using the equation 2-ΔΔC(t), 
where C(t) is the threshold cycle at which fluorescence is first detected significantly above 
background (384), as described in our previous publications (159, 164, 165, 342). Data are 
presented as a fold-increase relative to Wt. A variety of housekeeping genes were tested to 
determine the most stable primer (data not shown).   
 
Table 4.1. TaqMan probe details (Life Technologies) used for qRT-PCR 
Target gene NCBI reference sequence TaqMan assay ID Product size 
Cx3cr1 NM_133534.1 Rn02134446_s1 124 
18s X03205.1 4319413E 187 
Actb NM_031144.3 Rn00667869_m1 91 
Gapdh NM_017008.3 Rn99999916_s1 87 
B2m NM_012512.2 Rn00560865_m1 58 
 
4.2.6. Behaviour 
4.2.6.1. Open field 
To test general locomotor activity levels and anxiety-like behaviour we assessed the rats in a 
mini open field paradigm as described previously with some modifications (385). Mr Alita 
Soch assisted with the behavioural task. The testing arena was a black plywood box, 65 x 65 
x 65 cm. Each rat was placed in the centre of the arena and filmed and later scored, using 
Ethovision 11.5 (Noldus Information Technology, Wageningen, The Netherlands), by an 
experimenter blinded to genotypes. Zones were created in Ethovision that corresponded to 
the middle of the arena and the remaining space (edge). Rats were scored for the distance 
moved within the edge zone, the latency to enter the centre, the frequency of entries into the 
centre, and duration spent and distance moved in the centre. The open field was thoroughly 
cleaned with 70% ethanol between animals. 
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Figure 4.1. Open field task. (A) rodents were freely allowed to explore the arena. Rodents were placed in the 
centre of the arena and filmed for scoring. (B) Zones were created in Ethovision that corresponded to the centre 
of the arena and the remaining space (edge), movement was analysed using Ethovision.  
 
4.2.6.2. Elevated Plus Maze 
To test anxiety-like behaviour in a novel environment, we assessed the rats in an elevated 
plus maze as described previously with some modifications (147). The plus maze was raised 
50 cm above the floor. It consisted of two opposite open arms of (50 cm x 10cm) and two 
closed arms of the same dimensions with (40 cm) high walls. Each rat was placed in the 
centre of the plus maze and filmed and later scored by an experimenter blinded to the rat’s 
genotypes for the number of entries into and percentage time spent in each of the open and 
closed arms. The rat was regarded as having moved into an arm when all four paws had 
crossed the threshold of the arm. The maze was thoroughly cleaned with 70% ethanol 
between trials. 
 
Centre
A) B)
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Figure 4.2. Elevated plus maze task. Rodents were freely allowed to explore the arena. Rodents were placed 
in the centre of the maze and filmed for scoring.  
 
4.2.6.3. Y Maze 
To assess spatial recognition memory in animals, we performed the Y-Maze task as 
previously described in Chapter 2 under the section 2.6.1. Y-Maze.  
 
4.2.6.4. Novel Object Recognition 
To test the rodents working memory ability via recognition of a novel object in the 
environment, we assessed the rats in the novel object recognition task (342, 386), as 
previously described in Chapter 2 under the section 2.6.2. Novel Object Recognition.  
 
4.2.7. Data analysis 
As described for the experiments in Chapter 2 section 2.7. data were analysed by SPSS using 
Student’s unpaired t-tests or multi-factorial analyses of variance (ANOVAs) with Tukey’s 
post-hoc tests where significant interactions were found with genotype and behaviour or DT 
treatment as between factors where appropriate. Data are presented as the mean ± SEM. 
Statistical significance was assumed when p ≤ 0.05.  
 
4.3. Results 
  
 
 
 
 
 
Open 
Closed 
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4.3.1. Genotyping of Cx3cr1-Dtr and Wt rats  
To verify the successful breeding of the F1 generation, we assessed the genotype of these 
animals for the presence of either the Dtr insertion or no insertion, Cx3cr1-Dtr and Wt 
offspring.  
 
Figure 4.3. Genotyping of the F1 offspring. A) Representation illustrating the target Dtr-insertion at both the 
5’ and 3’ junction. B) 5’ junction. C) 3’ junction.  
 
4.3.2. Microglial profile in the hypothalamus and hippocampus are not affected by the Dtr-
insertion 
To verify that the Dtr-insertion does not affect the microglia under basal conditions, we 
examined microglial profiles in several regions of the brain in Wt and Cx3cr1-Dtr rats. We 
found no differences in the number and area per cell of microglia in the sub-regions of the 
hypothalamus or the hippocampus (n = 5-7; Figure 4.4. and Figure 4.5.).  
 
insertTarget*gene
5’*junction
3’*junction
WT Hetero
5’#junction
WT HomoHetero
3’#junction
N/A
Homo
A
B
C
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Figure 4.4. Numbers and area per cell of ionized calcium-binding adapter molecular-1 (Iba-1)-stained 
cells in wild-type (Wt) and Cx3cr1-Dtr animals. A, B) arcuate nucleus (ARC). C, D) paraventricular nucleus 
of the hypothalamus (PVN). E, F) lateral hypothalamus (LH). Data are mean ± SEM. 
 
 
Figure 4.5. Numbers and area per cell of ionized calcium-binding adapter molecular-1 (Iba-1)-stained 
cells in wild-type (Wt) and Cx3cr1-Dtr animals. A, B) CA1. C, D) CA3. E, F) Dentate gyrus (DG) hilus. G, 
H) DG sub-granular (SG)/granular region. I, J) DG molecular region. Data are mean ± SEM. 
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4.3.3. Cx3cr1-Dtr rats do not have differences in circulating and spleen monocytes 
Since Cx3cr1 is also expressed in monocytes, we investigated whether the Dtr-insertion 
would affect circulating and spleen monocytes under basal conditions. There was no 
difference in either circulating monocytes or spleen monocytes (n = 4-9 per group; Figure 
4.6. A-D).  
 
Figure 4.6. Characterization of basal monocytes in circulating blood and spleen in wild-type (Wt) and 
Cx3cr1-Dtr rats. A) Basal circulating blood representation. B) Basal circulating blood. C) Basal spleen 
representation. D) Basal spleen. Data are mean ± SEM. 
 
4.3.4. The Dtr- insertion does not affect brain Cx3cr1 expression 
We investigated if the Dtr-insertion was associated with changes in hypothalamic and 
hippocampal expression of the Cx3cr1 gene, key brain regions of interest for our future 
studies.  We found no differences between the groups in Cx3cr1 expression in the 
hypothalamus (n = 6 per group; Figure 4.7. A) or the hippocampus (n = 6 per group; Figure 
4.7. B).  
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Figure 4.7. Cx3cr1 expression. A) hypothalamus (HY) and B) hippocampus (HC) in wild-type (Wt) and 
Cx3cr1-Dtr rats. Data are mean ± SEM. 
 
4.3.5. The Dtr-insertion on Cx3cr1 does not induce indices of sickness 
To assess general locomotor activity levels and anxiety-like behaviour as indicators of 
sickness, we examined the rats’ performance in the open field test. The Cx3cr1-Dtr rats 
showed no significant differences in exploratory activity under basal conditions (n = 5-6; 
Figure 4.8. A-E). We also assessed general anxiety-like behaviour in the elevated plus maze. 
The Cx3cr1-Dtr rats did not show any differences in these behaviours under basal conditions 
(n= 7-8; Figure 4.8. F-H).  
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Figure 4.8. Exploratory and anxious behaviour testing in the open field test and elevated plus maze in 
wild-type (Wt) and Cx3cr1-Dtr rats. A-E. Open Field test. F-H. Elevated plus maze. Data are mean ± SEM. 
 
4.3.6. The Dtr insertion does not affect cognitive behaviour 
To verify that the Dtr-insertion does not affect cognitive behaviour, we assessed the rats’ 
performance in the Y Maze and NOR. There were no differences in the latency to enter an 
arm between the Cx3cr1-Dtr and Wt controls in the Y Maze (n = 8; Figure 4.9.A) and both 
groups showed an increased number of entries into the novel arm compared to the open arm 
in the Y Maze commensurate with adequate recall (Figure 4.9.B). There was no differences 
in the percentage of time spent in either the novel or open arm in either group (Figure 4.9.C). 
Both the Cx3cr1-Dtr and Wt controls rats preferred the novel object in the novel object 
recognition test to a similar degree (n = 7 per group; Figure 4.9.D).  
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Figure 4.9. Behavioural testing of learning and memory. (A-C) in the Y maze. D) novel object recognition in 
adult wild-type (Wt) and Cx3cr1-Dtr animals. Data are mean ± SEM. 
 
4.3.7. The Cx3cr1-Dtr rat allows selective inducible ablation of microglia 
To determine whether microglia could be ablated, we administered DT and assessed 
microglia throughout the brain. The application of DT successfully ablated microglia 
throughout the brain by 48 hr in Cx3cr1-Dtr and these were restored to Wt levels by 7 and 14 
days. Thus, in the hypothalamus, Iba-1 positive cells were 94% fewer in the ARC, 52% fewer 
in the PVN and 53% fewer in the LH (Table 4.2, Figure 4.10.). In the hippocampus, Iba-1 
positive cells were 93% fewer in the Cornus Ammonis (CA)1, 83% fewer in the CA3, 74% 
fewer in the dentate gyrus (DG) hilus, 54% fewer in the DG subgranular/ granular (SG) and 
84% fewer in the DG molecular region (Table 4.2., Figure 4.11.). 
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Table 4.2. Effects of the DT application on hypothalamic and hippocampal 
microglia in Wt and Cx3cr1-Dtr rats 
 Number Area per cell 
ARC 
Figure 4.10. A-C 
F(2,38) = 11.26; p < 0.001 F(2,43) = 3.824; p = 0.038 
PVN 
Figure 4.10. D-F 
F(2,31) = 18.75; p < 0.001 N/A 
LH 
Figure 4.10. G-I 
F(2,39) = 22.39; p < 0.001 F(2,43) = 18.987; p < 0.001 
CA1 
Figure 4.11. A-C 
F(2,39) = 6.60; p = 0.004 F(2,39) = 4.59; p = 0.017 
CA3 
Figure 4.11. D-F 
F(2,43) = 8.35; p < 0.001 Main effect of day:  
F(2,40) = 8.16; p = 0.001 
Main effect of genotype:  
F(2,40) = 52.49; p < 0.001 
DG Hilus 
Figure 4.11. G-I 
F(2,41) = 3.42; p = 0.044 
 
Main effect of day:  
F(2,40) = 13.40; p < 0.001 
Main effect of genotype:  
F(1,40) = 4.67; p = 0.038 
DG Sub-granular 
Figure 4.11. J-L 
Main effect of day:  
F(2,41) = 10.43; p < 0.001 
Main effect of day:  
F(2,40) = 9.07; p = 0.001 
DG Molecular 
Figure 4.11. M-O 
F(2,40) = 6.60; p = 0.004 F(2,39) = 4.20; p = 0.023 
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Figure 4.10. Numbers and area per cell of ionized calcium-binding adapter molecular-1 (Iba-1)-stained 
cells in wild-type (Wt) and Cx3cr1-Dtr animals. (A-C) arcuate nucleus of the hypothalamus (ARC). (D-F) 
paraventricular nucleus of the hypothalamus (PVN). G-I Lateral hypothalamus (LH). Representative 
photomicrographs of the C) ARC, F) PVN and I) LH illustrating differences in numbers and area of Iba-1-
stained cells. Scale bars = 50 µm. Data are mean ± SEM. * Tukey post-hoc after day by genotype interaction.  
p < 0.05. 
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Figure 4.11. Numbers, density and area per cell of ionized calcium-binding adapter molecular-1 (Iba-1)-
stained cells in wild-type (Wt) and Cx3cr1-Dtr animals. A-C) CA1. D-F) CA3. G-I) Dentate gyrus (DG) 
hilus. J-L) DG subgranular/ granular. M-O) DG Molecular. Representative photomicrographs of the C) CA1, F) 
CA3, I) DG Hilus, L) DG subgranular/ granular and O) DG Molecular illustrating differences in numbers and 
area of Iba-1-stained cells Scale bars = 50 µm. Data are mean ± SEM. # main effect of day. $ main effect of 
genotype. * Tukey post-hoc after day by genotype interaction. p < 0.05. 
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4.3.8. The Cx3cr1-Dtr rat allows selective inducible ablation of monocytes 
To determine whether peripheral monocytes could specifically be ablated, we administered 
DT and assessed numbers of monocytes. The application of DT successfully reduced 
numbers of circulating monocytes by 48 hrs in the Cx3cr1-Dtr but not Wt rats (F(2,27) = 6.59; 
p = 0.005; n = 4-9; Figure 4.10. A, B). By 7 and 14 days monocyte numbers were restored to 
Wt levels (Figure 4.12. A, B). DT had no effect on spleen monocytes (Figure 4.12. C, D).  
 
 
Figure 4.12. Numbers of circulating monocytes in wild-type (Wt) and Cx3cr1-Dtr animals. A, B) blood. C, 
D) spleen. Data are mean + SEM. # main effect of day. * Tukey post-hoc after day by genotype interaction. p < 
0.05. 
 
4.4. Discussion 
This study is the first to (A) show the successful ablation of microglial and monocytes within 
48 hr after a systemic application of DT in Cx3cr1-Dtr rats; and (B) show the successful 
repopulation of microglia and peripheral monocytes after depletion of these cell types in 
Cx3cr1-Dtr rats. These data verify this model as a precise and useful tool for studying the 
role of microglia in various physiological processes.  
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To ablate microglia from the CNS, both pharmacological and genetic strategies have been 
developed. However, to our knowledge this is the first model to specifically abolish microglia 
in rats as previous literature has shown microglia ablation in mice only. Upon DT 
administration, cytosolic inhibition of cellular protein synthesis occurs, leading to cell death, 
in both microglia and circulating monocytes (387). We have demonstrated that our model can 
achieve fast and robust microglial death throughout the brain, ranging from 55% to 95% 
depending on the region assessed, within 48 hrs after DT application. It is noteworthy that we 
observed microglial ablation in the ARC within 24 hrs after DT administration (75%, data not 
shown) with further ablation to approximately 95% after 48 hrs. The ARC lacks an effective 
blood brain barrier (BBB) (186), therefore, it is likely that microglial ablation occurs faster in 
this region and then extends into other regions of the hypothalamus and hippocampus. 
Pharmacological models using CSF-1R agents require between 7 and 21 days of treatment to 
deplete microglia the hippocampus (36, 96, 243), whereas others have shown a similar time 
course as our Cx3cr1-Dtr hippocampal reduction, illustrating an 80% depletion of cortex 
microglia 3 days after DT injection in Cx3cr1creER:iDTR mice (61, 257). Independent of the 
strategy used, previous literature in mice has shown that depletion of microglial cells can be 
achieved between 70 to > 95% (36, 61, 96, 243, 257).  
 
Despite the differences in species and the strategy applied to ablate microglia, the 
repopulation capacity of microglia is similar between rats and mice (36, 257). We have 
shown repopulation occurs approximately one week after depletion and the whole population 
is restored without obvious morphological deficits in microglia approximately 1 - 2 weeks 
later. Although, Parkhurst and colleagues have illustrated a slower repopulation with 
microglia remaining significantly lower than those of control mice within one week of 
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depletion (61). Unfortunately, this study did not further explore when the repopulating 
microglia are fully restored therefore we are unable to conclude that this particular model of 
ablating microglia is meaningfully different from our own. Ueno and colleagues have also 
shown that repopulation of microglia during development can occur within 36 hrs after 
microglial ablation suggesting that microglial regeneration could be faster during 
developmental periods (67).  
 
Further investigation is required to determine where the regenerated microglia in our Cx3cr1-
Dtr rats are deriving from. However, recent evidence suggests that regenerating microglia 
derive from proliferating resident microglia that were able to escape the ablation treatment 
and not from bone marrow-derived macrophages (36, 190, 243, 257). Repopulation may be 
dependent on cell populations expressing the neuronal stem cell marker Nestin (36, 257), but 
this has not been shown in all studies (41). 
 
To successfully ablate microglia, a variety of pharmacological strategies have been 
developed, with CSF-1R compounds being widely used in mice (36, 96, 243, 288, 289). It 
has been demonstrated that in the brain, microglia are the only cell type that expresses CSF-
1R under normal conditions (332, 333). Despite this strategy resulting in efficient elimination 
of microglia within the brain, these drugs need to be administered for 7 to 21 days to achieve 
near complete ablation in the hippocampus (36, 96, 243), whereas, our model allows quick 
and efficient ablation of microglia within the brain 48 hrs post-DT administration. 
Additionally, these drugs are not water soluble therefore need to be administered in the 
standard chow. As microglia are involved in satiety and the feeding regulatory pathway, this 
form of drug administration could potentially become problematic (180, 187).  
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There is conflicting evidence involving the two different CSF-1R compounds commonly 
used. The PLX3397 compound has been shown to yield a near complete ablation in the 
hippocampus after 7 to 21 days of systemic administration (290 mg/kg chow) (36, 96, 243) 
whilst a higher dose of PLX5562 (1200 mg/kg chow) is required to achieve this near 
complete ablation (289). However, Dagher and colleagues have shown that a lower dose (300 
mg/kg chow), similar to the PLX3397 dose, allows a sustained 30% elimination of microglia 
within the hippocampus (289). Dagher et al. have illustrated that c-Kit is not essential to 
robustly deplete microglia or aid in the regeneration of the microglial population, thus, 
further investigation into the CSF-1R compounds is required to determine why these 
differences are occurring with very similar doses. Additionally, this sustained 30% 
elimination of microglial cells altered the response to inflammatory stimuli in aged 3xTg- 
Alzheimer’s disease (AD) mice with a reduction in the number of microglial cells interacting 
with tau plaques (289). The authors postulate that PLX5562 compound’s mechanism of 
action is one of a non-inflammatory action and may alter the function, shifting the microglia 
into a “microglial shaper”, which prevents the association of microglia with plaques. This 
compound will need to be examined further to determine whether the altered function is 
solely due to the remaining microglia or whether it is due to the non-inflammatory action the 
compound may be having on the cells themselves.  
   
Genetic approaches in mice; similar to our model, have also used DT to ablate microglia. 
This ablation strategy has either been directly induced by tamoxifen expression of the DT in 
the target cells or cell type-specific expression of the Dtr in combination with the systemic 
application of DT so that only cells carrying the receptor are susceptible to death (61, 257). 
These studies have exclusively investigated adult microglial depletion rather than 
additionally ablating peripheral monocytes. This is achieved by taking advantage of the fact 
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that microglia and other Cx3cr1 cells have substantially different turnover rates with 
monocytes / macrophages having a rapid turnover (297, 298) compared to low turnover of 
microglia (1, 17). Therefore, administration of tamoxifen approximately 30 days prior to DT 
application is essential for microglia to be the only Cx3cr1 cell population effected by DT 
(61, 257). The necessity to administer tamoxifen 30 days prior to microglial ablation, reduces 
the diversity of these models and investigating the effects of microglial elimination / 
repopulation during development is not possible with this approach. Our model is not 
dependent on tamoxifen to specifically deplete microglia. Although we have currently only 
investigated systemic administration and therefore the depletion of both microglia and 
peripheral monocytes, it would be possible to perform intracranial and regional specific DT 
injections to specifically deplete microglia without disturbing peripheral monocytes.  
 
To our knowledge, we are the first to develop a microglial ablation model in rats. In 
summary, we have shown that the Cx3cr1-Dtr insertion does not alter the rats’ phenotype 
under basal conditionals. We have also shown that we can acutely eliminate both microglia 
and monocytes within 48 hrs after DT application and that microglia can repopulate within 7 
days. This rat model will be used for further applications particularly investigating whether 
the elimination as well as repopulation of microglia can affect learning and memory.   
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CHAPTER 5 
Microglial repopulation after ablation enhances 
working memory performance in association 
with suppressing the development of immature 
neurons 
 
 
Simone N. De Luca and Sarah J. Spencer 
 
 
 
 
 
 
	 	
131	
	 	
5.1. Introduction 
It is becoming increasingly evident that microglia play a crucial role in learning and memory. 
During development, microglia influence synaptic transmission and synaptogenesis (4, 59, 
388, 389) and contribute to the maturation of neural circuits (37, 66, 390). In the adult brain, 
microglia have also been found to play a key role in adult neurogenesis by phagocytosing 
apoptotic cells under normal physiological conditions (88), controlling the increased 
neurogenesis caused by environmental enrichment (391), as well as decreasing neurogenesis 
following inflammatory challenges (392). Importantly, microglial dysfunction has been 
associated with aging (e.g. microglial dystrophy) (393), neurodegeneration (e.g. stroke (394, 
395), Alzheimer’s disease (AD) (396)), and with neurodegenerative conditions associated 
with a decline in learning and memory. Microglia are also highly sensitive to adverse 
environmental factors such as diet, both in early life and adulthood that result in cognitive 
dysfunction (197, 198, 342).  
 
Disruptions to the microglia profile during development, through environmental factors such 
as stress and nutrition, are associated with synaptic dysfunction, as is evident from animal 
studies, primarily in rodents. Early life stress, for example, maternal deprivation during 
development, can reduce dentate gyrus (DG) dendritic spine complexity in adult rats (397). A 
poor postnatal environment with limited nesting and bedding decreases the number of 
dendritic spines in the Cornu Ammonis (CA)3 region of the hippocampus (397). 
Additionally, an 8 week high fat diet (HFD), initiated at postnatal day (P)35 in mice increases 
the dendritic spine density in CA1 pyramidal neurons (398). Cx3cr1 deficient mice also 
display deficits in hippocampal neurogenesis in the sub-granular zone (SGZ) compared to 
controls (399, 400). Transient depletion of microglia during development has pronounced 
effects on the CNS ultrastructure, particularly that involving synaptic tuning. Parkhurst and 
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colleagues have shown that microglia are important in baseline regulation of post-synaptic 
dendritic spines in the motor cortex in CX3CR1CreER:iDTR mice (61). Microglial depletion at P19 
or P30 induces decreases in both synapse elimination and formation as well as altering 
synaptic protein levels and impairing glutamatergic function (61).  
 
Impairments in synapses and dendritic spines as a result of either microglial hyper-activation 
or depletion can directly affect performance in various learning and memory tasks. There is 
evidence suggesting that disruptions to the microglial profile during development, such as 
early life nutrition, can induce long-lasting conflicting effects on learning and memory. We 
have shown that early life overfeeding in rats impairs both memory performance in adulthood 
and microglial responses to a memory task (Chapter 2 and (342)). Rogers and colleagues 
have reported hippocampal specific deficits in motor and spatial learning (using a standard 
rotarod and Morris water maze (MWM) respectively) as well as impaired learning and 
memory in a standard fear conditioning paradigm in Cx3cr1 knockout mice (64). Microglial 
elimination during early embryonic development also induces motor learning abnormalities 
in adulthood (401) and depletion during postnatal development results in long-term 
impairments in anxiety, social and locomotor behaviour (241).  
 
Environmental factors during adulthood, such as diet, have also been associated with 
microglial abnormalities, synaptic dysfunction and impairments in learning and memory. 
HFD-fed rodents have a hyper-activated microglial profile (195, 402, 403). Long-term HFD, 
i.e. between 8 to 12 weeks, induces microglial hyper-activation and also leads to synaptic 
loss, including reductions in the number of dendritic spines and expression of synaptic 
markers such as post synaptic density protein (PSD)95 and synaptopodin (195, 402, 403). 
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Hippocampal microglial activation associated with obesity has also been found to 
significantly impair performance in various learning and memory tasks (197, 198).  
 
Microglial depletion has also been shown to induce alterations in synaptic function and 
changes in cognitive functioning. As such, studies investigating the role of microglia in 
learning and memory through the use of microglial depletion approaches have yielded 
conflicting results. Short-term microglial depletion in adult CX3CR1CreER mice impairs motor 
learning in a rotarod task, stimulates a reduction in synapse formation in motor learning-
induced remodelling, and reduces working memory as assessed by a novel object recognition 
(NOR) task (61). Additionally, impairments were also found in social behaviour using a 
Crawley’s sociability task in mice that had microglia depleted in the hippocampus via 
intrahippocampal liposomal clodronate (96). Conversely, consumption of a CSF1R 
antagonist (PLX3397) for 2 months improves spatial memory performance in the Barnes 
maze (36). Thus, the precise role of microglia in memory performance remains to be fully 
determined. 
 
As we have previously seen that the physiological response to a spatial learning task is to 
reduce numbers of microglia in the hippocampus and retrosplenial cortex, (Chapter 2 and 
(325)), we hypothesised that depletion of microglia would improve measures of cognition. To 
test the role of microglia in adult memory we used our Cx3cr1-Dtr rat model to modulate 
microglial function. We thus induced a near complete ablation of microglia throughout the 
brain (Chapter 4) and investigated memory performance at the peak of microglial ablation 
(48 hrs post-diphtheria toxin (DT)) and upon repopulation (7 and 14 days post-DT). Here, we 
report that specific elimination of microglia does not affect cognition or the number of 
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immature and mature neurons when the microglia remain depleted. However, microglial 
regeneration improves working memory.  
5.2. Materials and Methods 
5.2.1. Animals 
All experiments were conducted in accordance with the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes, with approval from the RMIT University 
Animal Ethics Committee.  
 
In these experiments, we used 132 male rats aged between 9 and 12 weeks. Specific n are 
indicated in the figure legends. The rats were kept under standard laboratory housing 
conditions, with a 12 hr light cycle (0700 – 1900 hr), an ambient temperature of 22 °C and 
free access to water and standard rat chow. To acutely ablate microglia, DT was administered 
to Wt and Cx3cr1-Dtr rats as two separate injections, 8 hr apart, of 25 ng / g DT in sterile 
saline, subcutaneous (s.c.), according to the protocol of Uneo and colleagues (67) and as 
reported in Chapter 4.  
 
To establish chronic ablation of microglia, DT was administered every 5 days for 25 days, 25 
ng / g DT in sterile saline, s.c. Post-DT tissue collection was performed after the rats were 
deeply anaesthetized with 150 mg/kg sodium pentobarbital intraperitoneal (i.p.). Additional 
specific experiments are described below.  
 
5.2.2. Gene expression 
 To assess changes in expression of genes involved in neurogenesis and synaptic receptors, 
we dissected hippocampi from wildtype (Wt) and Cx3cr1-Dtr rats and conducted quantitative 
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real-time PCR (qRT-PCR) as described in Chapter 4 under the section 4.2.5. Gene 
expression.  
 
Table 5.1. TaqMan probe details (Life Technologies) used for qr-PCR 
Target gene NCBI reference sequence TaqMan assay ID Product size 
Rbfox3 (Neun) NM_001134498.2 Rn01464214_m1 82 
Dcx NM_053379.3 Rn00670390_m1 72 
Vglut1 NM_053859.2 Rn01462431_m1 71 
Glua2 NM_001083811.1 Rn00568514_m1 122 
Glun2a NM_012573.3 Rn00561341_m 68 
B2m NM_012512.2 Rn00560865_m1 58 
 
5.2.3. Doublecortin (DCX) Immunohistochemistry 
To assess the number of immature neurons in the dentate gyrus of the hippocampus, DCX 
immunohistochemistry was performed as previously described in Chapter 2 under the section 
2.4. Immunohistochemistry.  
 
5.2.4. Neuronal nuclei (NeuN) Immunofluorescence   
Hippocampal sections were immunolabelled with the fluorescent marker neuronal nuclei 
(NeuN). One 1 in 5 series of sections from each animal was used. Sections from each 
treatment group were randomly selected and processed at the same time in batches. Sections 
were washed with 0.01M PBS and blocked for 30 min with 3% BSA, 0.3% Triton X-100 in 
0.01M PBS. The sections were incubated in the primary antibody overnight at room 
temperature (RT) (NeuN: 1:5000, rabbit, Abcam, Cambridge, England, UK). Following the 
incubation period, sections were washed 5 x 5 min in 0.01M PBS to remove excess primary 
antibody solution and then incubated with the fluorescent secondary antibody for 120 
minutes (kept in the dark from this point; NeuN: 1:500, Vector Laboratories). Afterwards 
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sections were washed, then incubated in DAPI as a nuclear counterstain (10 min; 1:2000 
from 5 mg / mL stock), followed by immediate coverslipping with Dako (Dako, Glostrup, 
Denmark).  
 
Hippocampal sections were assessed by an experimenter blinded to treatment groups for 
numbers of cells positive for NeuN as previously described in Chapter 3. Briefly, we 
manually counted NeuN-positive cells in the CA1 and CA3 sub-regions of interest and 
conducted thresholding with the Image J software for the DG.  
 
5.2.5. Golgi complex 
To assess changes in dendritic spines, we dissected 10 mm thick brain slices from Wt and 
Cx3cr1-Dtr rats that included hippocampi over ice and conducted Golgi Cox staining using 
the FD Rapid GolgiStain kit (FD Neurotechnologies, Columbia, MD, USA). Brains were 
rinsed with double distilled water and then immersed in the impregnation solution (1:1 
mixture of FD Solution A:B) for 2 weeks at RT in the dark. FD Solution A:B was replaced 
after the first 6 hours. Brains were then transferred to FD Solution C in the dark for 72 hrs. 
FD Solution C was replaced after the first 24 hrs. In preparation for sectioning, the tissue was 
rapidly frozen in isopentane pre-cooled on dry ice. Brains were then kept at -80 °C until 
sectioning. Cryosectioning was performed on a Leica CM 1950 at -22 °C, coronal sections of 
100 µm thickness were cut and transferred to gelatin coated slides onto a small drop of FD 
solution C. After allowing the sections to dry at RT in the dark overnight, slides were then 
stained with FD Solution D:E. DPX (Sigma-Aldrich, St Louise, MO, USA) was used for 
coverslipping.  
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Dendritic spine density of pyramidal neurons in the hippocampus (subfield CA1 and CA3) 
were assessed by an experimenter blinded to treatment groups. Pyramidal neurons were 
located and basal and apical dendritic tree lengths as well as basal dendritic tree branches 
were measured. Dendritic spines were counted according to the general methods of Gould et 
al (404). To ensure that the same population of dendrites and spines were analysed within 
and across subjects, specific criteria were included: 1) cell bodies needed to be within the 
area of interest, 2) the length of the branch was unbroken, 3) the length of the dendrite was 
isolated well enough for an unobstructed view. To analyse dendritic spines, three neurons per 
three independent coronal sections per rat, which contained the hippocampus (2.52 and 4.56 
mm caudal to bregma) were photographed at 40x magnification on an Olympus DP72 digital 
camera. Spines on the branches were counted, and the spine density / µm of the dendrites 
were calculated and averaged for each rat.  
 
5.2.6. Behaviour 
Cx3cr1-Dtr and Wt controls underwent behavioural tasks at three time points after acute 
microglial ablation via DT administration; at 48 hrs post-DT when microglial depletion was 
greatest and 7 and 14 days when microglia have repopulated (Chapter 4). To examine the 
effects of chronic ablation, behavioural tasks were performed at 16 days after the initial 
exposure to DT. 
 
5.2.6.1. Y Maze 
To assess spatial working memory in animals, we performed the Y-Maze task as previously 
described in Chapter 2 under the section 2.2.6.1. Y-Maze.  
 
5.2.6.2. Novel Object Recognition (NOR) 
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To test the rodents’ working memory ability via recognition of a novel object in the 
environment, we assessed the rats in the NOR task (342, 386), as previously described in 
Chapter 2 under the section 2.2.6.2. Novel Object Recognition. 
 
5.2.6.3. Novel Place Recognition (NPR) 
To further assess the rodents’ working memory ability, we assessed the rats in the novel place 
recognition task (342, 386). The objects were identical both in height and volume. The task is 
similar to the previously described methods for NOR. However, during the retention phase, 
rather than replacing a familiar object with a novel object, the familiar object is moved to a 
novel place as seen in Figure 5.1. 
 
 
Figure 5.1. Novel place recognition task. Rats were freely allowed to explore the arena as well both identical 
objects during the acquisition phase. After a 1 hr inter-trial interval, rats were placed back into the arena with 
one familiar and one novel location and allowed to explore the arena once again. 
 
5.2.6. Data analysis 
As described for the experiments in Chapter 2 section 2.7. data were analysed by SPSS using 
Student’s unpaired t-tests or multi-factorial analyses of variance (ANOVAs) with Tukey’s 
A  A  A  
1	hour 
Acquisition	Phase 
3	min 
Retention	Phase 
3	min 
B 
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post-hoc tests where significant interactions were found, with genotype and behaviour as 
between factors where appropriate. Data are presented as the mean ± SEM. Statistical 
significance was assumed when p ≤ 0.05.  
 
5.3. Results 
5.3.1. Cognitive function in tests of learning and memory is not affected by the absence of 
microglia 
To test the role of microglia in learning and memory, we depleted microglia with s.c. DT in 
our Cx3cr1-Dtr rats and assessed their performance, relative to Wt controls, in three memory 
tests. For the Y maze, at 48 hr after DT, when the microglia are ablated throughout the brain, 
the Cx3cr1-Dtr rats showed an increased latency to enter the novel arm compared with the 
Wt controls (t(17) = 2.318, p = 0.003; n = 8-11 per group; Figure 5.2. A) but microglial 
ablation did not affect performance in terms of the number of entries into the novel arm nor 
the duration of time spent in the novel arm (Figure 5.2. B-D).  
 
To assess working memory, we examined the rats’ performance in the NOR task. There were 
no differences between the Cx3cr1-Dtr and Wt rats in the acquisition phase of the NOR task 
with rats spending equal time with both objects (n = 10-11 per group; Figure 5.2. E). Cx3cr1-
Dtr rats showed no significant differences in the duration spent exploring the novel object 
compared to Wt rats during the retention phase, both groups showing a positive 
discrimination ratio (n = 10-12 per group; Figure 5.2. F). 
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Figure 5.2. Learning and memory behavioural testing 48 hrs post-DT when microglial have been ablated. 
Y maze (A-D), novel object recognition test (E-F) in wildtype (Wt) or microglial depletion (Cx3cr1-Dtr) rats. 
Data are mean + SEM. N = 10-12 per group. * p < 0.05 in Wt compared with Cx3cr1-Dtr rats. # main effect of 
arm in Wt compared with Cx3cr1-Dtr rats.  
 
5.3.2. Microglial ablation does not cause differences in neuronal numbers in our Cx3cr1-
Dtr rats  
We next investigated if microglial ablation was associated with changes in neurogenesis by 
assessing numbers of cells positive for DCX, a marker of immature neurons. We found no 
differences in expression of Dcx mRNA in the hippocampus of microglial-depleted animals, 
i.e. at 48 hr after DT administration (n = 6 per group; Figure 5.3. A). There were also no 
differences in the number of DCX-positive cells in the sub-granular/ granular region of the 
hippocampus between Wt and Cx3cr1-Dtr DT-treated animals (n = 6 per group; Figure 5.3. 
B). We also found no differences in the mature marker Neun expression (Figure 5.3. C) or in 
the number of NeuN-positive cells in any regions of the hippocampus (Figure 5.3. D-G).  
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Figure 5.3. Microglial ablation does not affect neurogenesis at 48 hrs post-DT. Gene expression of DCX, a 
marker for immature neurons (A; doublecortin (DCX) and NeuN, a marker for total neurons (C; neuronal nuclei 
(NeuN)). Numbers of hippocampal immature neurons (B, (DCX)) and total neurons (D-G; (NeuN)) in wildtype 
(Wt) and microglial depleted (Cx3cr1-Dtr) rats. Data are mean ± SEM. N = 5-6 per group.  
 
5.3.3. Microglial regeneration transiently affects cognitive function in tests of learning and 
memory 
To determine whether regeneration of microglia at 7 days post-DT could affect learning and 
memory behaviours, we tested the rats’ memory in the Y-maze, NOR and NPR tests. The 
Cx3cr1-Dtr rats showed an increased latency to enter the novel arm compared with the Wt 
controls (t(20) = 2.111, p = 0.047; n = 8-11 per group; Figure 5.4. A) but did not affect 
performance in the number of entries into the novel arm of the Y maze nor the duration of 
time spent in the novel arm (Figure 5.4. B-D). There were no differences between the 
Cx3cr1-Dtr and Wt rats in the acquisition phase of the NOR with rats spending equal time 
with both objects (n = 10-11 per group; Figure 5.4. E). Cx3cr1-Dtr rats had an increased 
positive discrimination ratio compared to Wt rats in the NOR task (t(22) = 4.198, p < 0.001; n 
= 12 per group; Figure 5.4. F). As these rodents illustrated an increased memory recall in the 
NOR, we then assessed another form of working memory, the NPR task. We saw no 
differences in the acquisition phase of the NPR between the Cx3cr1-Dtr and Wt rats, with 
both groups spending equal time with both objects (n = 7 per group; Figure 5.4. G). The 
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Cx3cr1-Dtr rats had an increased positive discrimination ratio compared to Wt rats in the 
NPR task (t(12) = 2.537, p = 0.026; n = 7 per group; Figure 5.4. H), which suggests that these 
rodents are able to recall the task more efficiently than the Wt controls, thus have an 
enhanced working memory. 
 
 
Figure 5.4. Learning and memory behavioural testing 7 days post-DT when microglial have regenerated. 
Y maze (A-D), novel object recognition (NOR) task (E, F), novel place recognition (NPR) task (G, H) in 
wildtype (Wt) or microglial depletion (Cx3cr1-Dtr) rats. Data are mean ± SEM. N = 7-12 per group. * p < 0.05 
in Wt compared with Cx3cr1-Dtr rats. # main effect of arm in Wt compared with Cx3cr1-Dtr rats. 
 
5.3.4. Microglial regeneration alters neuronal numbers  
We have previously shown that spatial learning in the radial arm maze is associated with a 
suppression of neurogenesis (342), therefore, we hypothesised that this increase in working 
memory would be associated with a suppression of immature neurons. There were no 
differences in Dcx mRNA expression in the hippocampus of microglial-depleted animals at 7 
days after DT administration (Figure 5.5. A). However, at this time point our Cx3cr1-Dtr rats 
had fewer immature neurons in the SGZ than Wt controls (t(10) = 2.239, p = 0.049; n = 6 per 
group; Figure 5.5.B). There were no differences between the groups in Neun gene expression 
(Figure 5.5. D). Interestingly, we found that microglial regeneration increases the number of 
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total neurons in the hilus region of the dentate gyrus (t(7) = 2.438, p = 0.044; n = 4-5 per 
group; Figure 5.5.E). We did not see this effect in other regions of the hippocampus (Figure 
5.5. F-H).  
 
 
Figure 5.5. Microglial ablation does not affect neurogenesis at 7 days post-DT. Gene expression of DCX, a 
marker for immature neurons (A; doublecortin (DCX)) and NeuN, a marker for total neurons (D; neuronal 
nuclei (NeuN)). Numbers of hippocampal immature neurons (B,C; (DCX)) and total neurons (E-I; (NeuN)) in 
wildtype (Wt) and microglial depleted (Cx3cr1-Dtr) rats. Data are mean ± SEM. N = 4-6 per group. 
Representative photomicrographs of hippocampal C) DCX and F) NeuN. Scale bars = 50 µm. * p < 0.05 in Wt 
compared with Cx3cr1-Dtr rats.   
 
5.3.5. Repopulation of microglia does not affect neuronal function  
To examine whether microglial repopulation could affect the density of spines on pyramidal 
neurons in the CA1 and CA3 regions of the hippocampus, we stained hippocampal sections 
with FD Rapid GolgiStain. Our Cx3cr1-Dtr rats had an increased number of basal dendritic 
branches compared to controls in the CA3 region of the hippocampus (t(5) = 2.894, p = 0.034; 
n = 3-4 per group; Figure 5.6.C) but no differences in dendritic tree length or dendritic spine 
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density. There were no differences in the CA1 region of the hippocampus for dendritic tree 
length, branches or dendritic spine density (Figure 5.6. E-H). We also found no differences in 
pre- or post- synaptic gene expression (Figure 5.6. J-L).  
 
 
Figure 5.6. Analysis of the dendritic trees in the CA3 and CA1 regions of the hippocampus upon 
microglial repopulation at 7 days post-DT. Basal dendritic tree length (A, E), apical dendritic tree length (B, 
F), basal dendritic tree branches (C, G) and dendritic spine density (D, H) in wildtype (Wt) or microglial 
depleted (Cx3cr1-Dtr) rats. (I) Representative photomicrographs of CA1 golgi stain. Gene expression of Vglut1, 
a presynaptic marker (J), GluA2, a presynaptic marker (K) and GluN2A, a postsynaptic marker (L). Data are 
mean ± SEM. N = 3-4 per group for Golgi. N = 4-7 per group for gene expression. * p < 0.05 in Wt compared 
with Cx3cr1-Dtr rats. 
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5.3.6. Initial changes to neuronal number and cognitive function dissipate 14 days after 
microglial depletion 
To determine if the increase in total neurons after microglial repopulation is sustained long-
term, we examined neurogenesis 14 days after-DT, at which point the microglia have fully 
repopulated the brain and have normal morphology (Chapter 4). There were no differences in 
the NOR task during the acquisition or test phase at this time point (n = 11-12 per group; 
Figure 5.7. A, B). There were also no differences in Dcx mRNA expression or in the number 
of immature (n = 6 per group; Figure 5.9. A, B) or in Neun mRNA expression or in mature 
neurons (n = 5-6 per group; Figure 5.8. C-G) in the hippocampus.  
 
 
Figure 5.7. NOR task at 14 days post-DT when microglial have regenerated in wildtype (Wt) or 
microglial depletion (Cx3cr1-Dtr) rats. Data are mean ± SEM. N = 11-12 per group. 
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Figure 5.8. Microglial ablation does not affect neurogenesis at 14 days post-DT. Gene expression of DCX, 
a marker for immature neurons (A; doublecortin (DCX)) and NeuN, a marker for total neurons (C; neuronal 
nuclei (NeuN)). Numbers of hippocampal immature neurons (B; (DCX)) and total neurons (D-G; (NeuN)) in 
wildtype (Wt) and microglial depleted (Cx3cr1-Dtr) rats. Data are mean ± SEM. N = 4-6 per group.  
 
5.3.7. Chronic microglial ablation does not affect learning and memory 
To determine whether the memory improvements seen at 7 days post-DT in our Cx3cr1-Dtr 
rats is due to microglial repopulation, we chronically ablated microglia and assessed the rats’ 
performance in two different working memory tasks: NOR and NPR tasks. Consistent with 
acute microglial ablation, the Cx3cr1-Dtr rats showed no significant differences in the 
duration spent exploring the novel object (positive discrimination ratio) compared to Wt rats 
in the NOR (n = 8 per group; Figure 5.9. A) and no differences in the NPR (Figure 5.9. B) at 
16 days after microglial ablation if the microglia remained suppressed. 
 
 
Figure 5.9. Behavioural testing of learning and memory after chronic microglial ablation. NOR (A) and 
NPR task (B) in wildtype (Wt) or microglial depletion (Cx3cr1-Dtr) rats. Data are mean ± SEM. N = 8 per 
group. 
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5.4. Discussion 
In this study, we aimed to determine if microglia play an important role in cognition in 
healthy adult rats (Fig 5.10.). We show that acute and chronic depletion of microglia in adult 
Cx3cr1-Dtr rats results in no deficits in any of the behavioural cognitive tasks tested. 
However, upon regeneration of the microglial population, these rats showed a transient 
enhancement in tasks involving working memory.  
 
 
Figure 5.10. Timeline and summary of the data. Diphtheria toxin (DT) specifically ablated microglia within 
48 hrs in the Cx3cr1-Dtr rats compared to wildtype (Wt) controls. Microglia are completely regenerated by 7 
and 14 days post-DT. Depletion of microglia does not affect memory or neurons. Repopulation of microglia 
transiently enhances working memory and alters neurogenesis at 7 days but dissipates by 14 days post-DT.  
 
Microglia are known to play a key role in learning and memory, regulating apoptosis and 
synaptic plasticity (331). In our study, ablation of microglial cells in our Cx3cr1-Dtr rats did 
not affect learning and memory while the microglia were absent. Previously, however, 
specific depletion of brain microglia has shown conflicting effects on learning and memory in 
the healthy adult brain. Parkhurst et al. have shown that short-term microglial depletion in 
CX3CR1CreER mice affects synaptic remodelling as well as reducing spontaneous glutamate 
release therefore impairing working memory in the NOR and rotarod motor learning (61). 
Alternatively, longer-term (2 months) microglial depletion via a CSF1R antagonist, 
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PLX3397, can significantly improve spatial memory performance in the Barnes maze (36). 
These studies used different modes of microglial ablation than our model and different 
species, which could account for the differences in outcomes. For instance, all of these 
studies are in mice whereas our model is in rats (36, 61, 96). Rats are known to learn 
cognitive behavioural tasks more efficiently and perform the tasks more reliably than mice 
(299-301) and so may be able to effectively process the learning tasks despite the absence of 
microglia. It is possible that different responses would be seen with more difficult tasks or 
those testing other aspects of memory such as the Delayed Spatial Win-shift Test Radial Arm 
Maze which examines both spatial working and reference memory. 
 
It is worth considering the utility of the tests we selected compared to other memory tasks to 
assess working memory in rats. The NOR and NPR tasks offer robust tests for working 
memory in rodents where memory is demonstrated when an animal spends greater time with 
the novel object or place than the familiar object (405-407). These tasks offer advantages 
over other working memory tests such as the delayed non-match to sample (DNMS) task as 
they do not require any external motivation, reward or punishment (408, 409). The enhanced 
positive discrimination ratio that we see in our Cx3cr1-Dtr rats upon microglial repopulation 
compared to Wt controls is unlikely to be due to a heightened motivation to explore the 
environment as these rats do not have explorative differences in an open field task (see in 
Chapter 6). It is possible that upon microglial repopulation the rats experience an increased 
preference for novelty. However, this is also unlikely since the groups spend equal time 
exploring the objects in the acquisition phase. Thus, it is highly plausible that the enhanced 
discrimination ratio in our Cx3cr1-Dtr rats reflects a subtle enhancement in working memory 
compared to controls upon repopulation of microglia. Further investigation is required to 
determine whether other forms of memory are enhanced upon microglial repopulation.  
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Neurogenesis occurs in the SGZ of the dentate gyrus between the granule cell layer and the 
hilus (94). In addition to behavioural changes, microglial repopulation was also associated 
with neuronal alterations, specifically a reduction in the number of immature DCX-positive 
cells in the SGZ and a transient increase in the number of mature neurons in the hilus region 
of the dentate gyrus. Neurons reach maturity after approximately seven weeks (410), 
however, immature markers such as DCX, poly-sialated neural cell adhesion molecule (PSA-
NCAM) and calretinin are only expressed during the first three weeks of the post-mitotic 
differentiation phase (411, 412). Under normal physiological conditions, neurogenesis and 
microglia numbers are inversely correlated, suggesting that microglia inhibit the proliferation 
of neural progenitor cells (NPCs; immature neurons) (413, 414). Additionally, in vitro co-
cultures of NPCs with an increasing proportion of microglia reduce the number of NPCs 
(414). Thus, it is possible that the reduction in the number of immature neurons within the 
SGZ 7 days post-DT is due to the repopulation of microglia within the hippocampus.  
 
Enhanced performance in a variety of cognitive tasks have been associated with apoptosis of 
young neurons (89, 342). Our Cx3cr1-Dtr, but not control rats, had reduced levels of 
immature neurons indicating that microglial regeneration after depletion may lead to 
increased apoptosis of immature neurons, greater stability of the existing neuronal 
population, and improved working memory in the NOR and NPR tasks. These Cx3cr1-Dtr 
rats also expressed a transient increase in the number of mature neurons in the hilus region of 
the dentate gyrus compared to controls upon microglial repopulation at 7 days post-DT. This 
enhanced number of mature neurons could be explained by a reduction in apoptosis of mature 
neurons in the absence of microglia between depletion and repopulation post-DT, which is 
normalized by 14 days. While further analysis is required to determine whether there are 
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differences in neuronal apoptosis in our Cx3cr1-Dtr rats, a reduction in apoptosis of mature 
neurons is typically associated with overlapping expression of neuronal markers during the 
initial few days of the early post-mitotic neuronal maturation phase of hippocampal 
neurogenesis (410). During this phase, there is an overlap in the expression of DCX 
(immature neurons) and NeuN (mature neurons) markers (410, 415, 416). Therefore, the 
transient increase in the number of NeuN-positive cells found in the hilus region of our 
Cx3cr1-Dtr rats could be accounted for by this overlapping expression as the increased 
number dissipates by 14 days post-DT.  
 
There have been recent advances in studying microglia in both physiological and 
pathological states, however, few to none have studied whether repopulated microglia affect 
cognition. We have previously illustrated that the adult brain has the capacity to repopulate 
itself with new microglial cells following near complete microglial elimination (see Chapter 
4). To our knowledge this is the first study indicating that the repopulation of microglia, 
following elimination, enhances learning and memory. Despite the different pharmacological 
approaches, studies have shown no cognitive differences under physiological conditions upon 
microglial repopulation in mice (96, 243). These studies examined cognitive behavioural 
tasks 14 to 20 days after cessation of treatment despite repopulation occurring from as early 
as 7 days after depletion (96, 243). We demonstrated that the enhanced working memory 
associated with microglial repopulation may be transient as the effect is lost at 14 days after 
depletion and therefore the previous studies may have missed this crucial outcome when 
examining cognitive performance at a later stage. Our Cx3cr1-Dtr rats showed a complete 
replenishment of microglia to similar levels to the Wt controls (Chapter 4), whilst the Torres 
et al. study illustrates that the new microglia population displays an activated morphology 
(96). A ramified state of microglia may be necessary for the elimination of synapses and 
	 	
151	
	 	
structural plasticity, which is crucial for normal cognition (331).  Therefore, potentially this 
altered microglial profile seen in other models may account for the differences in memory, 
with the activated regenerated microglia being unable to modify synapses normally.  
 
Most literature studying the role of microglia in synaptic regulation examines the early 
development period, focusing on microglia’s modulatory role in global neuronal circuitry 
(417). Previous studies have shown that complement receptor 3 deficiency (50) or Cx3cr1 
deficiency in mice (37, 51) results in reductions in pruning and altered network connectivity 
during development. During adulthood microglia are thought to be involved in synaptic 
regulation. Adult microglial elimination can cause a reduction in dendritic spine formation 
and elimination in the neurons of the motor cortex (61) and olfactory bulb (97). Whereas in 
the hippocampus, dendritic spines are increased after ablation of microglia (98). However, to 
date there are no studies investigating the effects of microglia repopulation on dendritic 
spines. Upon repopulation of microglia in the hippocampus, we do not see any differences in 
dendritic spine elimination or formation. However, it would be interesting to differentiate 
between the mature and immature neurons. Further research is required to determine whether 
there are differences in dendritic spines in immature neurons in our Cx3cr1-Dtr rats. 
Moreover, there is a strong relationship between memory and dendritic spine density in the 
hippocampus. Leuner and colleagues have demonstrated that in adult male rats an acquisition 
of new memories in a trace eye blink conditioning paradigm is associated with increased 
density of dendritic spines in the CA1 pyramidal cells but not in the dentate gyrus or 
somatosensory cortex (418). Additionally, enhanced spatial memory in the Morris water 
maze is also linked to increased spine density in the CA1 region (419). Furthermore, an 
impairment in working memory correlates with a reduction in dendritic spine density on 
pyramidal cells of the CA1 and medial prefrontal cortex (420). Thus, it could be speculated 
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that the enhanced working memory we see would be associated with an increase in dendritic 
spines in immature neurons.  
 
In summary, we have shown that elimination of microglia in our Cx3cr1-Dtr rats does not 
alter learning and memory or affect neurogenesis. Interestingly, we have found that upon 
microglial repopulation, working memory is enhanced and this is associated with a reduction 
in the number of immature neurons and an increase in the number of mature neurons in the 
hilus of the dentate gyrus.  This rat model illustrates a subtle role of microglia in learning and 
memory which merits further research, and could have far-ranging implication for cognitive 
dysfunction conditions, including Alzheimer’s disease and stroke where an accumulation of 
activated microglia cause impairments in learning and memory.  
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CHAPTER 6 
Microglial depletion leads to anorexia and 
weight loss despite orexigenic changes to 
feeding circuitry 
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6.1. Introduction 
Feeding and central regulation of food intake are essential for energy homeostasis and 
survival of all mammalian species. Feeding and metabolism are controlled through 
homeostasis of neuroendocrine circuits consisting of particular regions of the brain, including 
the hypothalamus, as well as gut and adipose tissue hormones (421-423). The hypothalamus 
is capable of tightly regulating food intake and can directly sense peripheral signals, thus 
modifying energy status (423, 424). The neuronal circuits orchestrating feeding behaviour are 
known to be disrupted in metabolic pathologies of hyperphagia (e.g. obesity) and hypophagia 
(e.g. anorexia nervosa (AN)). A recent genome-wide association report found that the 
majority of body mass index (BMI)-associated genes are expressed in the hypothalamus 
(425).  
 
Obesity is now an epidemic in our population. Worldwide, more than 1.4 billion adults are 
overweight (BMI >25) and over 200 million men and nearly 300 million women are obese 
(BMI >30) (133). It is now widely accepted that obesity is associated with low-grade 
inflammation in peripheral tissue and the circulation (172, 426), as well as central 
inflammation that is initiated in the hypothalamus (187). D’Souza and colleagues have 
observed that a consumption of hyperlipidic diet for 16 weeks in rodents elicits a 
significantly increased gene expression of interleukin (IL)-6, tumour necrosis factor (TNF)a, 
and IL-1b in the arcuate nucleus of the hypothalamus (ARC) and lateral hypothalamus (LH) 
(187). Furthermore, elevated pro-inflammatory cytokines in the hypothalamus develop within 
the initial 3 days of high-fat diet (HFD) exposure in rats and mice, prior to significant weight 
gain and parallel with the onset of leptin resistance and upregulation of neuronal stress 
markers (180, 188, 189). This pro-inflammatory cytokine profile in obesity and HFD is 
accompanied by an increase in activated microglial cells in humans and rodents. During 
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exposure to a HFD, activated microglia are found in the mediobasal hypothalamus and this 
increases local inflammatory mediators, such as cytokines (180, 187, 189). There is evidence 
to suggest that hypothalamic inflammation, particularly gliosis, has an effect on feeding and 
satiety, however the specifics of these effects are still largely unknown and have focused on 
inflammation in obese humans and rodents (427).  
 
Metabolism and energy balance regulation in the hypothalamus are governed by circulating 
hormones, ghrelin and leptin. Ghrelin is a fast-acting hormone whose role is to initiate food 
intake (428, 429) via activation of neuropeptide Y (NPY)/ Agouti related protein (AgRP) 
neurons. Genetic or chemical deletion of NPY and AgRP completely blunts ghrelin-induced 
feeding (430-434). Conversely, leptin, secreted from adipose tissue, regulates energy balance 
long-term, acting to suppress food intake (435, 436). Leptin also inhibits NPY/ AgRP 
neurons and stimulates pro-opiomelanocortin (POMC) neurons thus causing a reduction in 
food intake (437-439). Reports show that obesity lowers ghrelin secretion and plasma ghrelin 
(440), induces an impairment of ghrelin transport across the blood-brain barrier (BBB) (441, 
442), and causes deficits in NPY/AgRP function (443), suggesting that obesity causes ghrelin 
resistance by reducing the hypothalamic neurocircuitry responses controlling food intake 
(443). Importantly, microglial activation and the associated inflammation in the 
hypothalamus and the weight gain that ensues contribute to leptin- and insulin-resistance, 
requiring elevated leptin for normal energy homeostasis (187, 189). Prolonged exposure to a 
HFD can also result in permanent damage to or loss of POMC neurons thereby further 
potentiating weight gain and food intake (180, 185). Thus, inhibiting hypothalamic 
inflammation can reduce food intake and body weight and increase hypothalamic insulin and 
leptin sensitivity (183, 187, 189).   
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Microglial activation and hypothalamic inflammation appear to be of great importance in the 
perpetuation of weight gain and obesity (180, 187, 189). HFD-induced obesity research has 
provided a large amount of literature on the effects of microglia and neuroinflammation on 
metabolism (180, 187, 189). It is now apparent that microglial cells are fundamental in the 
physiological control of metabolism, however, the mechanisms behind this are not well 
understood. It remains to be elucidated how hypothalamic microglial activation causes 
metabolic dysfunction. Additionally, the interaction between microglia and feeding and 
satiety neurons, such as NPY/AgRP and POMC, under physiological and pathological 
conditions needs to be further investigated. Thus, additional research is necessary to 
investigate unknown microglia-associated functions involving feeding and satiety in healthy 
weight individuals.  
 
The use of pharmacological or genetic manipulation to inhibit or ablate microglia is 
flourishing in mouse models in memory-dependent regions of the brain such as the 
hippocampus and cortex (36, 61, 96, 243, 257). However, there are very few reports 
investigating microglial disruptions in feeding-regulatory regions such as the hypothalamus. 
We now have a novel model to test microglia’s involvement in many aspects of physiology 
including hypothalamic regulation of food intake. Notably, while conducting our initial 
validation and characterization of this model (Chapter 4), we observed that microglial 
ablation led to weight loss in the Cx3cr1-Dtr rats given diphtheria toxin (DT), supporting the 
hypothesis that microglia have a role in weight regulation. We therefore used our conditional 
microglial knockout rats to ablate microglia and tested the rats’ cytokine profiles, energy 
expenditure, responses to satiety signalling and hypothalamic circuitry. Here, we report that 
despite enhanced orexigenic signalling after elimination of microglia, these Cx3cr1-Dtr rats 
show acute and reversible anorexia and weight loss.  
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6.2. Materials and Methods 
6.2.1. Animals 
All experiments were conducted in accordance with the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes, with approval from the RMIT University 
Animal Ethics Committee.  
 
In these experiments, we used 125 male rats aged between 9 and 12 weeks. Specific n are 
indicated in the figure legends. The rats were kept under standard laboratory housing 
conditions, with a 12 hr light cycle (0700 – 1900 hr), an ambient temperature of 22 °C and 
free access to water and standard rat chow except where stated below. DT was administered 
as two separate injections, 8 hr apart, of 25 ng / g DT in sterile saline, subcutaneous (s.c.), 
according to the protocol of Uneo and colleagues (67). Post-DT tissue collection was 
performed after the rats were deeply anaesthetized with 150 mg/kg sodium pentobarbital i.p. 
Additional specific experiments are described below. Microglial and monocyte 
characterization at the various time points after DT have been described in Chapter 4.  
 
6.2.2. Body Weight, Food and Water Intake 
To examine whether microglial depletion altered weight gain, we weighed both wildtype 
(Wt) and Cx3cr1-Dtr rats daily. We also measured the consumption of ad libitum chow and 
water in both Wt and Cx3cr1-Dtr rats at various time points.  
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6.2.3. Pair Feeding  
To examine if the weight loss after microglial depletion is due to a reduction in food intake 
independent of energy expenditure, we pair-fed Wt rats with an amount of food that matched 
the mean consumption of the Cx3cr1-Dtr ad libitum fed rats. From this point onwards, all 
experiments were conducted when hypothalamic ablation was maximal, i.e. at 48 hrs post-
DT. 
 
6.2.4. Indirect calorimetry  
To assess if depletion of microglia affected metabolic functioning, age-matched rats were 
housed individually in an indirect calorimetry system (comprehensive laboratory animal 
monitoring system; CLAMS, Columbus Instruments, OH, USA) immediately following the 
second injection of DT. After a 24 hr acclimatization, data collection began and continued for 
a further 24 hrs. The system monitors home cage physical activity, heat production, oxygen 
consumption and carbon dioxide production. From these measurements, we are able to derive 
indications of metabolic performance such as total energy expenditure and substrate 
utilization where respiratory exchange ratios of 1.0 represent 100% carbohydrate oxidation 
and 0.7 represent 100% fat oxidation. Physical activity was determined by measuring total 
activity and ambulatory activity. Ambulatory activity was determined by measuring 
interruptions in the infrared beams (breaks X-beam total and breaks Y-beam total).  
 
6.2.5. Behaviour  
6.2.5.1. Open field 
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To test general locomotor activity levels and anxiety-like behaviour, we assessed the rats in a 
mini open field paradigm as described previously in Chapter 4 under section 2.6.1. Open 
Field.  
 
6.2.5.2. Elevated Plus Maze 
To test anxiety-like behavior in a novel environment, we assessed the rats in an elevated plus 
maze as described previously in Chapter 4 under section 2.6.2. Elevated Plus Maze.  
 
6.2.5.3. Light and Dark Box 
To test anxiety-like behaviour in a novel environment, we assessed the rats in a light and dark 
box. Briefly, rats were tested in locomotor boxes (44.5 cm x 44.5 cm x 30.5 cm; Med 
Associates, USA) with a black plastic insert (22 cm x 22 cm x 30.5 cm) that occupied half of 
the locomotor box. The two compartments were connected by a small opening. An 
incandescent lamp was placed near the box so that the light side of the box was brighter than 
the normal brightness of the animal facility. Rats were placed in the dark half of the box and 
behaviour recorded for 8 min. The following behavioural measures were recorded: latency to 
emerge into the light compartment, number of visits into the light compartment, number of 
nose pokes, and total rearing whilst in the light compartment.  
 
6.2.6. Peripheral cytokines  
To assess peripheral markers of inflammation, we examined concentrations of a number of 
pro- and anti-inflammatory cytokines in the plasma using a Bio-Plex assay allowing multiple 
analytes to be assessed in one sample. We collected the blood samples on EDTA over ice and 
subsequently centrifuged and stored the plasma supernatant at -20 °C until analysed. Samples 
were then diluted in Bio-Plex Sample Diluent and assayed using a magnetic beads-based Bio-
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Plex Pro rat TH1/TH2 12-Plex MAGPIXTM instrument and the data were analysed using Bio-
Plex Manager Software 6.1 (Bio-Rad). 
 
6.2.7. Hypothalamic cytokines 
To determine if microglial depletion affected hypothalamic cytokines, Wt and Cx3cr1-Dtr rat 
hypothalami were isolated and frozen immediately in liquid nitrogen and subsequently stored 
at -80°C. The tissue was homogenized in RIPA buffer (150 mM NaCl, 0.5% C24H39NaO4, 
0.1% SDS, 50 mM Tris-HCl, pH 8, 1% Igepal CA-630 (NP-40), supplemented with 
phosphatase and protease inhibitor cocktails (Sigma-Aldrich), 5% 200 mM sodium fluoride 
(Sigma-Aldrich), and 1% 1 mM phenylmethanesulphonyl fluoride (Sigma-Aldrich). We then 
determined protein concentrations using Pierce BCA Protein Assay kit, according to the 
manufacturer's instructions.  Samples were assayed in duplicate and assayed samples in a 
final concentration of 1.5 mg / mL, following the manufacture’s instruction (Millipilex Rat 
Cytokine/Chemokine Magnetic Bead Panel, Millipore, Billerica, MA, USA). Intra-assay 
variability was <10% CV, inter-assay variability <25% CV. This assay was performed by Dr 
Luba Sominsky.  
 
6.2.8. Gene expression 
To assess changes in gene expression, we dissected the hypothalamus from Wt and Cx3cr1-
Dtr rats and conducted quantitative real-time PCR (qRT-PCR) as described in Chapter 4 
under the section 2.5. Gene expression. qRT-PCR primers are summarized in Table 6.1. 
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Table 6.1. TaqMan probe details (Life Technologies) used for qRT-PCR 
Target gene NCBI reference sequence TaqMan assay ID Product size 
Il-6 NM_012589.2 Rn01410330_m1 121 
Il-1b NM_031512.2 Rn00580432_m1 74 
Il1rn (Il1ra) NM_022194.2 Rn02586400_m1 77 
Ghsr NM_032075.3 Rn00821417_m1 61 
Lepr NM_012596.1 Rn01433205_m1 94 
Npy NM_012614.2 Rn00561681_m1 63 
Agrp NM_033650.1 Rn01431703_g1 67 
Pomc NM_139326.2 Rn00595020_m1 92 
B2m NM_012512.2 Rn00560865_m1 58 
 
6.2.9. Circulating ghrelin 
To assess if depletion of microglia affected circulating ghrelin to signal feeding, we assessed 
acyl and des-acyl ghrelin levels 48 hrs after microglial ablation with DT. We collected 
cardiac blood for assessment of serum ghrelin. Blood was treated with Pefabloc (1 mg / mL 
final concentration) in a tube that contained no anticoagulant. Blood was left to clot at room 
temperature for 30 min then centrifuged at 2500 centrifugal force g (g) for 15 min at 4 ± 2 
°C. Serum (top layer) was transferred into a fresh tube then 0.5 M HCl (final concentration 
0.05 M HCl) was added. The samples were mixed, aliquoted and stores at -20 °C, avoiding 
freeze-thaw cycles.  
 
To determine serum acyl and des-acyl ghrelin concentrations, we performed standard ghrelin 
ELISAs for total and acyl ghrelin (Millipore, Billerica, MA, USA) following the 
manufacturer's instructions. Intra-assay variability was 0.3-7% and 0.7-1.3% CV, inter-assay 
variability 1-10% and 1.8-4.5% CV, and lower limit of detection 0.8 pg / mL and 0.04 ng / 
mL for acyl and total ghrelin respectively. Acyl ghrelin concentrations were subtracted from 
total ghrelin concentrations to derive a value for serum des-acyl ghrelin (444). 
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6.2.10. Responses to exogenous ghrelin 
To assess if microglial depletion was likely to influence the rats’ ability to respond to 
circulating feeding signals, we assessed weight changes and food intake in response to 1 mg / 
kg s.c. acyl ghrelin (or equivalent volume of saline) on day 2 after microglial ablation with 
DT, the peak of the reduction in food intake. Rats were fasted for 2.5 hrs prior to the ghrelin 
injection in an effort to standardise the feeding background between the groups. Rats and 
their food were weighed immediately before and 2 h after injection and food intake assessed 
as the amount remaining minus the amount present at the start of the experiment. This 
experiment was thus completed between 0900 and 1300 hr to limit potential effects of 
circadian rhythms on any parameters measured. 
 
6.2.11. Circulating leptin 
To assess if depletion of microglia affected circulating leptin to signal feeding, we assessed 
leptin levels after microglial ablation. We collected the cardiac blood in EDTA-coated tubes 
over ice and subsequently centrifuged and stored the plasma supernatant at -20 °C until 
analysed. We performed standard leptin ELISA (Millipore, Billerica, MA, USA) following 
the manufacturer's instructions. Intra-assay variability was 1.9-2.5% CV, inter-assay 
variability 3.0-3.9% CV, and lower limit of detection was 0.04 ng / mL.  
 
6.2.12. Circulating triglycerides 
To determine whether circulating triglycerides were affected after microglial ablation, we 
assessed triglyceride levels after microglial depletion. We collected the cardiac blood in 
EDTA-coated tubes over ice and subsequently centrifuged and stored the plasma supernatant 
at -20 °C until analysed. We performed a standard triglyceride colorimetric assay (Cayman 
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Chemical, Ann Arbour, MI, USA) following the manufacturer's instructions. Intra-assay 
variability was 1.34% CV, inter-assay variability 3.17% CV, and lower limit of detection was 
0.5 mg / dL. Samples were assayed in duplicate and all samples were processed in the same 
assay.  
 
6.2.13. Hypothalamic leptin protein 
To determine if microglial depletion affected hypothalamic leptin, Wt and Cx3cr1-Dtr rat 
hypothalami were isolated and frozen immediately in liquid nitrogen and subsequently stored 
at -80°C. The tissue preparation and assay were performed according to section 6.2.7. 
Hypothalamic cytokines. Dr. Luba Sominsky ran and analysed the data.  
 
6.2.14. Immunofluorescence 
Hypothalamic sections were immunolabelled with fluorescent markers as summarised in 
Table 6.2. One 1 in 5 series of 30 µm sections (120 µm apart) from each animal was used for 
each marker. Sections from each treatment group were randomly selected and processed at 
the same time in batches. Sections were washed with 0.01M PBS and blocked for 30 min 
with 3% BSA, 0.3% Triton X-100 in 0.01M PBS. The sections were incubated in the primary 
antibody as described in Table 6.2. Sections were washed with 0.01M PBS and incubated in 
the secondary antibody as described in Table 6.2. We mounted the sections on super frost 
slides and coverslipped with Fluoroshield with DAPI mounting medium (Sigma-Aldrich, ST 
Louis, MO, USA).  
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Table 6.2. Primary and secondary antibodies used in immunohistochemistry 
Antigen Primary Antibody Secondary Antibody 
Neuropeptide Y (NPY) Rabbit-anti NPY (Sigma-
Aldrich, ST Louis, MO, USA) 
(1:1000, 4°C, overnight) 
Alexa Fluoro 488 anti-rabbit, 
(Life Technologies, 
Burlingame, CA, USA)  
(1:500, RT, 2 hrs) 
Proopiomelanocortin 
(POMC) 
Rabbit-anti POMC (Santa Cruz 
Biotechnology Inc., Dallas, TA, 
USA) 
(1:5000, 4°C, overnight) 
Alexa Fluoro 488 anti-rabbit, 
(Life Technologies)  
 
(1:200, RT, 1 hr) 
Agouti-related peptide 
(AgRP) 
Goat-anti AgRP (Neuromics, 
Edina, MN, USA) 
(1:500, RT, 42 hrs)  
Alexa Fluoro 594 anti-goat, 
(Life Technologies)  
(1:500, RT, 2 hr) 
 
ARC and paraventricular nucleus of the hypothalamus (PVN) images were viewed under the 
20× objective lens using laser-scanning microscope (Nikon Eclipse 90i, Tokyo, Japan) and 
photomicrograph images were taken using 488 nm or 594 nm lasers, with DAPI being 
detected under the 408 nm laser. NIS Elements Advanced Research Software (Nikon) was 
used to estimate fluorescence signal intensity within the ARC and PVN separately. Laser and 
detector levels were optimised on sections not included in the analysis and kept constant 
throughout the imaging. All slides were blinded from the experimenter. NPY and AgRP cell 
fibres were detected by the thresholding method. Briefly, background was subtracted, and 
mean threshold lower and upper limits were determined based on brain sections from the 
control group of animals. These settings were then applied to all sections, including controls 
and kept constant throughout the analysis. POMC-positive cells in the ARC were manually 
counted using ImageJ (National Institutes of Health) in four brain sections between 2.76 and 
3.48 mm caudal to bregma per animal. Summed counts of the four sections were taken as our 
sampled result.  
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6.2.15. Data analysis 
We analysed the data using Student’s unpaired t-tests or two-way analyses of variance 
(ANOVA)s with genotype and day, light phase and ghrelin treatment as between factors 
where appropriate. Where significant interactions were found, we then performed Tukey 
post-hoc tests. Weight, food and water intake were analysed as mixed-design ANOVAs with 
genotype as the between factor and day as the within factor. Data are presented as the mean ± 
SEM. Statistical significance was assumed when p ≤ 0.05.  
 
6.3. Results 
6.3.1. Acute microglial depletion causes pronounced reversible anorexia and weight loss  
Acute microglial ablation led to a dramatic and reversible weight loss over the first two to 
five days. By seven days, a time at which we also see microglial restoration, weights in the 
Cx3cr1-Dtr rats given DT had caught up to those of Wt controls (F(5,205) = 6.83; p < 0.001; n 
= 10-22; Figure 6.1.A). In accordance with the weight loss, microglial ablation dramatically 
suppressed feeding compared with controls, with the Cx3cr1-Dtr rats eating less than the Wt 
controls for at least six days after the DT, with particularly large effects on food intake in the 
first three days (F(5,70) = 15.85, p < 0.001; n = 7-8; Figure 6.1. B). Water intake was 
suppressed in the first two days (F(6,132) = 14.195, p < 0.001; n = 8-12; Figure 6.1. C).  
 
 
 
	 	
166	
	 	
 
Figure 6.1. Acute microglial ablation led to a dramatic and reversible reduction in weight and food intake 
over the first two to five days. A) weights. B) food intake. C) water intake. Data are mean ± SEM. N= 8-12 
per group. * significantly different from wild-type. p < 0.05.  
 
6.3.2. Weight loss in Wt pair-fed controls is nearly identical to microglial depleted rats 
To determine whether this suppression of weight and food intake was solely due to microglia 
ablation, we pair-fed Wt rats to the food intake of Cx3cr1-Dtr rats. We see that the weight 
loss caused by microglial ablation was predominantly accounted for by the reduced food 
intake (F(12,126) = 27.87, p < 0.001; n = 8-12; Figure 6.2. A), since Wt rats pair-fed to the level 
of Cx3cr1-Dtr’s consumption had nearly identical weight loss from three days onwards 
(F(12,126) = 8.35, p < 0.001; n = 8 per group; Figure 6.2. B). We found no difference in the 
water intake in pair-fed rats (F(12,126) = 4.142, p < 0.001; Figure 6.2. C).  
 
 
Figure 6.2. Pair-feeding wild-type controls to that of acute microglial depleted rats led to a dramatic and 
reversible reduction in weight and food intake from the first three days onwards. A) food intake in pair-fed 
rats. B) weight loss with pair-feeding. C) water intake in pair-fed rats. Data are mean ± SEM. N= 8-12 per 
group. * significantly different from wild-type; # significantly different from pair-fed. p < 0.05. 
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6.3.3. Cx3cr1-Dtr rats reduced both their active period activity levels 
We investigated whether the reduced food intake in our microglial depleted rats would have 
altered activity levels to compensate the reduced energy intake. Physical activity was 
determined whilst the animals were in an indirect calorimetry system. We found that our 
Cx3cr1-Dtr rats had a reduction in total and ambulatory activity levels during the night-time 
(dark phase) which is when animals are most active (total activity: genotype by light period 
interaction: F(1,26) = 96.91, p < 0.001; n =8; Figure 6.3. A, B and ambulatory activity: 
genotype by light period interaction, F(1,26) = 43.70, p < 0.001; Figure 6.3. C, D). 
 
 
Figure 6.3. Cx3cr1-Dtr rats reduced both their active period activity levels. A, B) total activity levels. C, D) 
ambulatory activity levels. n = 8 per group. Data are mean ± SEM. * significantly different from wild-type p < 
0.05. B, D) Activity level heatmaps. Each row of the heatmap represents one animal, and each column 
represents the average activity per hour.  
 
6.3.4. Microglial depleted rats reduce their active period energy expenditure 
To assess if depletion of microglia affected metabolic functioning, we tested the rats’ energy 
expenditure and respiratory exchange ratio in an indirect calorimetry system. In 
compensatory fashion to their reduced energy intake, Cx3cr1-Dtr rats reduced energy 
expenditure (genotype by light period interaction: F(1,28) = 25.73, p < 0.001; Figure 6.4. A, B). 
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In both phases, energy expenditure was increased as body weight increased in the wild-type 
rats (the linear regression lines of best fit slopes were significantly different from zero; dark 
phase: p = 0.029; light phase: p = 0.004) but not in the Cx3cr1-Dtr rats. Figure 6.4. C, D). 
Their respiratory exchange ratio (RER) shifted towards a more fat-consumptive ratio 
(significant genotype effect: F(1,28) = 30.85, p < 0.001; Figure 6.4. E).  
 
 
Figure 6.4. Cx3cr1-Dtr rats reduced their active period energy expenditure. A, B) energy expenditure. C, D) 
correlation between energy expenditure and weight. In both phases, energy expenditure was increased as body 
weight increased in the wild-type rats but not in the Cx3cr1-Dtr rats. E) RER. n = 8 per group. Data are mean ± 
SEM. * significantly different from wild-type. # main effect of genotype. B) Energy expenditure heatmap. Each 
row of the heatmap represents one animal, and each column represents the average energy expenditure per hour. 
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tests of activity and anxiety in an open field task at 48 hrs after microglial depletion (Figure 
6.3. A-E). The Cx3cr1-Dtr rats showed no significant differences in either exploratory or 
anxious behaviours after microglial ablation. There were also no differences between the 
groups on day two in EPM (Figure 6.3. F-H) or light / dark box performance (Figure 6.3. I-
L). 
 
 
 
Fig 6.5. Microglial ablation did not disrupt open field, EPM or light / dark box exploration. A) open field 
distance moved on edge. B) open field latency to enter centre. C) open field frequency of centre entries. D) open 
field time spent in the centre. E) open field distance moved in centre; n = 6. F-H) EPM; n = 8 per group. I-L) 
light / dark box; n = 7-8. Data are mean ± SEM. 
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6.3.6. Microglial depletion-induced anorexia and weight loss does not disrupt circulation 
cytokines 
To assess if the anorexia and weight loss associated with microglial ablation was likely to be 
due to an inflammation-induced sickness response, we examined circulating cytokines at 48 
hrs after microglial depletion. We found that circulating cytokines were not affected by 
microglial ablation, indicating that our Cx3cr1-Dtr rats have a normal peripheral 
inflammatory response and are not sick (Figure 6.6. A-L).   
 
 
Fig 6.6. Microglial ablation did not disrupt circulating cytokines. n = 6 per group. Data are mean ± SEM. 
 
6.3.7. Microglial depletion-induced anorexia and weight loss does not disrupt 
hypothalamic cytokines 
To test if the anorexia and weight loss after microglial depletion was associated with a pro-
inflammatory hypothalamic cytokine profile, we assessed hypothalamic cytokines at 48 hrs 
after microglial depletion. Cytokines in the hypothalamus were, if anything, reduced with 
microglial ablation, with no change in IL-6 and a reduction in IL-1β (T(10) = 3.233, p = 0.009; 
IL
#1
β&
(p
g/
m
L)
IL
#2
&(p
g/
m
L)
IL
#4
&(p
g/
m
L)
IL
#1
⍺(pg/m
L)
IL
#5
&(p
g/
m
L)
IL
#6
&(p
g/
m
L)
BA C
E
D
F
IL
#1
0&
(p
g/
m
L)
IL
#1
2&
(p
g/
m
L)
IL
#1
3&
(p
g/
m
L)
HG
I
GM
#C
SF
&(p
g/
m
L)
IF
N#
!(pg/m
L)
TN
F#
⍺(pg/m
L)
KJ L
WT
Cx3cr1'Dtr
0
4
8
12
0
5
10
15
20
25
0
5
10
15
20
0
4
8
12
0
5
10
15
0
5
10
15
20
25
0
4
8
12
16
0
5
10
15
20
0
5
10
15
0
4
8
12
16
0
10
20
30
0
5
10
15
20
25
WT
Cx3cr1'Dtr
	 	
171	
	 	
n =6; Figure 6.7. B) and IL-10 (T(10) = 3.61, p = 0.004; Figure 6.7. C). There was a 
significant increase in hypothalamic gene expression of Il-1β (T(13) = 34.07, p < 0.001; n =6; 
Figure 6.7. E) and a decrease in IL-1 receptor antagonist (Il-1rn; T(9) = 2.45, p = 0.036; 
Figure 6.7. F), with no change in IL-6. Thus, the reduced food intake and weight gain 
associated with microglial ablation is not due to an overt sickness response.  
 
 
Fig 6.7. Hypothalamic cytokines and cytokine gene expression were not affected by microglial ablation. 
A) IL-6. B) IL-1β. C) IL-10. D) IL-6. E) IL-1β. F) Il-1rn. Data are mean ± SEM. N = 6-8 per group. * 
significantly different from wild-type p < 0.05. 
 
6.3.8. Microglial depletion-induced anorexia and weight loss are independent of 
perturbations in responses to circulating ghrelin signals 
To assess if the anorexia and weight loss associated with microglial depletion were due to 
changes in circulating feeding signals or to an inability to respond to these, we assessed 
endogenous circulating levels of a hormonal signal of negative energy balance, ghrelin. We 
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circulating total ghrelin compared to Wt rats (t(16) = 2.65, p = 0.017; n = 8-10; Figure 6.8. A). 
However, there were no differences between acyl ghrelin (Figure 6.8. B) or des-acyl ghrelin 
(Figure 6.8. C). There was also no difference in expression of growth hormone secretagogue 
receptor (Ghsr) in the hypothalamus (Figure 6.8. D). Exogenous ghrelin stimulated 
significant weight gain (significant genotype effect: F(1,29) = 10.72, p = 0.003, and ghrelin 
treatment effect: F(1,29) = 22.05, p < 0.001; n = 7-10; Figure 6.8. E), and food intake 
(significant ghrelin treatment effect: F(1,30) = 19.70, p < 0.001; Figure 6.8. F) over 2 hrs in the 
Cx3cr1-Dtr rats, indicative that responses to ghrelin are intact after microglial inactivation.  
 
 
Fig 6.8. Responses to ghrelin are intact after microglial inactivation. A) total circulating ghrelin. B) acyl 
ghrelin. C) des-acyl ghrelin. D) hypothalamic Ghsr. E) weight gain in response to exogenous ghrelin. F) food 
intake in response to exogenous ghrelin. Data are mean ± SEM. * significantly different from wild-type, p < 
0.05. # significantly different from saline. 
 
6.3.9. Perturbations in responses to circulating leptin signals are independent of short-term 
anorexia and weight loss 
To assess if the anorexia and weight loss associated with microglial depletion were due to 
changes in circulating leptin signals, we assessed endogenous circulating leptin levels. 
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receptor (Lepr) expression (t(9) = 2.33, p = 0.044; n = 6; Figure 6.9. B) were both reduced 
after microglial ablation, suggesting that rather than driving the suppression of food intake, 
changes to leptin signalling are compensatory to restore feeding. Circulating triglycerides 
were suppressed, commensurate with the reduced food intake which would suggest increased 
leptin transport across the blood-brain barrier (triglycerides: t(15) = 3.137, p = 0.006; n = 8-9; 
Figure 6.9. C.). However, we also saw a reduction in hypothalamic leptin protein levels (t(10) 
= 2.667, p = 0.023; n = 6; Figure 6.9. D.).  
 
 
Fig 6.9. Microglial ablation disrupts leptin and triglyceride signalling. A) circulating leptin. B) 
hypothalamic lepr. C) circulating triglycerides. D) hypothalamic leptin protein. Data are mean ± SEM. N= 6-9 
per group. * significantly different from wild-type. 
 
6.3.10. Hypothalamic neuroanatomy is altered after microglial ablation 
To assess whether these findings that satiety signalling is intact and compensating for the 
drive to suppress feeding, we tested whether the reduced food intake is due to neuronal 
changes in the hypothalamic circuitry itself. The expression of hypothalamic Npy, Agrp, and 
Pomc mRNA was normal after microglial ablation (Figure 6.10. A-C). However, we found 
that the density of NPY neuronal fibres is increased in the ARC and PVN (ARC: t(9) = 2.49, p 
= 0.034; n = 5-6, PVN: t(9) = 2.88, p = 0.018; n = 6; Figure 6.10. D-G). The density of AgRP 
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neuronal fibres is not increased in the ARC (Figure 6.10. H, I), but is increased in the PVN 
(t(12) = 2.24, p = 0.044; n = 7-8; Figure 6.10. J, K). We also found that the number of POMC 
cells in ARC is decreased by microglial ablation (t(9) = 2.41, p = 0.039; n = 5-6; Figure 6.10. 
L, M). This all suggests that neuronal remodelling, if anything, should drive increased food 
intake in our Cx3cr1-Dtr rats. 
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Fig 6.10. Hypothalamic neuroanatomy remains intact after microglial ablation. A-C) Expression of Npy, 
Agrp, Pomc in the hypothalamus (n = 6). D, E) NPY immunolabelling in the ARC. F, G) NPY immunolabelling 
in the PVN. H, I) AGRP immunolabelling in the ARC. J, K) AGRP immunolabelling in the PVN. L, M) POMC 
immunolabelling in the ARC. Data are mean ± SEM. * significantly different from wild-type, p < 0.05. 
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6.4. Discussion 
To our knowledge, this is the first study to show that acute conditional specific ablation of 
microglia induces pronounced anorexia and short-term weight loss that is reversed upon 
microglial repopulation. This acute anorexia and weight loss (A) is not due to an overt 
sickness response (B) is independent of alterations to circulating satiety signals, such as 
ghrelin and leptin and (C) is not likely to be due to hypothalamic AgRP, NPY, and POMC 
circuitry dysfunction.  
 
Metabolism and energy balance regulation in the brain is governed by circulating hormones, 
ghrelin and leptin, which either initiate or inhibit food intake (445, 446). The ghrelin receptor 
in the brain is predominantly expressed in NPY/AgRP neurons (447) and deletion of NPY 
and AgRP blunts ghrelin-induced feeding (430-434). Moreover, the stimulatory effects on 
NPY/AgRP neurons are accompanied by increasing inhibitory GABAergic inputs onto 
POMC cells enabling an even greater orexigenic effect on food intake (433, 448, 449). 
Ghrelin administration has been shown to be neuroprotective via inhibition of microglial 
activation (450-452). The mechanism underlying the inhibitory actions is unknown, however, 
it is suggested that it may be indirect or through a growth hormone secretagogue receptor 1a 
(GHSR1a) independent pathway (453, 454). As we see a suppression of food intake in our 
Cx3cr1-Dtr rats after microglial depletion, we hypothesised that ablation of microglia caused 
a suppression of ghrelin, thus suppressing the drive to eat. However, we found that upon 
microglial elimination, our Cx3cr1-Dtr rats undergo dramatic and reversible weight loss and 
suppression of food intake that is accompanied by elevations in total circulating ghrelin. This 
finding is supported by a large body of literature reporting alterations in ghrelin signalling as 
well as other central and peripheral modulators of appetite in patients with AN (455, 456). 
AN is an eating disorder characterized by extreme restricted eating resulting in severe weight 
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loss, a distorted body image and a pathological fear of becoming fat (455, 456). Similar to 
our microglial depleted rats, AN patients have increased plasma levels of total ghrelin as well 
as elevated acyl- and desacyl- ghrelin isoforms, which is not seen in our study (457-459). 
Altered plasma ghrelin has also been reported in rodent AN models. In rodents, the activity 
based anorexia (ABA) model is commonly used to study AN as rodents undergo increased 
physical activity and metabolic changes that resemble AN symptoms (455, 460-462). This 
model of ABA resembles that of AN patients with elevated plasma ghrelin levels (461, 462). 
Although we see an overall increase in total ghrelin in our microglial depleted rats, there is no 
ghrelin-mediated drive to eat, thus may be a typical response to the weight loss and reduction 
of food intake that ensues.  
 
This acute and reversible anorexia seen in our Cx3cr1-Dtr rats is also accompanied by an 
attenuation in both circulating and central leptin. Leptin is an anorexigenic hormone that 
suppresses food intake and induces weight loss (463), therefore, a reduction in leptin levels in 
our rats should stimulate food intake and weight gain. These findings suggest that the 
reduction in leptin signalling in our microglial depleted rats may be a normal response to this 
anorexic environment. In addition to changes in leptin and ghrelin, that should act to drive 
food intake, we have shown that our microglial depleted rats have changes to their 
hypothalamic circuitry that should also contribute to this drive. After microglial ablation, the 
rats have increased orexigenic NPY and suppressed anorexigenic POMC immunolabelling. 
Thus, elevated orexigenic and reduced anorexigenic signalling seen in our Cx3cr1-Dtr rats is 
a typical hypothalamic response to a negative energy balance in an attempt to promote 
feeding and weight gain.  
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We have shown that the anorexia induced by microglial ablation in our Cx3cr1-Dtr rats is 
occurring despite alterations in circulating satiety signals, at least ghrelin and leptin, or 
alterations to hypothalamic AgRP, NPY, and POMC circuitry. Therefore, it is possible that 
this short-term anorexia is due to alterations in other pathways involved in energy 
metabolism and feeding. For example, corticotrophin releasing hormone (CRH) and CRH 
related peptides; urocortins, have known inhibitory effects on food intake (464, 465). Thus, 
this acute anorexia after microglial depletion in our Cx3cr1-Dtr rats, could be due to elevated 
CRH or urocortins in the hypothalamus, thus, suppressing food intake. CRH is widely 
distributed throughout the rodent brain with particularly robust expression in the PVN (465). 
There are two CRH receptors, corticotrophin releasing factor (CRH)1 and CRH2. CRH1 has a 
wide distribution throughout the brain with low expression in the hypothalamus (466, 467). 
In contrast, CRH2 distribution is mainly found in the amygdala, hypothalamus and nucleus of 
the solitary tract (NTS) (468). Reports have demonstrated the physiological relevance of 
CRH2 signalling in the regulation of food intake. CRH2 knockout mice show increased dark-
phase food intake in normal chow and high fat foods in comparison to controls (469, 470). 
Moreover, urocortin i.c.v. injections decrease food intake and increase satiation (471). 
Additional to CRH and urocortin’s inhibitory effects on food intake, reports have indicated 
that activation of these neuropeptide signals increases energy expenditure via elevations in 
oxygen consumption and body temperature (472-474). Our Cx3cr1-Dtr rats have a 
suppression of energy expenditure during this short-term anorexia, therefore, elevations in 
CRH or urocortin may not be driving the suppression of food intake and body weight, 
however, further investigation is required. 
 
Additional neuropeptides have also been demonstrated to alter feeding and satiety in humans 
and rodents. Nesfatin-1 (often referred to as NUCB2 in mature cells) is a neuropeptide, 
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known to have anorexigenic effects, primarily expressed in the PVN, but is also found in 
other hypothalamic nuclei such as the ARC, as well as in the supraoptic nucleus and the NTS 
(475-478). Nesfatin-1 cells co-localize with other neuropeptides and neurotransmitters known 
to be involved in food intake regulation, such as POMC and cocaine-amphetamine regulated 
transcript (CART) (between 60 – 80% affinity) and NPY (~40% affinity), further supporting 
nesfatin-1’s role in satiety signalling (478-480). Central or peripheral administration of this 
neuropeptide specifically reduces the dark-phase food intake and overall body weight in 
freely fed rats and mice (475, 481-483). Moreover, PVN-specific NUCB2 knockdown mice 
have increased food intake and weight gain compared to controls, further supporting the idea 
that nesfatin-1 is an important neuropeptide involved in energy metabolism (484). Therefore, 
it is possible that nesfatin-1 is elevated in the PVN of our microglial depleted rats, thus, 
overriding the normal circulating satiety signals, and hypothalamic AgRP, NPY, and POMC 
circuitry causing the significant reduction in food intake and body weight. Interestingly, Oh 
and colleagues found that the satiety induced by nesfatin-1 was independent of leptin (475), 
further supporting the idea that an elevation of nesfatin-1 in the hypothalamus may be 
producing the acute anorexia in our Cx3cr1-Dtr rats, but this idea remains to be tested.  
 
We have illustrated that the anorexia induced by microglial depletion in our Cx3cr1-Dtr rats 
is not due to altered circulating satiety signalling or changed hypothalamic circuitry 
responses reducing food consumption. Therefore, it is also possible that this short-term 
anorexia is due to alterations in the dopaminergic reward system that would over-ride all 
compensatory drives towards food consumption. Dopamine is involved in the mesolimbic 
reward system, projecting from the ventral tegmental area (VTA) to the nucleus accumbens 
(NAc) to promote reward-seeking behaviour (485). Aberman and Salamone identified that 
rats are unwilling to exert effort to obtain food despite being physically capable of eating if 
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dopamine fibres innervating the NAc are destroyed (486). Thus, suggesting that NAc 
dopamine stimulates and motivates feeding behaviour independently of appetitive effects 
(487). Specifically, du Hoffmann and Nicola have shown that dopamine invigorates food 
reward seeking behaviour through selective excitation and not inhibition in the NAc during a 
discriminative stimulus task for sucrose reward in rats (488). Intriguingly, while NAc 
dopamine has been shown to be involved in the motivation to feed, the dorsal medial 
prefrontal cortex (mPFC) has been elucidated to be involved in the ability to feed, although 
its role needs to be investigated further. During fasting, a subset of mPFC neurons expressing 
dopamine D1 receptors become activated and drive food intake, potentially via a direct 
downstream target of VTA dopamine axons (489). There are numerous studies investigating 
the effects of microglia on the dopaminergic system in Parkinson’s Disease (PD), however, 
majority have focused on the nigrostriatal region and do not investigate feeding behaviour 
motivation despite PD patients having disordered eating. For example, rodent models of PD 
have illustrated that microglial activation induces degeneration of dopamine neurons (490-
492). However, it is possible that the dopamine activity is reduced in the NAc and/or the 
mPFC in our Cx3cr1-Dtr rats after microglial elimination, altering feeding behaviour 
motivation thus overriding all compensatory drives towards food consumption. 
 
Previous literature using either genetic or pharmacological approaches to inhibit or ablate 
microglia have focused on memory-dependent regions of the brain including the 
hippocampus and cortex, with very limited reports in feeding-regulatory regions such as the 
hypothalamus and the effects on feeding and satiety (36, 61, 96, 243, 257). Valdearcos and 
colleagues are the only group that have shown hypothalamic differences after either 
microglial inhibition (NFkB deficiency) or ablation (PLX5622) (190, 244). However, the 
reduced weight gain and body fat they reported was only seen in mice fed a HFD for 4 
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weeks, when there is initial neuroinflammation, and does not impact daily food intake in 
mice fed a standard low-fat chow diet (190, 244). However, another study has shown that 
microglial inhibition with minocycline for 5 days leads to an increased standard low-fat chow 
food intake (493). There are two possible reasons for this lack of information regarding 
microglial inhibition / ablation literature and satiety: either feeding and satiety were not 
reported despite differences as the finding was not pertient to the study, or no such 
differences were examined or found. In the latter case, differences between rats and mice 
may be responsible for different microglial roles in feeding and satiety. Thus, our study 
illustrating this acute and reversible anorexia in rats fed a standard chow diet is very novel 
and warrants further investigation.  
 
In summary, we have shown that elimination of microglia in our Cx3cr1-Dtr rats induces a 
drastic and reversible weight loss and a reduction in food intake that is associated with a 
suppression of activity and energy expenditure during the dark-phase. This acute anorexia is 
not due to alterations in circulating satiety signals, such as ghrelin and leptin, or alterations to 
hypothalamic AgRP, NPY, and POMC circuitry and further research is needed to determine 
the drivers behind this anorexia and weight loss.  
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CHAPTER 7 
General Discussion 
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7.1. Novel roles for microglia 
The main finding from this collective work is that microglia have roles outside of their 
historically-described responses to immune challenge and injury that include acute and long-
term responses to overfeeding, and acute regulation of satiety signalling and cognition. In 
Chapter 2 (and (342)), we first describe microglia’s important role in cognition, showing that 
the normal response of the brain to a learning task is to reduce microglial sensitivity in the 
hippocampus and retrosplenial cortex. This is in accordance with work from Elmore et al. 
who show that microglial ablation, using a CSF1R antagonist (PLX3397 for 2 months), can 
significantly improve spatial memory performance on the Barnes maze (36). Conversely, 
however, other reports have shown that short-term microglial depletion impairs motor 
learning in a rotarod task as well as reduces working memory, as assessed by a novel object 
recognition (NOR) task (61). Impairments have also been found in social behaviour after 
microglial depletion, using a Crawley’s sociability task (96). Still others have reported no 
behavioural differences upon microglial ablation (245, 289). In our work, we have shown, in 
Chapter 5, that ablating microglia does not alter working memory in the NOR or novel place 
recognition (NPR), but that memory is improved when the microglia repopulate.  
 
In addition to microglia’s role in cognition, we have described microglia’s role in response to 
an immune challenge in neonatally overfed rats, showing that these rats have a hyper-
responsive microglial profile in the hippocampus compared to control-fed rats (Chapter 3 and 
(382)). This is in accordance with work from Bilbo and Tsang who show that maternal HFD 
increases microglial activation in the hippocampus of adult mice (202). We also reveal 
important effects of a repeated injection protocol, regardless of the treatment, during the 
neonatal period that must be taken into consideration. We are the first to demonstrate that a 
neonatal injection protocol, irrespective of whether minocycline or saline, strongly 
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suppresses microglial number and density. However, other early-life treatments, such as 
handling, can have similar effects on the microglial profile in adulthood (361, 362).  
 
We have also revealed an entirely novel role for microglia in acutely regulating feeding and 
metabolism, in Chapter 6, showing that microglial ablation induces acute anorexia and 
weight loss. This weight loss and reduction in food intake is independent of perturbations in 
circulating and hypothalamic orexigenic (ghrelin) and anorexigenic (leptin) signals. Evidence 
in the literature to suggest a role of microglia in acutely regulating feeding and satiety is 
largely absent, with most studies focusing on inflammation in the obese state (427). For 
instance, reports have shown activated microglia as well as a pro-inflammatory cytokine 
profile in the mediobasal hypothalamus within 3 days to 3 weeks after the onset of a high-fat 
diet (HFD) (180, 187, 189), but no such studies of microglia in healthy animals have been 
conducted until now. 
 
7.2. Future Directions 
7.2.1. Impairments associated with neonatal overfeeding could be restored by suppression 
of microglial activity during development.  
Throughout this dissertation, we have illustrated that the early-life period is extremely 
vulnerable to programing effects from the environment and these effects are maintained into 
adulthood. Our laboratory has previously shown that early-life over-nutrition results in short-
term reductions in ghrelin signalling during development, which are partially alleviated in 
adulthood. We have also found that early-life over-nutrition results in long-term elevations in 
leptin. Centrally, the effects of neonatal overfeeding on the hypothalamic appetite circuitry 
are acute, and are not maintained into adulthood, despite the long-term weight gain (168, 
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494). An acute neonatal leptin antagonist treatment reverses some detrimental effects of 
neonatal overfeeding, but it does not alleviate the weight gain in neonatally overfed rats (168, 
494). While the effects of neonatal overfeeding on the central metabolic circuitry are reversed 
by adulthood, their neuroinflammatory profile and neurocognitive deficits are maintained 
long-term. We have shown that adult rats that were overfed during the first three-weeks of 
life have increased numbers of hypothalamic (159, 310) and hippocampal microglia (Chapter 
2), and these microglia are hyper-responsive to an immune challenge with lipopolysaccharide 
(LPS) (Chapter 3 and (382)). We have also seen hippocampal microglial hyper-sensitivity 
associated with a learning task in adult rats that were overfed as neonates (Chapter 2 and 
(342)). We hypothesised that the early-life overfeeding microglial profile could be restored to 
that of control-fed rats through treatment during the weaning period with minocycline, an 
FDA approved second-generation antibiotic that suppresses microglial activity (267, 272-
274, 353). Unfortunately, our attempts to reverse these neonatally overfed microglial effects 
revealed that the neonatal exposure to a protocol of repeated injections, regardless of 
treatment, i.e. either with minocycline or with saline, have a pronounced long-term impact 
(Chapter 3 and (382)). Repeated neonatal injections markedly suppress microglial number 
and density throughout the hippocampus and hypothalamus, abolishing differences between 
non-injected and injected rats in response to an immune challenge, irrespective of litter size. 
An alternative protocol is therefore required to reverse the microglial profile in our neonatally 
overfed rats, to alleviate the development of an obesity-like phenotype and to potentially 
restore both the cognitive impairments and the hyper-responsiveness to an immune challenge 
to that of the control-fed counterparts.  
 
A common alternative form of drug administration to neonatal rats is via oral administration 
in the dams’ drinking water. The presence of minocycline in the dams drinking water has 
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previously been shown to have no adverse effects on water consumption, maternal distress or 
changes in maternal care of pups, or have an impact on the amount of milk consumed by the 
pups (495-498). With this method, minocycline is able to pass from the dam to the offspring 
through the milk (495-497). It, therefore, may not be suitable to use in our early life 
overfeeding model as the neonatally overfed pups consume more milk from the dams thus, 
would unavoidably receive more minocycline than the control-fed counterparts.  
 
To overcome the effects of the neonatal repeated injections protocol, seen in Chapter 3, 
another alternative approach is administering either minocycline (to inhibit microglial 
activation) or diphtheria toxin (DT) in Cx3cr1-Dtr rats (to ablate microglia as seen in Chapter 
4) directly into the brain through a mini-osmotic pump during the first 3 weeks of 
development. This is an ideal system for constant drug delivery that avoids daily injection 
stress in the neonatally overfed and control-fed pups (499-501). Doucette and colleagues 
have validated the effectiveness of mini-osmotic pumps for sustained drug delivery in 
neonatal rats. They have shown that pump implantation and the associated surgical stress 
does not result in any immediate or long-term changes in physical or neurobehavioural 
development (502). However, a limiting factor of this administration method is the minimum 
required weight of the pups prior to implantation (503). The animal must weigh a minimum 
of 10g, therefore inhibition of microglial activity could not begin until approximately P5 
(503). At this time point the neonatally overfed pups are not significantly different in weight 
nor are there any differences in microglial morphology compared to control-fed rats (159, 
342), thus may be an ideal period to begin the treatment. This alternative approach to 
restoring the microglial profile in adult rats that were overfed during development to that of 
control would be an interesting research prospect. Minocycline or DT would be continuously 
administered into the brain via mini-osmotic pumps starting at P5 when the pups weigh 
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approximately 10-12g, until weaning at P21. We would then mimic the cognitive 
experimental protocol from Chapter 2 to examine how microglial suppression during 
development affects memory in the Y-maze, NOR task, and Radial Arm Maze (RAM) in 
adulthood. An additional cohort would be required to examine the effects of microglial 
suppression on microglial responsiveness to a 24hr immune challenge with LPS in adulthood.  
 
It is noteworthy that inhibition of microglial activity may restore the neuroinflammation and 
cognitive impairments in our neonatally overfed rats, however, this may not amend the obese 
phenotype in our adult rats that were overfed during this critical developmental period. The 
Valdearcos group recently demonstrated that in a model of diet induced obesity and 
microglial ablation, metabolic inflammation in peripheral tissues develops independently of 
the central nervous system (CNS) and is thought to result from chronic nutrient overload 
and/or obesity itself (244). We have also shown that our neonatally overfed rats maintain the 
obese phenotype despite reductions in microglia number and density by neonatal exposure to 
a protocol of repeated injections (Chapter 2 and (382)). Therefore, it may be of interest in 
future studies to explore the utility of dietary interventions, such as supplementation of the 
dams’ diet with omega 3 polyunsaturated fatty acids (n-3 PUFAs). Supplementation of high 
fat diet (HFD) with n-3 PUFAs reduces HFD-induced inflammation and is able to reverse 
weight gain (504). While its effects in our model of neonatal overfeeding remain to be 
established, it may be an interesting future direction with a strong potential for clinical 
implications.   
 
7.2.2. Assessing long-term spatial memory after microglial depletion 
We have previously shown that acute or chronic microglial ablation does not affect working 
memory in short-term behavioural tasks such as the NOR and NPR (Chapter 5). The NPR 
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task examines both working and spatial memory as the object is familiar but placed in a novel 
location during the test phase, therefore, combines visual object and spatial information to 
recognise the relationship between the novel and familiar object (505). However, we did not 
specifically examine whether spatial memory was altered. Literature has shown conflicting 
reports on the effect of microglial ablation on spatial memory and this has been related to the 
duration of microglial elimination. During a short period of microglial ablation, with 
PLX3397 for 7 days, Torres and colleagues have shown transient spatial memory 
impairments in the Barnes maze with longer escape latencies during training. However, these 
impairments dissipate with a longer depletion period of 21 days (506), while, a longer 
ablation protocol (2 months of PLX3397) enhances spatial memory in the Barnes maze with 
shorter escape latencies and reductions in the average escape latencies across all training days 
(36). Considerable experimental evidence has demonstrated the role of Cornus Ammonis 
(CA)1 hippocampal long-term potentiation (LTP; increase in synaptic strength) and long-
term depression (LTD; decrease in synaptic strength) in spatial memory (507-509). Inhibition 
of CA1 LTD but not LTP induces impairments in spatial memory (510-513). Specifically, 
LTD inhibition in the consolidation, but not acquisition or retrieval phase of spatial memory, 
affects probe-test performance but not spatial memory (513). Therefore, it could be 
hypothesised that the transient spatial memory impairments seen in the Torres study is due to 
a suppression of LTD, whilst, the enhanced spatial memory that Elmore and colleagues found 
may be due to an increased LTD; however, this remains to be tested.  
 
There are a variety of behavioural tasks which examine spatial learning and memory in 
rodents. We have previously studied spatial learning and memory using the delayed spatial 
win-shift radial arm maze (DSWS-RAM), which investigates the rats’ ability to retain spatial 
information both within the task (working memory) and across a delay (reference memory) 
	 	
189	
	 	
(Chapter 2 and (325, 514)). To successfully learn the task, the experiment utilizes a strong 
deprivation stimulus, restricting food intake to approximately 80-85% of the usual intake, to 
motivate the rats to complete the task and receive the food pellet reward (325, 514, 515). 
Microglial depletion in the Cx3cr1-Dtr rats induces short-term voluntary suppression of food 
intake (Chapter 6) therefore these rats would not be motivated to receive the reward pellets, 
thus, would not learn the RAM behavioural task. Therefore, an alternative behavioural task is 
required to examine spatial memory in the microglial depleted rats. The Morris water maze 
(MWM) tests the rat’s capacity to remember spatial cues to locate a hidden underwater 
platform (516). This behavioural task overcomes the food deprivation/ reward limitation 
therefore is an ideal behavioural task to examine spatial memory (516). The MWM is a 
valuable tool to study short-term but not long-term spatial memory. Rats commonly display 
good probe retention when tested within 10 min of a one day training protocol, however, 
retention is diminished when the probe session is extended to 4 hrs or more (517). Barrientos 
and colleagues have recently developed a one day MWM training protocol that the rats are 
able to quickly learn and they display robust long-term spatial memory retention extending 
from 1 to 4 days after training (518).   
 
To investigate spatial memory in our microglial depleted rats, it will be interesting in future 
experiments to use the one day MWM training protocol. Previous literature has shown 
conflicting spatial memory data after acute and chronic microglial ablation, therefore, it will 
be valuable to conduct two separate cohorts for either acute or chronic ablation. To examine 
spatial memory after microglial depletion either acute (described in Chapter 4) or chronic 
ablation (described in Chapter 5), rats would be trained in the one day MWM protocol 48 
hours- or 15 days- post-DT. As previously described by Barrientos and colleagues, the 
training protocol would include four trials in each of four sessions separated by a 2.5 hr 
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intersession interval. It would be interesting to examine both the short-term and long-term 
spatial memory in a retention probe test by examining the rats’ memory at 10 min, 1, 4 and 7 
days (when microglia have repopulated) after the training sessions. If memory impairments 
occurred, it would be valuable to examine whether the impairments were due to alterations in 
LTD. This could be achieved by administering a LTD agonist (GluN2B receptor agonist) in 
an additional cohort either before or immediately after training, as LTD has been shown to be 
specifically involved in the consolidation phase, but not the acquisition or retrieval phase, of 
long-term spatial memory (513). 
 
7.2.3. Microglial depletion may alter the parabrachial nucleus neuronal activation and 
reduce motivation to increase food intake 
We have demonstrated that elimination of microglia in the Cx3cr1-Dtr rats produces a 
dramatic and reversible suppression of weight and food intake. This acute anorexia is 
associated with increases in circulating satiety signals, such as ghrelin and leptin, as well as 
elevated hypothalamic orexigenic and reduced anorexigenic circuitry functioning (Chapter 
6). The specific mechanism by which microglial ablation modifies weight and food intake is 
still unknown. However, one hypothesis to explain this may be that microglial elimination 
alters the rats’ motivation to eat and this lack of motivation would over-ride all compensatory 
drives towards food consumption. Beyond the scope of the work presented here, preliminary 
data from our laboratory have indicated that the Cx3cr1-Dtr rats display a strong aversion to 
both saccharin and sucrose in a two-bottle preference test. Thus, we hypothesise that the 
Cx3cr1-Dtr rats may have alterations in their nausea circuitry, particularly in the pontine 
parabrachial nucleus (PBN).  
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Research into the specific neuronal circuitry that play a role in suppressing appetite and 
reward has recently been elucidated. Metabolic signals within the CNS that control  
motivation for eating and thus regulating food consumption (meal-size) are required to 
maintain energy homeostasis (519). Satiety signals including the hormones cholecystokinin 
and glucagon-like peptide 1 transmit visceral signals to the neurons in the nucleus of the 
solitary tract and the PBN (520, 521). The external lateral subdivision of the PBN (lPBN) 
expresses a distinct population of neurons, calcitonin gene-related peptide (CGRP) neurons, 
which mediate appetite suppression upon activation (522-525). Ablation of hypothalamic 
agouti-related peptide (AgRP) neurons inhibits CGRP neuronal activation, thus the nausea 
circuitry is inhibited (522, 526). Campos and colleagues have reported that inhibition of 
CGRP neurons markedly increases meal size and reduces meal frequency in a compensatory 
manner, whereas activation of these neurons does not affect meal frequency but rather 
suppresses food intake and meal size (523). Thus, we hypothesise that microglial depletion in 
the Cx3cr1-Dtr rats, stimulates an increase in the number of CGRP neurons activated in the 
lPBN inducing a suppression of meal size and food intake, possibly without altering meal 
frequency. 
 
To investigate if the anorexia and lack of motivation to eat in our microglial depleted rats’ is 
due to alterations in the lPBN, it will be interesting in future experiments to perform meal 
pattern behaviour assessment, to determine whether there is a suppression of meal size 
without alterations to meal frequency. Upon microglial depletion, the rats would undergo 
meal pattern analysis and food monitoring in Biological Data Acquisition (BioDAQ) food 
intake monitoring systems to measure the episodic ad libitum feeding activity and feeding 
bouts to assess meal size and frequency. It would also be essential to assess CGRP 
immunoreactivity and neuronal activation, c-Fos, in the lPBN. This would allow us to 
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identify whether the anorexia seen in our microglial ablated rats’ is associated with an 
activation of neurons known to inhibit food intake.  
 
Interestingly, in obesity, homeostatic regulation is perturbed, with an increased motivation to 
eat resulting in sustained overeating despite normal or excessive energy storage. This 
overeating is associated with an increase in meal size and meal frequency (527-529). It is 
noteworthy that if our hypothesis is correct and depletion of microglia induces a suppression 
of meal size and food intake due to alterations in lPBN neuronal activity, we may be able to 
use our model to reverse this increased motivation to eat, to that of controls and abolish the 
obese phenotype in our early life overfed animals that we see in Chapters 2 and 3.  
 
7.3. Summary 
Based on our results, we conclude that microglia have a role in acute and long-term responses 
to overfeeding as well as have a role in acute regulation of cognition and satiety signalling. 
We see that the nutritional environment during early life is crucial in cognitive behavioural 
tasks as well as in response to an immune challenge in adulthood. The neonatally overfed rats 
display deficits in cognitive tasks, specifically being unable to recall the NOR as well as 
having deficits in spatial working memory in the RAM, which is associated with a reduced 
microglial sensitivity profile. The prevalence of childhood obesity is steadily increasing 
worldwide. Alarmingly, overweight and obese children have an increased susceptibility to 
becoming an obese adult, with a strong relationship between obesity and cognitive 
dysfunction. Our neonatal overfeeding findings are necessary to further understand the 
effects of the early life nutritional environment on the adult phenotype. This thesis also shows 
that conditional microglial ablation in Cx3cr1-Dtr rats does not impair working memory and 
repopulation of microglia transiently enhances working memory. These findings provide 
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further insight into how microglia can affect cognition and provide a tool to investigate the 
role of microglia in childhood obesity but also in cognitive dysfunction conditions associated 
an accumulation of activated microglia such as Alzheimer’s disease and stroke.   
 
We also see that microglial depletion results in anorexia and weight loss showing the 
importance of microglia in feeding and satiety, which is potentially useful for intervening in 
metabolic disorders such as obesity and anorexia nervosa. This research could be used to 
educate and inform the public on the importance of the nutritional environment during 
pregnancy and post-partum to avoid overweight and obese children, which would reduce the 
susceptibility to adult obesity and the associated cognitive disorders. Importantly, if 
microglial depletion is able to suppress food intake and reverse an obese phenotype, these 
findings have the potential to inform the development of strategies for management of 
microglial activity in obese patients, through the use of anti-inflammatories, dietary 
interventions and other therapeutic approaches.   
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Early life overfeeding impairs spatial
memory performance by reducing
microglial sensitivity to learning
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Abstract
Background: Obesity can lead to cognitive dysfunction including poor performance in memory tasks. However,
poor memory is not seen in all obese humans and takes several months to develop in animal models, indicating
the adult brain is relatively resistant to obesity’s cognitive effects. We have seen that, in the rat, overfeeding for as
little as 3 weeks in early life leads to lasting obesity and microglial priming in the hypothalamus. Here we
hypothesized that microglial hyper-sensitivity in the neonatally overfed rats extends beyond the hypothalamus into
memory-associated brain regions, resulting in cognitive deficits.
Methods: We tested this idea by manipulating Wistar rat litter sizes to suckle pups in litters of 4 (overfed) or 12
(control).
Results: Neonatally overfed rats had microgliosis in the hippocampus after only 14 days overfeeding, and this
persisted into adulthood. These changes were coupled with poor performance in radial arm maze and novel object
recognition tests relative to controls. In controls, the experience of the radial arm maze reduced cell proliferation in
the dentate gyrus and neuron numbers in the CA3. The learning task also suppressed microglial number and
density in hippocampus and retrosplenial cortex. Neonatally overfed brains had impaired sensitivity to learning,
with no neuronal or cell proliferative effects and less effective microglial suppression.
Conclusions: Thus, early life overfeeding contributes to a long-term impairment in learning and memory with a
likely role for microglia. These data may partially explain why some obese individuals display cognitive dysfunction
and some do not, i.e. the early life dietary environment is likely to have a vital long-term contribution.
Keywords: Microglia, Radial arm maze, Obesity, Neonatal overfeeding, Neurogenesis, Inflammation
Background
Obesity, now epidemic in our population, is associated
with deficits in cognitive processing, including in learn-
ing, memory, and executive function [1–5]. It has also
been linked to a greater risk of dementia and Alzhei-
mer’s disease later in life [6–8]. However, not all obese
subjects develop cognitive deficits [9, 10], and factors
that make individuals vulnerable to this complication of
obesity are largely unknown. We suggest that early life
diet may be important in programming cognitive func-
tion with obesity.
Recent studies have suggested inflammation may con-
tribute to cognitive dysfunction in some obese subjects
[11]. Systemic markers of chronic low-grade inflamma-
tion have been linked with poor cognitive ability in
obese humans [12, 13]. In rodent models, microgliosis
(microglial proliferation, accumulation, and activation
[14, 15]), astrogliosis, and elevated tumour necrosis fac-
tor (TNF)α protein are seen in the hippocampi of mice
fed a high-fat diet long term [16, 17]. These mice also
have impaired spatial memory function in behavioural
tests, with high-fat diet-fed mice taking longer to learn the
location of an escape platform in the Morris Water Maze
and recalling their training poorly in the probe trial [16,
18]. Importantly for the idea that the inflammatory and
* Correspondence: Sarah.Spencer@rmit.edu.au
School of Health and Biomedical Sciences, RMIT University, Melbourne, Vic.
3083, Australia
© 2016 De Luca et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
De Luca et al. Journal of Neuroinflammation  (2016) 13:112 
DOI 10.1186/s12974-016-0578-7
	 	
226	
	 	
 
Journal of Neuroendocrinology. 2017;29:e12540.	 wileyonlinelibrary.com/journal/jne	 	 | 	1 of 14
https://doi.org/10.1111/jne.12540
© 2017 British Society for Neuroendocrinology
 
Received:	1	June	2017  |  Revised:	22	August	2017  |  Accepted:	1	October	2017
DOI:	10.1111/jne.12540
O R I G I N A L  A R T I C L E
Neonatal overfeeding by small- litter rearing sensitises 
hippocampal microglial responses to immune challenge: 
Reversal with neonatal repeated injections of saline or 
minocycline
S. N. De Luca1 | I. Ziko1 | K. Dhuna1 | L. Sominsky1 | M. Tolcos1 | L. Stokes1,2 |  
S. J. Spencer1
1School of Health and Biomedical Sciences,  
RMIT	University,	Melbourne,	VIC,	Australia
2School	of	Pharmacy,	University	of	East	
Anglia,	Norwich	Research	Park,	Norwich,	UK
Correspondence
Sarah J. Spencer, School of Health and 
Biomedical	Sciences,	RMIT	University,	
Melbourne,	VIC,	Australia.
Email:	sarah.spencer@rmit.edu.au
Funding information
RMIT	University;	National	Health	and	Medical	
Research	Council;	Club	Melbourne;	Brain	
Foundation
Abstract
The	early-	life	period	is	extremely	vulnerable	to	programming	effects	from	the	environ-
ment, many of which persist into adulthood. We have previously demonstrated that 
adult	rats	overfed	as	neonates	have	hypothalamic	microglia	that	are	hyper-	responsive	
to an immune challenge, as well as hippocampal microglia that respond less efficiently 
to learning. We therefore hypothesised that neonatal overfeeding would alter the abil-
ity of hippocampal microglia to respond to an immune challenge with lipopolysaccha-
ride (LPS) and that concomitant minocycline, a tetracycline antibiotic that suppresses 
microglial activity, could restore these responses. We induced neonatal overfeeding 
by manipulating the litter sizes in which Wistar rat pups were raised, so the pups were 
suckled	in	litters	of	four	(neonatally	overfed)	or	12	(control-	fed).	We	then	examined	
the hippocampal microglial profiles 24 hour after an immune challenge with LPS and 
found that the neonatally overfed rats had dramatically increased microglial numbers 
in	the	hippocampus	after	immune	challenge	compared	to	control-	fed	rats.	Attempts	to	
reverse these effects with minocycline revealed repeated that neonatal injections, 
whether	with	minocycline	or	with	saline,	markedly	suppressed	microglial	number	and	
density throughout the hippocampus and abolished the difference between the groups 
in	their	responses	to	LPS.	These	data	suggest	that	neonatal	overfeeding	not	only	can	
have	lasting	effects	on	hippocampal	immune	responses,	but	also	that	neonatal	expo-
sure to a protocol of repeated injections, irrespective of treatment, has a pronounced 
long-	term	impact,	highlighting	the	importance	of	considering	these	effects	when	inter-
preting	experimental	data.
K E Y W O R D S
cytokine,	diet,	neuroimmune,	perinatal
1  | INTRODUCTION
Early-	life	 diet	 in	 children	 and	 animals	 can	 strongly	 influence	 body	
weight	long-	term.1-5	As	such,	children	and	rodents	that	overeat	or	have	
poor diet during vulnerable windows of development are at significant 
risk	of	long-	term	obesity	and	the	myriad	associated	comorbidities	that	
ensue.6	For	example,	rodents	suckled	in	small	litters,	where	they	have	
greater	access	to	their	mother’s	milk	compared	to	controls,	have	accel-
erated	growth	and	weight	gain	early	on;	this	excess	weight	and	body	
fat persists at least to young adulthood.5,7-9	In	addition	to	metabolic	
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[Abstract] The radial arm maze (RAM) is used to assess reference and working memory in rodents. 8 
This task relies on the rodent’s ability to orientate itself in the maze using extra-maze visual cues. This 9 
test can be used to investigate whether a rodent’s cognition is improved or impaired under a variety of 10 
experimental conditions. Here, we describe one way to test spatial working and reference memory. This 11 
delayed spatial win-shift (DSWS) procedure on the RAM was adapted from Packard and White (1990). 12 
The win-shift component of the test refers to the alternation of baiting, or rewarding, arms during the trial 13 
and test phase. The rodent is required to hold spatial information both within the task and across a delay 14 
to obtain the food-pellet reward (Taylor et al., 2003b). This task measures the incidence and type of 15 
memory errors made by the rodent both in the training and test phases of the learning task. A working 16 
memory error (re-entry of an arm that has been baited) can occur in both phases of the task, whilst a 17 
reference memory error (entry into an arm that has been baited during the training phase and is no 18 
longer baited) can only occur during the test phase.  19 
Keywords: Delayed spatial win-shift (DSWS), Radial arm maze (RAM), Spatial working memory, 20 
Spatial reference memory, Trial phase, Test phase 21 
 22 
[Background] The radial arm maze (RAM) can be used to examine the effects of hippocampal and 23 
prelimbic cortex (PLC) damage, ageing, as well as a variety of pharmacological agents (Wenk, 2001; 24 
Taylor et al., 2003b; Floresco et al., 1997; Vann et al., 2003). The hippocampus is widely accepted to 25 
be involved in both spatial working and reference memory. Lesions to the hippocampus in rodents have 26 
shown impairments in the ability to perform memory tasks, including the RAM, involving spatial 27 
navigation (O'Keefe and Nadel, 1978; Morris et al., 1982). The PLC region of the rat prefrontal cortex, 28 
the approximate equivalent of primate dorsolateral region of the prefrontal cortex (Groenewegen, 1988), 29 
is also involved in spatial working memory (Robbins, 1990). Taylor et al. have demonstrated that rodents 30 
with lesions to the PLC make more spatial reference and memory errors compared to controls in the 31 
delayed spatial win-shift (DSWS) procedure on the radial maze (Taylor et al., 2003b). The traditional 32 
RAM studies an animal’s explorative behaviour during the task, particularly investigating working 33 
memory (Seamans et al., 1995). The adaptation of the task to include the DSWS element is a well-34 
established procedure in the literature. This technique investigates the rats’ ability to retain spatial 35 
information both within the task and across a delay (Taylor et al., 2003b; Lapish et al., 2008; De Luca 36 
et al., 2016).  37 
 38 
 39 
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A B S T R A C T
Microglia are the primary innate immune cells in the CNS. Since their initial discovery and characterization,
decades of research have revealed their unique roles not only in maintaining immune homeostasis, but also
being indispensable to brain development and cognitive function. As such, microglia drive synaptogenesis, sy-
naptic pruning, neurogenesis and neuronal activity. Microglia-speciﬁc mutations are implicated in several
neurodevelopmental disorders, and dysregulation of microglial function is strongly linked to several pathologies,
including cognitive decline and Alzheimer’s disease. Importantly, developmental insults can lead to long-term
changes in microglial function that may compromise the ability of the adult brain to ﬁght infections and process
cognitive information. Adult lifestyle or injury can also lastingly inﬂuence microglial morphology and function.
Here we highlight key research on microglia’s role in neuronal plasticity across the lifespan.
1. Introduction
Microglia, the central nervous system (CNS)’s resident innate im-
mune cells, were ﬁrst identiﬁed in 1880 by Franz Nissl and W. Ford
Robertson. Their name was coined in the 1920s by Pio del Rio-Hortega,
who went on to describe their activation in response to brain injury and
their origin from the mesoderm (Arcuri et al., 2017).
Microglial morphology varies throughout the brain depending upon
tissue type, region, age, sex and presence or absence of immune chal-
lenge or injury (Arcuri et al., 2017). In white matter, microglia or-
ientate along ﬁber tracts and have elongated soma. In grey matter,
these cells typically have round soma and radial branching “ramiﬁed”
processes. In circumventricular regions and perivascularly, they are
relatively more compact, with fewer, shorter processes (Fig. 1). Ori-
ginally observed under static conditions, this morphology was ﬁrst
thought of as “resting” or “quiescent”, but is now accepted as a sur-
veillant state where microglia constantly sample and monitor the CNS
milieu (Davalos et al., 2005; Nimmerjahn et al., 2005). Thus, in
adulthood under non-pathological conditions, microglia are highly
motile, with the continuous expansion and retraction of long radial
processes at a rate of 1.47 μm/min, while the soma remains relatively
stationery (Davalos et al., 2005; Nimmerjahn et al., 2005).
In response to an immune challenge, pathogen, or injury, microglia
typically extend their processes towards the site of injury (Davalos
et al., 2005; Nimmerjahn et al., 2005), although, some conditions, such
as chronic stress, can lead to a hyper-ramiﬁed morphology (reviewed in
(Karperien et al., 2013)). However, static microglial morphology can be
diﬃcult to interpret and there are no strictly deﬁned categories to de-
scribe a microglial cell’s function based on its morphology (Karperien
et al., 2013). A cell with shorter fewer processes may be retracting its
processes and orientating to a stimulus or it may be re-ramifying after
recovery (Fig. 1). Indeed, functional changes are sometimes seen in
these cells in the absence of any detectable change in morphology
(reviewed in (Karperien et al., 2013)). Assessment of microglial mor-
phological changes should thus be taken in this context of variable
presentation given similar stimuli.
2. Cell origin and plasticity
Microglia develop during early prenatal life, ﬁrst appearing at ap-
proximately embryonic day (E)8 in mice and at E4.5 to 5 weeks in
humans (Ginhoux et al., 2010). Evidence supports a yolk sac origin
where microglia are derived from primitive myeloid progenitor cells
that migrate to the brain before the vasculature is robustly established
(Ginhoux et al., 2010). Initial gradual inﬁltration of microglial pro-
genitors occurs around E8-14 in mice, either through the meninges or
through the ventricle walls (Reemst et al., 2016; Swinnen et al., 2013).
In zebraﬁsh, the migratory cues for this inﬁltration derive from apop-
totic neurons and it is likely that apoptotic signals play a similar role in
mammals (Reemst et al., 2016). Later microglial migration and early
brain distribution are also likely regulated by neuronal-microglial sig-
naling through, for instance, CX3CL1/CX3CR1 interactions; the former,
c-x3-c motif ligand 1 (fractalkine), expressed by neurons and the latter,
its receptor, expressed by microglia (Paolicelli et al., 2011). From E14-
https://doi.org/10.1016/j.biocel.2017.11.012
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chronic early-life stress exposure in a sex-speciﬁc manner
K.Y. Yama, S.R. Ruigroka, I. Zikob, S.N. De Lucab, P.J. Lucassena, S.J. Spencerb,1, A. Korosia,⁎,1
a Swammerdam Institute for Life Sciences, Centre for Neuroscience, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, The Netherlands
b School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia
A R T I C L E I N F O
Keywords:
Early-life stress
Acylated and desacylated ghrelin
Leptin
Insulin
Hypothalamus
Neuropeptide Y
Agouti-related peptide
Sex diﬀerences
A B S T R A C T
Early-life stress (ES) is a risk factor for metabolic disorders (e.g. obesity) with a notoriously higher prevalence in
women compared to men. However, mechanisms underlying these eﬀects remain elusive. The development of
the hypothalamic feeding and metabolic regulatory circuits occurs mostly in the early sensitive postnatal phase
in rodents and is tightly regulated by the metabolic hormones leptin and ghrelin. We have previously demon-
strated that chronic ES reduces circulating leptin and alters adipose tissue metabolism early and later in life
similarly in both sexes. However, it is unknown whether chronic ES might also aﬀect developmental ghrelin and
insulin levels, and if it induces changes in hypothalamic feeding circuits, possibly in a sex-dependent manner. We
here show that chronic ES, in the form of exposure to limited nesting and bedding material from postnatal day
(P)2 to P9 in mice, aﬀects ghrelin levels diﬀerently, depending on the form of ghrelin (acylated vs desacylated),
on age (P9 vs P14) and on sex, while insulin levels were similarly increased in both sexes after ES at P9. Even
though ghrelin levels were more strongly aﬀected in ES-exposed females, hypothalamic neuropeptide Y (NPY)
and agouti-related peptide (AgRP) ﬁber density at P14 were similarly altered in both sexes by ES. In the
paraventricular nucleus of the hypothalamus, both NPY and AgRP ﬁber density were increased, while in the
arcuate nucleus of the hypothalamus, NPY was increased and AgRP unaltered. Additionally, the hypothalamic
mRNA expression of ghrelin’s receptor (i.e. growth hormone secretagogue receptor) was not aﬀected by ES.
Taken together, the speciﬁc alterations found in these important regulatory circuits after ES might contribute to
an altered energy balance and feeding behavior in adulthood and thereby to an increased vulnerability to de-
velop metabolic disorders.
1. Introduction
The incidence of obesity has risen dramatically over the last few
decades. A growing body of evidence suggests that the perinatal en-
vironment greatly modulates the risk of such disorders. In particular,
(pre-)clinical studies suggest that not only adverse early-life nutrition,
but also exposure to other forms of early-life stress (ES), enhance the
risk of metabolic disorders in adulthood (Murphy and Loria, 2017; Yam
et al., 2017). Yet, the exact mechanisms leading to such vulnerability
are unknown.
Metabolic processes are largely regulated by the arcuate nucleus of
the hypothalamus (ARH) (Bouret and Simerly, 2006). Neurons in the
ARH co-express the orexigenic neuropeptide Y (NPY) and agouti-related
peptide (AgRP) and project to, among others, the paraventricular nu-
cleus of the hypothalamus (PVH) to exert their metabolic eﬀects. The
development of these hypothalamic circuits, occurring mainly during
the ﬁrst two postnatal weeks in rodents, is tightly controlled by leptin
originating from the adipose tissue and possibly from ingested maternal
milk during this early postnatal period (Bouret and Simerly, 2006;
Nozhenko et al., 2015; Wattez et al., 2017).
A leptin surge from approximately postnatal day (P)4 to P16 in
rodents controls the formation of hypothalamic feeding and metabolic
circuits, and disruptions of this surge alter ARH and PVH connections,
which can result in long-term changes in body weight and adiposity
(Yura et al., 2005). We have previously shown that chronic ES reduces
circulating leptin at P9 (Yam et al., 2017), suggesting that ES might
alter the hypothalamic circuits and thereby possibly contribute to the
susceptibility to metabolic disorders.
There is emerging evidence that, next to leptin, ghrelin (mainly
secreted by the stomach and possibly maternal milk), might also be
involved in regulating the neurodevelopment of hypothalamic circuits
(Nozhenko et al., 2015; Slupecka et al., 2016; Steculorum and Bouret,
http://dx.doi.org/10.1016/j.psyneuen.2017.09.006
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Neonatal overfeeding during the first weeks of life in male rats is associated with a dis-
ruption in the peripheral and central leptin systems. Neonatally overfed male rats have 
increased circulating leptin in the first 2 weeks of life, which corresponds to an increase in 
body weight compared to normally fed counterparts. These effects are associated with a 
short-term disruption in the connectivity of neuropeptide Y (NPY), agouti-related peptide 
(AgRP), and pro-opiomelanocortin (POMC) neurons within the regions of the hypothal-
amus responsible for control of energy balance and food intake. Female rats that are 
overfed during the first weeks of their life experience similar changes in circulating leptin 
levels as well as in their body weight. However, it has not yet been studied whether these 
metabolic changes are associated with the same central effects as observed in males. 
Here, we hypothesized that hyperleptinemia associated with neonatal overfeeding would 
lead to changes in central feeding circuitry in females as it does in males. We assessed 
hypothalamic NPY, AgRP, and POMC gene expression and immunoreactivity at 7, 12, 
or 14 days of age, as well as neuronal activation in response to exogenous leptin in 
neonatally overfed and control female rats. Neonatally overfed female rats were hyper-
leptinemic and were heavier than controls. However, these metabolic changes were not 
mirrored centrally by changes in hypothalamic NPY, AGRP, and POMC fiber density. 
These findings are suggestive of sex differences in the effects of neonatal overfeeding 
and of differences in the ability of the female and male central systems to respond to 
changes in the early life nutritional environment.
Keywords: hypothalamus, nutrition, leptin, sex, satiety, obesity, neonatal
INTRODUCTION
Early life obesity is associated with increased risk of developing diabetes, cardiovascular complica-
tions and, consequently, increased rates of premature death (1, 2). Clinical studies have shown an 
association between the nutritional environment during early life and obesity, and obesity-related 
comorbidities, in adulthood (3). Similarly, in a neonatally overfed animal model representative of 
childhood obesity, both male and female rat pups raised in small litters, with greater access to their 
mothers’ milk, experience significantly increased body weight, accompanied by obesity-related 
comorbidities in adulthood compared to pups raised in normal litters. These comorbidities include 
hypothalamic–pituitary–adrenal (HPA) axis dysfunction, impaired reproductive function, memory 
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Effects of Exercise on Adolescent and Adult Hypothalamic and
Hippocampal Neuroinflammation
Alita Soch,1 Steven Bradburn,2 Luba Sominsky,1 Simone N. De Luca,1
Christopher Murgatroyd,2 and Sarah J. Spencer1*
ABSTRACT: Adolescence is a period of significant brain plasticity that
can be affected by environmental factors, including the degree of physi-
cal activity. Here we hypothesized that adolescent rats would be more
sensitive to the beneficial metabolic and anti-inflammatory effects of vol-
untary exercise than adult rats, whose more mature brains have less
capacity for plasticity. We tested this by giving adolescent and adult Wis-
tar rats four weeks’ voluntary access to running wheels. At the end of
this period we assessed metabolic effects, including weight and circulat-
ing leptin and ghrelin, as well as performance in a novel object recogni-
tion test of memory and central changes in neuronal proliferation,
survival, synaptic density, and inflammatory markers in hippocampus.
We found exercise reduced fat mass and circulating leptin levels in both
adults and adolescents but suppressed total weight gain and lean mass in
adults only. Exercise stimulated neuronal proliferation in the suprapyra-
midal blade of the dentate gyrus in both adults and adolescents without
altering the number of mature neurons during this time frame. Exercise
also increased dentate microglial numbers in adolescents alone and
microglial numbers in this region were inversely correlated with perfor-
mance in the novel object recognition test. Together these data suggest
that adolescent hippocampal microglia are more sensitive to the effects
of exercise than those of adults, but this leads to no apparent improve-
ment in recognition memory. VC 2016 Wiley Periodicals, Inc.
KEY WORDS: inflammation; metabolism; Iba-1; novel object; feeding
INTRODUCTION
Regular exercise has clear beneficial effects on an array of physiological
functions, including maintaining healthy heart rate, blood pressure,
metabolism, and body weight (Ryan and Nolan, 2015), lowering the risk
of high cholesterol, hypertension and heart attack (Stults-Kolehmainen,
2013). Recently, exercise has also been identified as having significant
positive effects on the brain, including to increase hip-
pocampal neurogenesis and improve cognition, while
suppressing the neuroinflammation that can be detri-
mental to both (Ryan and Nolan, 2015). For instance,
in mice, voluntary wheel running stimulates dentate
gyrus neuronal proliferation and survival and improves
spatial memory and learning (van Praag et al., 1999;
van Praag et al., 1999). In humans, exercise programs
lead to improved blood flow to the hippocampus and
better declarative memory compared with nonexercis-
ing controls (Pereira et al., 2007).
While exercise at any phase of life is likely to be bene-
ficial, there are particular stages when an individual may
be especially sensitive to its effects. The in utero period,
when the brain and peripheral organs are undergoing
substantial development, is one critical window of sensi-
tivity. The period around puberty is a second, although
currently less well investigated, window. During puberty,
hormonal changes stimulate significant neuronal plastic-
ity and brain development (Romeo and McEwen, 2006;
Sisk and Zehr, 2005). The adolescent human and
rodent brain is particularly sensitive to environmental
factors that may influence these hormonal changes
(Andersen, 2003; Dahl, 2004; Romeo and McEwen,
2006; Spear, 2000). Adolescents are more sensitive to
the detrimental effects of alcohol than adults (Broad-
water and Spear, 2013a,b; Broadwater, Liu, Crews and
Spear, 2014; Broadwater and Spear, 2014; Vetreno
et al., 2014). They have different molecular strategies
for responding to hippocampal injury (McPherson
et al., 2011). They are highly sensitive to the long-term
effects of stress (Chaby et al., 2015; Wong and Marine-
lli, 2016), and, if maintained on a high fat diet, they
have exacerbated emotional memory of negative events,
while adults do not (Boitard et al., 2015). Encouraging-
ly, it has also recently been demonstrated that exercise
during adolescence can have a lasting positive effect.
Thus, four weeks of voluntary exercise in the rat
improved memory retention in the novel object recogni-
tion task so that the exercised but not the adolescent
sedentary rats retained recognition memory when tested
two weeks after the first phase of the study. Adults
showed no such learning and memory improvement
with the same exercise protocol (Hopkins et al., 2011).
At least part of this effect may be due to exercise miti-
gating the brain’s neuroinflammatory profile (Ryan and
Nolan, 2015). Thus, even very mild exercise in aged
1 School of Health and Biomedical Sciences, RMIT University,
Melbourne, Vic, Australia; 2Centre for Healthcare Science Research,
School of Healthcare Science, Manchester Metropolitan University,
Manchester, United Kingdom
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Neonatal obesity predisposes individuals to obesity throughout life. In rats, neonatal
overfeeding also leads to early accelerated weight gain that persists into adulthood. The
phenotype is associated with dysfunction in a number of systems including paraventricular
nucleus of the hypothalamus (PVN) responses to psychological and immune stressors.
However, in many cases weight gain in neonatally overfed rats stabilizes in early adulthood
so the animal does not become more obese as it ages. Here we examined if neonatal
overfeeding by suckling rats in small litters predisposes them to exacerbated metabolic
and central inflammatory disturbances if they are also given a high fat diet in later
life. In adulthood we gave the rats normal chow, 3 days, or 3 weeks high fat diet
(45% kcal from fat) and measured peripheral indices of metabolic disturbance. We also
investigated hypothalamic microglial changes, as an index of central inflammation, as well
as PVN responses to lipopolysaccharide (LPS). Surprisingly, neonatal overfeeding did not
predispose rats to the metabolic effects of a high fat diet. Weight changes and glucose
metabolism were unaffected by the early life experience. However, short term (3 day)
high fat diet was associated with more microglia in the hypothalamus and a markedly
exacerbated PVN response to LPS in control rats; effects not seen in the neonatally
overfed. Our findings indicate neonatally overfed animals are not more susceptible to the
adverse metabolic effects of a short-term high fat diet but may be less able to respond to
the central effects.
Keywords: inflammation, microglia, neonatal, obesity, paraventricular nucleus of the hypothalamus (PVN)
INTRODUCTION
The developmental origins of health and disease hypothesis sug-
gests the early life period is one of significant vulnerability to pro-
gramming of physiology by environmental influences (Forsdahl,
1977; Barker and Osmond, 1986; Wadhwa et al., 2009; Spencer,
2012). In particular, early life nutrition is important in program-
ming the development of central and peripheral mechanisms
regulating feeding and metabolism, and subsequent susceptibility
to overweight or obesity (Spencer, 2012, 2013a,b). As such, peri-
natal overfeeding has major short- and long-term physiological
consequences [e.g., reviewed in (Spencer, 2012, 2013a; Habbout
et al., 2013)].
We, and others, have reported neonatal overfeeding in a rodent
model leads to accelerated weight gain in early life that per-
sists long-term and is linked with immune and hypothalamic-
pituitary-adrenal (HPA) axis dysfunction (Plagemann et al., 1992;
Boullu-Ciocca et al., 2005; Spencer and Tilbrook, 2009; Clarke
et al., 2012; Smith and Spencer, 2012; Stefanidis and Spencer,
2012). These findings parallel those of human studies where
childhood obesity significantly increases the risk an individual
will become an obese adult (Whitaker et al., 1997; Stettler et al.,
2005; Biro and Wien, 2010). Obese children are also more likely
to suffer from immune and HPA axis disturbances as they grow
up (Reeves et al., 2008; Lee, 2009; Brune and Hochberg, 2013).
Although there are clear effects of early life nutrition on later
susceptibility to overweight/obesity and its pathophysiological
sequelae, it is also clear not all overweight children become obese
adults (Potter and Ulijaszek, 2013). Similarly, several studies of
neonatal overfeeding in rodents have shown that long-term exac-
erbated weight gain is mild and the animals do not always exhibit
hyperphagia or indices of diabetes. For instance, while some stud-
ies have demonstrated being suckled in small litters leads to
increased food intake in adulthood (Oscai and McGarr, 1978;
Rodrigues et al., 2007, 2009), this tends to normalize when cor-
rected for overall body weight (Mozes et al., 2004; Xiao et al.,
2007; Stefanidis and Spencer, 2012). Studies also differ in their
reporting of whether neonatal overfeeding influences glucose uti-
lization (Plagemann et al., 1999; Xiao et al., 2007). Although some
neonatally overfed cohorts show insensitivity to a glucose load
in a glucose tolerance test (GTT), differences in glucose uptake
into adipocytes, and differences in insulin signaling (Plagemann
et al., 1999; Boullu-Ciocca et al., 2005; Rodrigues et al., 2007),
indicating a pre-diabetic phenotype, we have seen only mild
changes in metabolic parameters (Stefanidis and Spencer, 2012).
In this regard neonatal overfeeding appears to result in a mod-
erate predisposition to excessive weight gain, with some indica-
tions of diabetic symptoms and significant, but mild, metabolic
impairment.
www.frontiersin.org January 2015 | Volume 8 | Article 446 | 1
	 	
233	
	 	
 
 
 
Named Series: Diet, Inflammation and the Brain
Neonatal overfeeding alters hypothalamic microglial profiles and central
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a b s t r a c t
The early life period is one of significant vulnerability to programming effects from the environment.
Given the sensitivity of microglial cells to early life programming and to adult diet, we hypothesized
overfeeding during the neonatal period would acutely alter microglial profiles within the developing
brain, predisposing the individual to a lasting central pro-inflammatory profile that contributes to
overactive immune responses long-term. We tested this idea by manipulating litter sizes in which Wistar
rat pups were raised, so the pups were suckled in litters of 4 (neonatally overfed) or 12 (control). This
manipulation induces obesity and susceptibility to lipopolysaccharide (LPS) long-term. We then exam-
ined microglial and central pro-inflammatory profiles during development and in adulthood as well as
susceptibility to neuroimmune challenge with LPS. Neonatally overfed rats have evidence of microgliosis
in the paraventricular nucleus of the hypothalamus (PVN) as early as postnatal day 14. They also show
changes in hypothalamic gene expression at this time, with suppressed hypothalamic interleukin 1b
mRNA. These effects persist into adulthood, with basal PVN microgliosis and increased hypothalamic
toll-like receptor 4, nuclear factor jB, and interleukin 6 gene expression. These neonatally overfed rats
also have dramatically exacerbated microglial activation in the PVN 24 h after an adult LPS challenge,
coupled with changes in inflammatory gene expression. Thus, it appears neonatal overfeeding sensitizes
PVN microglia, contributing to a basal pro-inflammatory profile and an altered response to a neuroim-
mune challenge throughout life. It remains to be seen if these effects can be reversed with early
interventions.
! 2014 Elsevier Inc. All rights reserved.
1. Introduction
Obesity is characterized by a chronic low-grade inflammation
that contributes to peripheral and central insulin resistance and
the development of type two diabetes and diabetic comorbidities
(Gregor and Hotamisligil, 2011). At the level of the hypothalamus,
this inflammation can lead to a disruption of the pathways regulat-
ing feeding and metabolism, and a resistance to satiety signaling
from leptin and insulin (De Souza et al., 2005; Posey et al., 2009;
Thaler and Schwartz, 2010). Recent work suggests adult obesity
and even high fat diet-feeding pre-obesity leads to microgliosis
in feeding-regulatory brain regions such as the arcuate nucleus of
the hypothalamus (ARC) and to neuronal injury, particularly in the
anorexigenic pro-opiomelanocortin (POMC) neuronal populations
(Thaler et al., 2012). This type of disruption to feeding and metab-
olism leads to a further exacerbation of the proximal causes of
obesity; excessive high fat food intake and storage of energy as
fat (Gregor and Hotamisligil, 2011; Miller and Spencer, 2014).
Although hypothalamic inflammation can be influenced by diet
at any stage of life (Thaler et al., 2012; Yi et al., 2012), the early life
nutritional environment is likely to be particularly important
because of its potential to influence how central immune cells
mature. Glial cells undergo a characteristic pattern of development
in early life (Cuadros and Navascues, 1998). In the rodent, microg-
lia progress from an ‘activated’ amoeboid morphology at birth to a
quiescent morphology characterized by a small cell body and long
thin processes. This morphology is evident in some brain regions
by around postnatal day (P)4 but continues to appear throughout
the juvenile and adolescent periods (Cuadros and Navascues,
1998; Bilbo and Schwarz, 2009). Early life environmental influ-
ences that disrupt this pattern of maturation can have lasting
effects on central immune function by encouraging the microglia
http://dx.doi.org/10.1016/j.bbi.2014.06.014
0889-1591/! 2014 Elsevier Inc. All rights reserved.
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I am pleased to advise that this project has been approved by the RMIT University Animal Ethics 
Committee (AEC) for the period from 24 June 2014 until 23 June 2017. An approved version of the 
application is attached.  
 
Animals 
Your application has been approved to use up to n=236 Wistar rats (dams + litters, as outlined in 
your application) over the duration of the project. 
 
The use of animals in scientific procedures is strictly regulated by the Australian code of practice for the 
care and use of animals for scientific purposes. The above project is conducted under a Scientific 
Procedures and Premises License issued by the Bureau of Animal Welfare. 
  
Responsibilities of investigators 
1. Dr Sarah Spencer 
2. Ms Simone De Luca 
3. Mr William Guohui Cai 
4. Dr Trisha Jenkins 
5. Mr Jason Nguyen 
6. Dr Luba Sominsky 
 
Responsibilities of investigators are described in the Australian code of practice for the care and use of 
animals for scientific purposes (section 3). Investigators have a ‘personal responsibility for all matters 
related to the welfare of animals they use and must act in accordance with all requirements of the code. 
This responsibility begins when an animal is allocated to a project and ends with its fate at the 
completion of the project’ (s.3.1.1). 
 
Amendments and extensions 
If you find reason to amend your research method you should advise the AEC and prepare a request for 
minor amendment form. Please note that the AEC may only deal with ‘minor’ amendment requests. 
Major amendments to projects normally require a new project application. 
 
Adverse events or unexpected outcomes 
As the primary investigator you have a significant responsibility to monitor the research and to take 
prompt steps to deal with any unexpected outcomes. You must notify the AEC immediately of any 
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GPO Box 2476V 
Melbourne VIC 3001 
Australia 
 
Tel. +61 3 9925 2251 
Fax +61 3 9925 6599 
 
 
24 June 2014 
 
 
 
Dr Sarah Spencer 
School of Health Sciences 
RMIT University 
 
 
 
 
 
Dear Sarah, 
 
AEC 1407: Targeting central inflammation to treat obesity and obesity-related disease. 
 
 
I am pleased to advise that this project has been approved by the RMIT University Animal Ethics 
Committee (AEC) for the period from 24 June 2014 until 23 June 2017. An approved version of the 
application is attached.  
 
Animals 
Your application has been approved to use up to n=992 Wistar rats (adults, dams & litters, as 
outlined in your application) over the duration of the project. 
 
The use of animals in scientific procedures is strictly regulated by the Australian code of practice for the 
care and use of animals for scientific purposes. The above project is conducted under a Scientific 
Procedures and Premises License issued by the Bureau of Animal Welfare. 
  
Responsibilities of investigators 
1. Dr Sarah Spencer 
2. Ms Simone De Luca 
3. Mr William Guohui Cai 
4. Ms Ilvana Ziko 
5. Ms Joanne Barwood 
6. Dr Luba Sominsky 
7. Dr Trisha Jenkins 
 
Responsibilities of investigators are described in the Australian code of practice for the care and use of 
animals for scientific purposes (section 3). Investigators have a ‘personal responsibility for all matters 
related to the welfare of animals they use and must act in accordance with all requirements of the code. 
This responsibility begins when an animal is allocated to a project and ends with its fate at the 
completion of the project’ (s.3.1.1). 
 
Amendments and extensions 
If you find reason to amend your research method you should advise the AEC and prepare a request for 
minor amendment form. Please note that the AEC may only deal with ‘minor’ amendment requests. 
Major amendments to projects normally require a new project application. 
 
Adverse events or unexpected outcomes 
As the primary investigator you have a significant responsibility to monitor the research and to take 
prompt steps to deal with any unexpected outcomes. You must notify the AEC immediately of any 
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Australia 
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26 June 2015 
 
 
 
Dr Sarah Spencer 
School of Health Sciences 
RMIT University 
 
 
 
 
 
Dear Sarah, 
 
AEC 1510: The role of microglia in brain cell development using CX3CR1-DTR transgenic Wistar 
rats for ablation of microglia/monocytes (immune cells). 
 
 
I am pleased to advise that this project has been approved by the RMIT University Animal Ethics 
Committee (AEC) for the period from 26 June 2015 until 25 June 2018. An approved version of the 
application is attached.  
 
Animals 
Your application has been approved to use up to n=378 rats (n=186 CX3CR1-DTR genetically 
modified and WT pregnant dams and offspring, and n=192 CX3CR1-DTR genetically modified and 
WT adults) over the duration of the project. 
 
Please note that no transgenic animals may be ordered, or used in this project unless 
appropriate approvals have been obtained from an Institutional Biosafety Committee. 
 
The use of animals in scientific procedures is strictly regulated by the Australian code for the care and 
use of animals for scientific purposes. The above project is conducted under a Scientific Procedures and 
Premises License. 
  
Responsibilities of investigators 
1. Dr Sarah Spencer 
2. Dr Luba Sominsky 
3. Mr William Guohui Cai 
4. Ms Simone De Luca 
5. Ms Ilvana Ziko 
6. Ms Joanne Barwood 
 
Responsibilities of investigators are described in the Australian code for the care and use of animals for 
scientific purposes (section 2.4). Investigators have a ‘personal responsibility for all matters that relate to 
the wellbeing of animals that they use, including their housing, husbandry and care. This responsibility 
extends throughout the period of use approved by the AEC until provisions are made for the animal at 
the conclusion of their use’ (s.2.4.1). 
 
Amendments and extensions 
If you find reason to amend your research method you should advise the AEC and prepare a request for 
minor amendment form. Please note that the AEC may only deal with ‘minor’ amendment requests. 
Major amendments to projects normally require a new project application. 
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Australia 
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Fax +61 3 9925 6599 
 
 
19 April 2016 
 
 
 
Associate Professor Sarah Spencer 
School of Health and Biomedical Sciences 
RMIT University 
 
 
 
 
 
Dear Sarah, 
 
AEC 1612: Investigating the role of immune cells (microglia) in the brain development of 
genetically modified rats - model validation. 
 
 
I am pleased to advise that this project has been approved by the RMIT University Animal Ethics 
Committee (AEC) for the period from 19 April 2016 until 19 April 2019. An approved version of the 
application is attached.  
 
Animals 
Your application has been approved to use up to n=126 rats (CX3CR1-DTR transgenic and wild type 
rats) over the duration of the project. 
 
Please note that no genetically modified animals may be ordered, or used in this project unless 
appropriate approvals have been obtained from an Institutional Biosafety Committee. 
 
The use of animals in scientific procedures is strictly regulated by the Australian code for the care and 
use of animals for scientific purposes. The above project is conducted under a Scientific Procedures and 
Premises License. 
  
Responsibilities of investigators 
1. Associate Professor Sarah Spencer 
2. Dr Luba Sominsky 
3. Ms Simone De Luca 
4. Ms Ilvana Ziko 
5. Mr William Guohui Cai 
 
 
Responsibilities of investigators are described in the Australian code for the care and use of animals for 
scientific purposes (section 2.4). Investigators have a ‘personal responsibility for all matters that relate to 
the wellbeing of animals that they use, including their housing, husbandry and care. This responsibility 
extends throughout the period of use approved by the AEC until provisions are made for the animal at 
the conclusion of their use’ (s.2.4.1). 
 
Amendments and extensions 
If you find reason to amend your research method you should advise the AEC and prepare a request for 
minor amendment form. Please note that the AEC may only deal with ‘minor’ amendment requests. 
Major amendments to projects normally require a new project application. 
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26 August 2016 
 
 
 
Associate Professor Sarah Spencer 
School of Health and Biomedical Sciences 
RMIT University 
 
 
 
 
 
Dear Sarah, 
 
AEC 1621: Investigating the role of immune cells (microglia) in feeding and behaviour in a 
genetically modified Wistar rat. 
 
 
I am pleased to advise that this project has been approved by the RMIT University Animal Ethics 
Committee (AEC) for the period from 26 August 2016 until 26 August 2019. An approved version of the 
application is attached.  
 
Animals 
Your application has been approved to use up to n=180 rats (Wistar Han rats) and n=180 rats 
(CX3CR1-DTR transgenic rats*) over the duration of the project. 
 
*Please note that no genetically modified animals may be ordered, or used in this project unless 
appropriate approvals have been obtained from an Institutional Biosafety Committee. 
 
The use of animals in scientific procedures is strictly regulated by the Australian code for the care and 
use of animals for scientific purposes. The above project is conducted under a Scientific Procedures and 
Premises License. 
  
Responsibilities of investigators 
1. Associate Professor Sarah Spencer 
2. Dr Luba Sominsky 
3. Ms Simone De Luca 
4. Ms Ilvana Ziko 
5. Mr William Guohui Cai 
6. Mr Alita Soch 
7. Dr Stanley Chan 
 
Responsibilities of investigators are described in the Australian code for the care and use of animals for 
scientific purposes (section 2.4). Investigators have a ‘personal responsibility for all matters that relate to 
the wellbeing of animals that they use, including their housing, husbandry and care. This responsibility 
extends throughout the period of use approved by the AEC until provisions are made for the animal at 
the conclusion of their use’ (s.2.4.1). 
 
Amendments and extensions 
If you find reason to amend your research method you should advise the AEC and prepare a request for 
minor amendment form. Please note that the AEC may only deal with ‘minor’ amendment requests. 
Major amendments to projects normally require a new project application. 
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12 April 2017 
 
 
 
Associate Professor Sarah Spencer 
School of Health and Biomedical Sciences 
RMIT University 
 
 
 
 
 
Dear Sarah, 
 
AEC 1708: Investigating the role of immune cells (microglia) in feeding and in the development of 
obesity in a genetically modified Wistar rat. 
 
 
I am pleased to advise that this project has been approved by the RMIT University Animal Ethics 
Committee (AEC) for the period from 1 May 2017 until 1 May 2020. An approved version of the 
application is attached.  
 
Animals 
Your application has been approved to use up to n=60 rats (Wistar Han rats) and n=60 rats (CX3CR1-
DTR transgenic rats*) over the duration of the project. 
 
*Please note that no genetically modified animals may be ordered, or used in this project unless 
appropriate approvals have been obtained from an Institutional Biosafety Committee. 
 
The use of animals in scientific procedures is strictly regulated by the Australian code for the care and 
use of animals for scientific purposes. The above project is conducted under a Scientific Procedures and 
Premises License. 
  
Responsibilities of investigators 
1. Associate Professor Sarah Spencer 
2. Dr Luba Sominsky 
3. Ms Simone De Luca 
4. Ms Ilvana Ziko 
5. Mr Alita Soch 
 
Responsibilities of investigators are described in the Australian code for the care and use of animals for 
scientific purposes (section 2.4). Investigators have a ‘personal responsibility for all matters that relate to 
the wellbeing of animals that they use, including their housing, husbandry and care. This responsibility 
extends throughout the period of use approved by the AEC until provisions are made for the animal at 
the conclusion of their use’ (s.2.4.1). 
 
Amendments and extensions 
If you find reason to amend your research method you should advise the AEC and prepare a request for 
minor amendment form. Please note that the AEC may only deal with ‘minor’ amendment requests. 
Major amendments to projects normally require a new project application. 
 
 
 
